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QUILL ON SCALPEL
This section provides a medium through which Canadian 
surgeons can declare themselves, briefly and informally, on 
the day-to-day affairs of surgery.
In spite of the introduction and progres­
sive refinement of chemotherapy over the 
past 40 years, tuberculosis continues to 
present a problem, particularly in large 
American and Canadian cities. The 
Center for Disease Control of the United 
States Public Health Service predicts that 
tuberculosis will not be eradicated before 
the year 2100 and draws attention to the 
large number of infected individuals, 
identified only by a positive skin test, 
who carry a lifelong risk of tuberculous 
breakdown.1 Emigration of people from 
countries of high prevalence is undoubt­
edly partly responsible for persistence of 
the disease, but another factor is the loss 
of interest on the part of both government 
and private health-care agencies.
The classic picture of tuberculosis with 
fever, night sweats and wasting is now 
less often seen, and the disease frequently 
presents in an insidious fashion. The
skin test may be negative and the 
sedimentation rate normal. Other features 
of “ modern” tuberculosis are the occur­
rence in older age groups of manifesta­
tions usually seen in the young, such as 
pleurisy and meningitis, and an increas­
ing proportion of extrapulmonary forms.2 
Because it may be confused with other 
entities, patients with the disease are often 
referred to the surgeon. In this issue of 
the Journal, two unusual examples of 
extrapulmonary tuberculosis involving 
the liver are presented, by Mustard and 
associates (pages 449 and 450) and Gal- 
linger and associates (pages 451 and 452).
Hepatic granulomas are frequently 
found, not only in miliary tuberculosis 
but also in localized pulmonary and 
extrapulmonary forms of the disease.3 
Nevertheless, the liver does not appear to 
provide a favourable environment for the 
tubercle bacillus. Klatskin3 has shown
that caseation is rare in these granulomas 
and it is difficult to demonstrate the 
bacilli. In general, liver involvement is 
asymptomatic and unassociated with 
functional abnormalities. Single or mul­
tiple macronodular forms, with symp­
toms suggestive of liver disease, such as 
those described in this issue, are rare,4 
but it is possible that more such lesions 
might be demonstrated with the newer 
imaging techniques.
Most cases of tuberculosis can be 
managed with chemotherapy alone, and 
the role of surgery has become limited. 
Short-course regimens, using combina­
tions of all the major agents at the same 
time, are popular. The possibility that 
drugs may fail to penetrate some tuber­
culous foci, such as an abscess in the 
spine, or a necrotic lesion in the lung, has 
been discounted.5,6 However, the 
experience of Mustard and associates, in
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which a tuberculous abscess in the liver 
became a problem after months of 
chemotherapy, suggests limited access of 
drugs to some lesions. In other forms of 
tuberculosis, including tuberculous lym­
phadenitis and intracranial tuberculomas, 
the development of new lesions or the 
enlargement of previous foci have been 
reported during chemotherapy.7,8 It has 
been suggested that the progression of dis­
ease in these instances is due simply to an 
immune reaction to tuberculoprotein.9 
However, the immune response occurs in 
all tuberculous lesions, and such a delay 
in healing is rarely seen in pulmonary 
tuberculosis. It is possible that such fac­
tors as the local vascular supply, extent 
of fibrosis or the simple bulk of an 
abscess10 are also involved in the 
response to therapy. A satisfactory result 
may eventually be obtained by persisting 
with chemotherapy, and in such cases 
short-course regimens seem inappropri­
ate. If surgical drainage is required, the 
percutaneous method described by
Mustard and coworkers is an attractive 
option for visceral lesions and for psoas 
abscesses.
The bottom line is that tuberculosis has 
not disappeared and is still seen in our 
hospitals. There are sometimes frequent 
delays in diagnosis, exposing the attend­
ing staff to the risk of infection, and the 
disease may, unfortunately, only be dis­
covered at autopsy. It may be impracti­
cal to carry out routine admission chest 
roentgenography and to do routine spu­
tum cultures for acid-fast bacilli in, for 
example, productive patients in intensive 
care units, but at the very least the possi­
bility of the disease should still be kept 
in mind.
Leo  M . Ka h a n a , m d , m s c , frcpc
Associate clinical professor of medicine, 
McMaster University,
Ste. 604,
25 Charlton Ave. E,
Hamilton, Ont.
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A Vascular Surgeon’s Dilemma
The article by Gagnon and colleagues in 
this issue of the Journal (pages 411 to 418) 
is of considerable interest to vascular sur­
geons. This group led by Dr. Guidoin at 
Laval University are known for their 
studies on vascular grafts and their 
interest in both the mechanical properties 
and the morphologic features of these 
grafts. They have developed a number of 
different techniques to assess the mechan­
ical properties of a graft, and they use 
vascular endoscopy, light microscopy, 
scanning and transmission electron 
microscopy to assess the morphologic fea­
tures. They, and others, have introduced 
a new set of criteria by which grafts 
should be evaluated. They have also 
introduced new terms into the vascular 
surgical literature, some of which may be 
poorly understood by vascular surgeons; 
they include such terms as dynamic com­
pliance, stress-strain tests and Young’s 
modulus.
From an analysis of the data reported 
in this study, a surgeon would have to be 
venturesome to use an umbilical vein 
graft. The authors demonstrated large 
variations in linear density between differ­
ent grafts and between different samples 
of the same graft. They pointed out that 
41% of the specimens presented irregular­
ities of wall thickness. Furthermore, 16%
of the specimens had a “ very thin wall” . 
The authors noted that the Dacron mesh 
had been knitted in a very open construc­
tion that easily stretched. Nearly all 37 
specimens had two longitudinal folds on 
the flow surface, running the full length 
of the graft. In 22% of the cases the lon­
gitudinal folds were deep. In 27% of cases 
the intimal surface had multiple trans­
verse folds and in some the intima looked 
crumpled. Furthermore, the pathological 
studies showed frequent ruptures of the 
basement membrane and 19% of the 
grafts showed intimal breakdown. Some 
of the authors’ specimens had their flow 
surfaces exposed to blood before harvest­
ing and even after such a short exposure 
thrombotic debris was detected on the 
flow surface. Furthermore, in terms of 
mechanical properties it appeared that the 
graft did not perform well. These studies 
were carried out on only short segments 
left over after the main segment of graft 
was implanted. Since there is such great 
variability between different segments of 
graft it would seem likely that every graft 
had a multitude of unsatisfactory charac­
teristics.
One must balance these findings with 
the experience reported in the literature 
using the human umbilical vein graft. 
Hirsch and Jarrett,1 Cranley and Haf-
ner,2 Eickhoff and colleagues3 and 
Dardick and associates4 have all demon­
strated that many of these grafts function 
well in patients for reasonable periods. 
Hirsch and Jarrett1 reported a 73.5% 
patency rate at 1 year and 54.5% at 5 
years. Furthermore, there were only two 
instances of aneurysm formation and two 
cases of graft infection which occurred 
after re-exploration for graft occlusion or 
bleeding. Cranley and Hafner2 compared 
saphenous vein, polytetrafluoroethylene 
(PTFE) and human umbilical vein grafts 
for revascularization of the femoro- 
popliteal arteries and concluded that the 
umbilical vein graft is acceptable when the 
saphenous vein is not available. Only two 
aneurysms were detected in 247 such 
grafts and only one was large. Eickhoff 
and associates,4 in a randomized clinical 
trial, concluded that the umbilical vein 
graft was better than the PTFE — the 
1-year patency rate was 75% compared 
with 40% in the PTFE group. Dardik and 
colleagues5 reported seven aneurysms in 
a series of 756 human umbilical vein 
grafts, the average time of occurrence 
being 5 years after implantation.
What, then, is the relevance of the 
study reported by Gagnon and associates 
to the practising vascular surgeon faced 
with a threatened limb in a patient whose
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saphenous vein is not available for graft­
ing? Alternative materials to the 
saphenous vein are limited and it appears 
that, under such conditions, the human 
umbilical vein graft is a reasonable 
choice. As Dardik and colleagues5 
pointed out, although aneurysm forma­
tion in human umbilical vein grafts has 
a low incidence it is still a concern. They 
recommended that periodic angiography, 
particularly 3 to 4 years after implanta­
tion, should be a routine part of the 
follow-up. Furthermore, the manufac­
turer of the Dardik Biograft (the biograft 
used in Gagnon’s study) has made several 
modifications, resulting in more uniform 
wall thickness and a much stronger and 
denser Dacron mesh.
Additional studies of the type carried 
out by Guidoin’s group are important in
the evaluation of graft materials, as are 
carefully performed studies in animals 
and careful analysis o f all human data. 
The authors have established an informa­
tion retrieval program to determine the 
fate of their grafts, and they plan to relate 
the clinical performance of the graft to 
the pre-im plant m orphologic and 
mechanical properties. This is essential. 
It would be extremely helpful if the 
manufacturer of the graft maintained a 
similar registry.
N.M. Sheiner, md, frcsc
Surgeon-in-chief,
Chief of cardiovascular and 
thoracic surgery,
Sir Mortimer B. Davis-Jewish General Hospital, 
3755 Cote Ste-Catherine,
Montreal, PQ 
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BOOK REVIEWS
COMPLICATIONS IN VASCULAR SUR­
GERY. 2nd ed. Victor M. Bernhard and 
Jonathan B. Towne. 983 pp. Illust. Grune 
&  Stratton, Inc., Orlando, Fla., Academic 
Press Canada, Don Mills, Ont., 1985. S130. 
ISBN 0-8089-1747-1.
This second edition of Complications in Vas­
cular Surgery is an extension of the first, which 
was based on a symposium held under the 
auspices of the Medical College of Wisconsin 
in June 1980. The purpose of this edition is to 
update the material, to keep pace with the 
many basic and technical advances that have 
occurred in the past 5 years, especially in the 
areas of diagnostic imaging, manipulation of 
the coagulation mechanism, refinements in 
noninvasive diagnostic methodologies and 
interventional radiology.
The book is divided into nine sections and 
46 chapters that analyse the etiology and 
management of complications associated with 
most vascular surgical procedures. These sec­
tions include aortoiliac and peripheral artery 
reconstruction and late problems associated 
with these procedures, renal revascularization, 
postoperative problems especially after aortic 
surgery, venous and coagulation problems, 
amputations, infections, complications of graft 
healing and cerebrovascular surgery.
There are many contributors, most of whom 
are well-recognized experts in their fields. They 
bring great personal experience and extensive 
reviews of the literature to their presentations. 
Because of the number of authors involved 
there is some unevenness in quality and for­
mat, but overall the information is well 
presented and the complications are clearly dis­
cussed. This is a complete review of the 
problems with sufficient depth to satisfy sur­
geons of varying experience, and it fills a 
needed place in the vascular literature. It will 
be a necessary addition to the library of all
practising vascular surgeons and especially to 
vascular residents who are approaching their 
examinations in vascular surgery.
T. Keith Scobie, md, frcsc
Professor and chairman,
Division of Vascular Surgery,
University of Ottawa,
Ottawa Civic Hospital,
CPC, Ste. 632,
1053 Carling Ave.,
Ottawa, Ont.
K1Y 4E9
CURRENT CONCEPTS OF INFECTIONS 
IN ORTHOPEDIC SURGERY. Edited by 
Hans K. Uhthoff and Elvira Stahl. 300 pp. 
Illust. Springer-Verlag, New York, 1985. 
S48.00 (US). ISBN 0-387-13560-X.
Uhthoff is to be complimented, not only for 
his initiative in organizing the applied basic 
science course on “ Infection in Orthopedic 
Surgery” at the University of Ottawa in 1984, 
but also for his editing of the papers in this 
book.
There is some repetition and overlap in the 
49 presentations from Europe, the United 
States and Canada. They concentrate on 
hospital-infection control (particularly in the 
operating room), early recognition of infection 
and the prophylaxis of infection by the rou­
tine use of antibiotics in joint replacement, 
open management of fractures and other 
orthopedic procedures in high-risk patients. 
Increased risk of infection is noted in patients 
with rheumatoid arthritis, diabetes, psoriasis, 
obesity and those treated with steroids.
Proof is provided of the value of hand scrub 
and skin preparation with chlorhexidine and 
alcohol and delaying shaving until the time of 
operation. Staphylococcus epidermidis is very
common on the skin and is best controlled by 
the bactericidal effect of cephalin drugs. Pen­
rose drains are shown to contribute to infec­
tion more than suction drains. Limitation of 
operating room traffic and talking is also 
shown to be important in controlling infection.
Operative infection of clean wounds should 
be less than 1%. Aminoglycosides in cement 
are appropriate and produce no noted side 
effects. Canadian surgeons will appreciate 
Papineau’s paper on open sky excision and 
bone grafting of infected bone. The importance 
of Haemophilus influenzae as a cause of sep­
tic joints in children is noteworthy. Experience 
with gentamicin beads and fibrin-antibiotic 
bone-graft complex is provided.
This volume is an excellent summary of the 
knowledge acquired in the last 25 years in the 
field and its contents make an excellent even­
ing of reading for residents and qualified sur­
geons practising orthopedic surgery.
John W. Hazlett, b sc <med), frcsc
Associate professor of surgery,
Division of Orthopedic Surgery,
Queen’s University,
Kingston, Ont.
DIAGNOSTIC IMAGING OF THE LOWER 
GENITOURINARY TRACT. Matthew D. 
Rifkin. 339 pp. Illust. Raven Press, New 
York, 1985. $49.50 (U S ). ISBN
0-88167-045-6.
The stated emphasis of this book is the male 
urinary and genital system, in particular the 
prostate and scrotal contents. Chapters on 
embryology and normal anatomy, the urinary 
bladder perivesical spaces, and the urethra and 
penis are also included. The book focuses on
continued on page 398
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SURGEONS’ UPDATE
in surgery is the subject of this column. The short items are designed to let readers know 
doing what and why. Surgeons are interested in what other surgeons are doing in 
research, education, practice and administration. Surgery is a vibrant specialty, and, as 
its practitioners, you must be the source as well as the readers of this column.
Revascularization and Reperfusion
Once billed as competing techniques — 
surgical versus medical — treatments for 
coronary artery disease have been refined 
so much since the first bypass operations 
that they now complement each other and 
can be selected according to the extent 
and location of the occlusion. So said 
specialists at one of the scientific sessions 
held during the annual meeting of the 
Canadian Medical Association in Winni­
peg in August.
B.N. Corbett, FRCPC, and S.K. Bhat- 
tacharya, FRCSC, both from the Univer­
sity of Manitoba, reviewed the data col­
lected and published over the years and, 
based on the findings, outlined criteria for 
selecting patients for percutaneous trans­
luminal angioplasty and for surgical 
bypass. Garry MacKenzie, FRCPC, of 
the Royal Jubilee Hospital in Victoria, 
BC, reviewed data on thrombolytic ther­
apy for myocardial infarction.
According to the presentations, the 
placement of mammary artery grafts to 
bypass occlusions is the most effective 
treatment for disease causing 50% or 
more occlusion of the left main coronary 
artery or for disease in three or more ves­
sels accompanied by dysfunction of the 
left ventricle. Angioplasty is preferred for 
patients who have disabling angina and 
proximal discrete, subtotal, noncalcified 
occlusions.
Contraindications to angioplasty, said 
Corbett, are stenosis greater than 95%, 
multiple-vessel disease, calcification and 
involvement of the left main vessel.
Of 157 lesions in 113 patients selected 
for angioplasty at the two hospitals 
affiliated  with the University of 
Manitoba, 137 were successfully dilated
Contributions to this column are welcome. 
Please send your material to: Mrs. Amy 
Chouinard, Canadian Journal o f Surgery, PO 
Box 8650, Ottawa, Ont. K1G 0G8.
(lumen increased more than 35% accord­
ing to angiographic evidence).
At the time, 61 patients held jobs: 14 
missed 1 to 3 days of work, 14 missed 3 
to 7 and another 29 missed 7 to 14 days’ 
work. The evidence, said Corbett, is that 
the pressure from the balloon inserted in 
the vessel compresses and cracks the 
plaque rather than destroying it, so the 
trauma to the vessels is probably less than 
originally anticipated. He reported that 
within 1.5 years just over 20% of occlu­
sions recurred at the site of removal. 
Thus, a major focus currently is to work 
out how to predict who will have recur­
rences.
Bhattacharya reviewed data in a 
cooperative study of 15 centres (14 in the 
United States and 1 in Canada), indicat­
ing that the percentage of patients dying 
during surgical revascularization varied 
from 0.3 to 6.4, according to where they 
were treated. Of the 766 patients who had 
had bypass, with grafts of either mam­
mary artery or saphenous vein, to correct 
left main coronary artery disease, 82% 
and 70% were still alive after 10 years and 
graft patency was 90% and 80% respec­
tively.
Re-establishing myocardial blood flow 
and preserving the myocardium were the 
benefits MacKenzie noted with strep­
tokinase administered intravenously 
within 3 hours of the onset of symptoms. 
Of 169 patients who had occlusions in 
either the left anterior descending or right 
coronary vessels, 70% experienced reper­
fusion when administered streptokinase. 
The in-hospital death rate was 6.2% for 
the group who experienced reperfusion 
and 12% for those who did not.
Although citing some controversy 
about whether thrombolysis actually 
minimizes damage to the myocardium, 
MacKenzie summarized four studies 
using measurements of the ejection frac­
tion as indicators of damage. He con­
cluded from them that the time of treat­
ment is critical, with streptokinase 
administered early minimizing the size of 
the infarct. The best results reported were 
in a small group of patients receiving 
streptokinase within 1.5 hours of the 
onset of symptoms.
Heart of the Matter
Research at the University of Ottawa 
Heart Institute provides partial answers 
to what mechanisms are at work after per­
cutaneous transluminal coronary artery 
balloon angioplasty and during infusions 
of streptokinase.
Reporting at the annual meeting of the 
Royal College of Physicians and Surgeons 
in September, V.M. Walley, FRCPC, and 
Gerald C. Taichman, Ph D, outlined their 
respective groups’ studies.
A pathologist, Walley presented find­
ings from autopsies of six patients who 
had died during or after angioplasty 
between 1982 and 1985 out of 594 who 
had undergone the procedure; 1 other 
patient died but had not been subjected 
to autopsy. In three of the patients, the 
balloons had been inflated in the left main 
artery as a last resort because, said Wal­
ley, “ the infarcts in these patients were 
so well established that the surgeons could 
not go in and perform a bypass” . The 
others had the balloon inserted in either 
isolated marginal or left anterior descend­
ing arteries. Serial sections of the arter­
ies revealed fracturing not only of the 
atherosclerotic plaque but also of the ves­
sel walls. Two of the patients had survived 
longer than 24 hours — one for 1 month 
and the other for 9 months — and had 
died from causes unrelated to the 
angioplasty. Their arteries showed heal­
ing of tears that had extended through the 
vessel walls to the adventitia.
Said Walley to CJS, “ We confirmed 
what has been alluded to in experimental 
settings: the balloon in the coronary 
artery does produce a considerable
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amount o f physical and mechanical 
trauma. But what is interesting is that the 
vessel seems to tolerate the severe histo­
logical disruption without major func­
tional impairment.”
Taichman presented information from 
recent work to determine whether strep­
tokinase has any pharmacologic effects 
besides its action as a thrombolytic agent. 
He and his colleagues used seven mongrel 
dogs, anesthetized them and then moni­
tored the effects o f the drug on the left 
anterior descending artery. In an inter­
view with CJS, Taichman said, “The 
overall result is that, given a whole series 
of measurements to quantitate coronary 
vasomotor activity, we found no differ­
ence in animals with and without an 
intracoronary infusion of half a million 
units o f streptokinase in 1 hour. There­
fore, the conclusion we reached was that 
streptokinase probably does not act 
directly on the coronary artery but 
relieves the thrombus, or gets rid of the 
thrombus, and thus causes reperfusion 
which increases the perfusion of the 
muscle.”
Using Lasers to Remove 
Atherosclerotic Plaque
Within a few months, the University of 
Ottawa Heart Institute will use Excimer 
lasers on patients to remove 
atherosclerotic plaque from coronary 
arteries, says a researcher who has been 
working on the technique for the last 24 
months.
BOOKS REVIEWS 
continued from  page 395 
the analysis and comparison of the newer imag­
ing techniques, namely ultrasonography, com­
puterized tomography, magnetic resonance 
imaging and nuclear techniques. Lower urinary 
tract disease, which can be evaluated by the 
newer imaging techniques, receives special 
emphasis.
There are six chapters. A short history of the 
development and progress, to the present, of 
ultrasonography, computerized tomography 
and magnetic resonance imaging begins the 
book. Chapter 2 describes the embryology and 
normal anatomy of the lower urinary tract. The 
use of the newer modalities in imaging and the 
normal and abnormal bladder and perivesical 
spaces are detailed in chapter 3. The next chap­
ter is devoted to imaging of the prostate and 
seminal vesicles and provides a detailed des­
cription of the various ultrasonographic 
approaches. Normal cross-sectional anatomy 
and evaluation of prostate and seminal vesi­
cle size are described followed by imaging in 
benign and malignant disease of the prostate. 
Prostatic biopsy techniques, including the 
ultrasonographic guidance of the biopsy nee­
dle in nonpalpable prostatic carcinoma, and 
imaging seminal vesicle disease are also 
described. Chapter 5 includes imaging tech-
Edward Farrell, MD, elaborating on 
studies reported at the Royal College 
meeting in Toronto, said to CJS: “We are 
directing our studies toward integrating 
a laser into our cardiac operating theatres 
as a tool to do coronary endarterectomies 
as opposed to the conventional technique 
that has been popularized around the 
world by Dr. Wilbert Keon and others.
“ The Excimer laser has the ability to 
remove the atherosclerotic tissue and to 
leave the normal tissue intact. This is in 
sharp contrast with its counterparts — for 
instance, carbon-dioxide and argon 
lasers.
“ What we are trying to do is generate 
an instrument that, in our hands, can be 
used to remove the blockages of coronary 
arteries in patients for whom standard 
bypass techniques are not applicable. 
Currently, about 25% of the patients in 
our institution undergo coronary endar­
terectomy because they have diffuse dis­
ease that is beyond the reach of conven­
tional bypass techniques designed for the 
treatment of discrete disease.
“ We exposed normal and athero­
sclerotic arteries to treatment by the laser; 
then we assessed healing responses and 
tissue effects o f the laser in atherosclerotic 
laboratory animals. We think we will be 
able to take this technology into clinical 
work within the next few months, when 
we are convinced that the laser can be 
used reliably without complications.”
A my Chouinard
niques in neuromuscular disorders, spinal cord 
injuries, bladder outlet obstruction, urethral 
strictures and diverticula, Peyronie’s disease, 
impotence, penile trauma and tumours. The 
final chapter outlines imaging modalities in the 
assessment of pathologic conditions of the 
scrotum and its contents. Emphasized are the 
two most important modalities — nuclear iso­
tope studies, and ultrasonography for the 
assessment of normal testes and epididymis, 
congenital testicular anomalies, testicular and 
extratesticular benign lesions. Malignant tes­
ticular lesions, testicular torsion and testicu­
lar trauma are also detailed.
Each of the chapters ends with a short sum­
mary indicating the value of each modality and 
the one of choice in the area of interest.
This book fulfils its stated objectives, focus­
ing on the newer imaging techniques and 
emphasizing the use of ultrasonography, par­
ticularly in the assessment of the prostate and 
scrotal contents. Some of the urethral 
ultrasonographic prints are dark but are 
accompanied by a diagrammatic explanation 
that will be helpful to readers uninitiated in the 
art of transrectal ultrasonography. If any criti­
cism can be levelled, it is that there is a lack 
of knowledge of the literature on urethrogra­
phy, and there are at least two misstatements
continued on page 418
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Actualites chirurgicales. Association fran?aise 
de chirurgie. 87e congres fran?ais de chirur- 
gie. 1. Chirurgie generate. Chirurgie diges­
tive. Textes publies par la Commission des 
publications sous la direction de M. 
Malafosse. 367 pp. Masson, Paris, 1986. 
Prix non mentionne, broche. ISBN 
2-225-80908-9.
Actualites chirurgicales. Association frangaise 
de chirurgie. 87e congres francais de chirur­
gie. 2. Endocrinologie chirurgicale. Chirur­
gie vasculaire. Chirurgie thoracique. 
Orthopedie. Urologie. Textes publie par la 
Commission des publications sous la direc­
tion de M. Malafosse. 284 pp. Illust. Mas­
son, Paris, 1986. Prix non mentionne, 
broche. ISBN 2-225-80909-7.
Anatomy of the Temporal Bone With Surgi­
cal Implications. Harold F. Schuknecht and 
A. Julianna Gulya. 350 pp. Illust. Lea & 
Febiger, Philadelphia, 1986. $125.00 (US). 
ISBN 0-8121-1011.
Atlas of Endourology. Kurtz Amplatz and 
Paul H. Lange..344 pp. Illust. Year Book 
Medical Publishers, Inc., Chicago, 1986. 
Price not stated. ISBN 0-8151-0160-0.
Basic Surgery. 2nd ed. Edited by John A, 
McCredie and Gerard P. Burns. Illustrated 
by Carol Donner. 656 pp. Illust. Collier 
Macmillan Canada Inc., Toronto, 1986. 
$44.95. ISBN 0-02-378750-3.
Drug Interactions in Anesthesia. 2nd ed. N. Ty 
Smith and Aldo N. Corbascio. 482 pp. 
Illust. Lea & Febiger, Philadelphia, 1986. 
$47.50 (US). ISBN 0-8121-0998-8.
Inflammatory Bowel Diseases 1986. Proceed­
ings of the Second International Sympo­
sium on Inflammatory Bowel Diseases, 
Jerusalem, Sept. 8-11, 1985. Edited by 
Daniel Rachilewitz. 330 pp. Martinus Nij- 
hoff Publishers, Dordrecht, The Nether­
lands; Kluwer Academic Publishers, Hin- 
gham, Mass., 1986. $82.50 (US). ISBN 
0-89838-796-5.
Introduction to Vascular Ultrasonography. 2nd
ed. Edited by William J. Zweibel. 503 pp. 
Illust. Grune & Stratton, Inc., Orlando, 
Fla.; Academic Press Canada, Don Mills, 
Ont., 1986. $82.75. ISBN 0-8089-1781-1.
Organ Procurement II. Proceedings of the 
Second International Congress on Organ 
Procurement October 3-5, 1985, Detroit, 
Michigan. Edited by Luis H. Toledo- 
Pereyra. 239 pp. Illust. Grune & Stratton, 
Inc., Orlando, Fla.; Academic Press 
Canada, Don Mills, Ont., 1986. $79.50. 
ISBN 0-8089-1822-2.
Pathology of the Testis and Its Adnexa. Edited 
by Aleksander Talerman and Lawrence M. 
Roth. 263 pp. Illust. Churchill Livingstone, 
Edinburgh; Academic Press Canada, Don 
Mills, O nt. 1986. $79.95. ISBN
0-443-08351-7.
Pediatric Surgical Oncology. (The Principles 
and Practice of the Pediatric Surgical 
Specialties). Edited by D.M. Hays. 292 pp. 
Illust. Grune & Stratton, Inc., Orlando, 
Fla.; Academic Press Canada, Don Mills, 
Ont., 1986. $86.50. ISBN 0-8089-1782-X.
Principles of Behavioral Neurology. (Contem­
porary Neurology Series: 26). M-Marsel 
Mesulam. 405 pp. Illust. F.A. Davis Co., 
Philadephia, 1985. $55.00. ISBN
0-8036-6151-7.
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(c lindam ycin  phosphate)
Recommendtd Applications
Action Clindamycin exerts its antibacterial effect by causing cessation of protein synthesis and also by 
causing a reduction in the rate of synthesis of nucleic acids.
Indications: Dalacin C Phosphate (clindamycin phosphate) is indicated for the treatment of infections 
where the oral route is not indicated or feasible.
Dalacin C Phosphate is indicated in the treatment of serious infections due to sensitive anaerobic 
bacteria, such as Bacteroides species, peptostreptococcus, anaerobic streptococci, Clostridium 
species and microaerophilic streptococci.
Dalacin C Phosphate is also indicated in serious infections due to sensitive Gram-positive organisms 
(staphylococci, including penicillinase-producing staphylococci, streptococci and pneumococci) when 
the patient is intolerant of, or the organism resistant to other appropriate antibiotics. 
Contraindications: The use of Dalacin C Phosphate (clindamycin phosphate) is contraindicated in 
patients previously found to be hypersensitive to this compound, the parent compound, clindamycin, or 
clindamycin palmitate. Although cross-sensitization w ith Lincocin® (lincomycin hydrochloride) has 
not been demonstrated, it is recommended that Dalacin C Phosphate not be used in patients who have 
demonstrated lincomycin sensitivity.
Until further clinical experience is obtained, Dalacin C Phosphate is not indicated in the newborn 
(infants below 30 days of age), or in pregnant women.
Warnings: Some cases of severe and persistent diarrhea have been reported during or after therapy w ith 
Dalacin C Phosphate (clindamycin phosphate). This diarrhea has been occasionally associated w ith 
blood and mucus in the stools and has at times resulted in acute colitis. When endoscopy has been 
performed, some of these cases have shown pseudomembrane formation.
If significant diarrhea occurs during therapy, this drug should be discontinued or, if necessary, 
continued only w ith close observation. Significant diarrhea occurring up to several weeks post-therapy 
should be managed as if antibiotic-associated.
If colitis is suspected, endoscopy is recommended. Mild cases showing minimal mucosal changes may 
respond to simple drug discontinuance. Moderate to severe cases, including those showing ulceration 
or pseudomembrane formation, should be managed w ith fluid, electrolyte, and protein supplementa­
tion as indicated. Corticoid retention enemas and systemic corticoids may be of help in persistent 
cases. Anticholinergics and antiperistaltic agents may worsen the condition. Other causes of colitis 
should be considered.
Studies indicate a toxin(s) produced by Clostridia (especially Clostridium difficile) may be a principal 
cause of clindamycin and other antibiotic-associated colitis. These studies also indicate that this 
toxigenic Clostridium is usually sensitive in-vitro to vancomycin. When 125 mg to 500 mg of vanco­
mycin were administered orally four times a day for 5 -1 0  or more days, there was a rapid observed 
disappearance of the toxin from faecal samples and a coincidental recovery from the diarrhea.
Is should be noted that serious relapses have occurred up to one month after apparently successful 
treatment. A relatively prolonged period of continuing observation is therefore recommended. 
Precautions: Dalacin C Phosphate (clindamycin phosphate), like any drug, should be prescribed w ith 
caution in atopic individuals.
Dalacin C Phosphate must be diluted for intravenous administration. (See Dosage and Administration) 
The use of antibiotics occasionally results in overgrowth of nonsusceptible organisms - particularly 
yeasts. Should superinfections occur, appropriate measures should be taken as indicated by the 
clinical situation.
As with all antibiotics, perform culture and sensitivity studies in conjunction with drug therapy. 
Since abnormalities of liver function tests have been noted occasionally in animals and man, periodic 
liver function tests should be performed during prolonged therapy. Blood counts should also be 
monitored during extended therapy.
Dalacin C Phosphate may be used in anuretic patients. Since the serum ha lf-life of clindamycin in 
patients with impaired hepatic function is greater than that found in normal patients, the dose of 
Dalacin C Phosphate should be appropriately decreased. Hemodialysis and peritoneal dialysis are not 
effective means of removing the compound from the blood. Periodic serum levels should be determined 
in patients with severe hepatic and renal insufficiency.
Adverse Reactions: Local.
(a) Intramuscular Injections: Of 404 patients treated w ith Dalacin C Phosphate (clindamycin phos­
phate) intramuscularly (w ith a solution containing 150 mg/mL), six (1.5%) demonstrated local 
reactions as follows: Two complained of pain at the injection site, two demonstrated induration at the 
injection site and two developed sterile abscesses.
(b) Intravenous Infusions: Of 192 patients treated w ith  Dalacin C Phosphate by intravenous infusion, 
14 (7.3%) demonstrated local reactions. Eleven patients developed superficial thrombophlebitis and 
one patient developed both superficial and deep thrombophlebitis. The majority of these cases 
developed in conjunction w ith the use of indwelling I V. catheters and it is difficu lt to know how much 
the drug contributed to the irritation. Two patients developed localized erythema, swelling and pain at 
the site of the infusion.
Systemic Side Effects: Twenty-eight patients of 596 treated with Dalacin C Phosphate (clindamycin 
phosphate) by either the intramuscular or intravenous routes developed systemic side effects as 
follows:
Number o f Patients
Rash.................................................................................................................................................................  7
U rtica ria ..........................................................................................................................................................  1
Pruritus............................................................................................................................................................  1
Fever, Leucocytosis ..................................................................................................................................  1
Nausea, w ith or without vo m itin g ..............................................................................................................  1
Diarrhea (See also under "Warnings") .....................................................................................................  4
Hypotension ................................................................................................................................................... 1
Hypertension................................................................................................................................................... 1
Shortness of Breath .................................................................................................................................. 1
Superinfection*..............................................................................................................................................  4
Cardiac arrest** ............................................................................................................................................ 1
Bad and bitter taste in m o u th ...................................................................................................................  5
* Superinfection is a complication of antibiotic therapy in general and is not necessarily a true 
side effect of clindamycin phosphate.
'* Due to underlying myocarditis in this patient.
Cllnlcil and Laboratory Findings: Patients treated during clinical trials of Dalacin C Phosphate 
(clindamycin phosphate) were followed w ith  clinical laboratory tests, including complete hematology, 
urinalysis and liver and kidney function tests. Some of these tests were abnormal in itia lly  and returned 
to normal during therapy w ith  Dalacin C Phosphate, while others were normal in itia lly  and became 
abnormal during therapy. Overall evaluation of clinical laboratory values in these patients does not 
indicate that Dalacin C Phosphate therapy has a toxic effect on the hematopoietic, hepatic or renal 
systems. Transient elevations of serum transaminases have occurred in some patients, but other liver 
function tests (alkaline phosphatase, serum bilirubin) have not shown any tendency to increase and 
there have not been clinical signs of drug-induced hepatic toxicity.
Symptoms ind Troitmont ol Owrdosaga: No cases of overdosage have been reported. No specific antidote 
is known. Doses as high as 1200 mg every six hours (4800 mg/day) by infusion for five days have been 
given without adverse effects.
DOSAGE AND ADMINISTRATION 
Adults
Intramuscular Injection: 600 mg/day in 2 equal doses.
Moderately severe infections: 600 to 1200 m g/day in 2 or 3 equal doses.
Severe infections: 1200 to 2400 mg/day in 2, 3 or 4 equal doses. Intramuscular injections of more than 
600 mg into a single site are not recommended
Intrsvimjus Administration: Dalacin C Phosphate (clindamycin phosphate) must be diluted p rio rto  I V. 
administration to a dilution of 300 mg in 50 ml of diluent (6 mg/ml) or more, and infused in not less 
than 10 minutes. Administration of more than 1200 mg in a single 1 hour infusion is not recommended. 
Dalacin C Phosphate should not be injected intravenously undiluted as a bolus.
Moderately severe infections: 900 to 1800 mg/day by continuous drip or in 2 or 3 equal doses, each 
infused over 20 minutes or longer.
Severe infections: 1800 to 2700 mg/day by continuous drip or in 3 or 4 equal doses, each infused over 
20 minutes or longer. In life-threatening infections, doses of 2700 to 4800 m g/day by continuous drip 
or in 3 or 4 equal doses each infused over 20 minutes or longer may be given.
Dilution and Infusion rates:
Dose Diluent Time
300 mg 50 ml 10 min.
600 mg 100 ml 20 min.
900 mg 150 ml 30 min.
1200 mg 200 ml 45 min.
Alternatively, drug may be administered in the form of a single rapid infusion of the first dose followed 
by continuous I V, infusion as follows:
To maintain serum Rapid Maintenance
clindamycin levels infusion rate infusion rate
Above 4 mcg/ml 10 mg/min. for 30 min. 0.75 mg/min.
Above 5 mcg/ml 15 mg/min. for 30 min. 1.00 mg/min.
Above 6 mcg/ml 20 mg/min. for 30 min. 1.25 mg/min.
Children: (Over one month of age)
Intramuscular injection: 10 to 15 m g/kg/day in 2, 3 or 4 equal doses.
Moderately severe infections: 15 to 20 m g/kg/day in 3 or 4 equal doses.
Severe infections: 20 to 30 m g/kg/day in 3 or 4 equal doses.
Intravenous Administration:
Moderately severe infections: 15 to 25 m g/kg/day by continuous drip or in 3 or 4 equal doses, each 
infused over 20 minutes or longer. In severe infections, it is recommended that children be given no less 
than 300 mg/day regardless of body weight. (D ilute Dalacin C Phosphate Sterile Solution in the same 
manner as for adults.)
Dilution and Compatibility:
4 ml (600 mg) Dalacin C Phosphate when diluted w ith  1000 ml of the following commonly used in­
fusion solutions was found to be physically compatible and demonstrated no significant change in pH 
or antimicrobial potency over a period of 24 hours:
Sodium chloride injection 
Dextrose 5% in water 
Dextrose 5% in saline 
Dextrose 5% in Ringer’s Solution
Dextrose 5% in half-strength saline plus 40 mEq potassium chloride 
Dextrose 2V;>% in Lactated Ringer’s Solution (Hartmann's Solution)
Dalacin C Phosphate was not stable when added to Dextrose 5% in water plus vitamins. Therefore it is 
not recommended that Dalacin C Phosphate be mixed w ith  any infusion solution containing B vitamins. 
Supplied:
Dalacin C Phosphate contains the following per m l of sterile solution:
Clindamycin phosphate equivalent to clindamycin base 150 mg 
Benzyl alcohol 5 mg 
Disodium edetate 0.5 mg 
Water for injection q.s.
When necessary the pH is adjusted w ith  sodium hydroxide and/or hydrochloric acid to maintain a pH 
range of 5.5 to 7.0.
Dalacin C Phosphate is available in 2 ml and 4 ml ampoules.
NOTE: Do not store below 15°C.
Product Monograph available upon request. CE 1377.1C
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HOST DEFENSE
*
Recent in-vitro research has shown that clindamycin concentrates within 
the PMN in amounts greater than are found outside of the PMN.1 The 
rates of chemotaxis, phagocytosis and killing of bacteria by PMNs are also 
enhanced by the presence of this antibiotic.2^3 These characteristics may 
help explain clindamycin’s outstanding record of clinical efficacy in both 
anaerobic and gram-positive aerobic infections.
Since host defense factors may be crucial in determining the outcome of 
an infection, selection of antibiotics based on host defense parameters 
may become a trend in infectious disease therapy.
1) Klempner MS, et al (Nov 1981) J Infect Dis 144(5)
2) Johnson JD, et al (March 1980) J Lab Clin Med 95(3)
3) Gemmell C, et al (1980) Current Chemotherapy and Infectious Disease 
(eds. J Nelson, C Grassi) Am Soc Microbiol Vol 2
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Oral Acetylsalicylic Acid Improves Patency Rates 
in Small-Vessel Anastomoses
Because p late let aggregation is the c r it i­
cal step in vascular throm bosis, th is 
study investigated the possib ility that 
ace ty lsa licy lic  acid given orally would 
im prove patency o f anastomoses in small 
arteries. Under clean conditions, in male 
Sprague-Dawley rats, the superficial 
fem oral arteries were divided and 
reanastomosed using the sleeve tech ­
nique w ith  10-0 nylon suture. F ifty-one 
rats received a fu ll laboratory diet and 
acety lsa licy lic  acid in their drinking water 
(1 .08  m g/m l), before and after operation. 
A  con tro l group o f 54 rats was matched 
fo r w e igh t, water intake and duration of 
vessel occlusion. Vessel patency was 
assessed on postoperative day 7, at 
sacrifice, by dye angiography.
In the experim ental group 7 (13 .7% ) 
anastom oses became occluded, com ­
pared w ith  20 (37.0% ) in the control 
group (x2 =  5.99, d f = 1, p <  0 .025 ). 
Serum throm boxane B2 levels in five  rats 
given acetylsa licylic acid orally (33.1 ± 
6.1 ng/m l) were s ign ifican tly  (p <
0 .001 ) lo w e r than in five contro l rats 
(86 .6  ±  49 .1  ng/ml).
The authors concluded th a t acetylsali­
cylic acid administered in the drinking 
w ater to  Sprague-Dawley rats improved
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the  patency rate of femoral artery 
anastomoses probably because of a 
reduction in platelet aggregation. Orally 
administered acetylsalicylic acid may be 
o f clinical benefit to  patients who 
undergo small-vessel anastomoses.
Comme I'agregation plaquettaire est un 
facteur critique dans la form ation des 
thromboses vasculaires, cette etude a 
voulu mesurer la possibility que I'acide 
acetylsalicylique administre par voie orale 
ameliore la permeabilite des anastomoses 
de petites arteres. Dans des conditions 
de chirurgie propre, chez des rats males 
Sprague-Dawley, les arteres femorales 
superficielles ont et£ divisees, puis rea- 
nastomos6es avec du fil de nylon 10-0 
par la methode en manchon. Cinquante- 
et-un rats ont recu de I'acide acetylsa- 
licylique dans leur eau (1.08 mg/ml) 
avant et apres I'operation, ainsi qu 'un 
regime com plet de laboratoire. Un groupe 
temoin de 54 rats a ete apparie pour le 
poids, la quantity  d'eau absorbee et la 
durye d 'occlusion des vaisseaux. La per- 
m yability vasculaire a ete evaluee au 
moment du sacrifice, 7 jours apres ('ope­
ration, par angiographie sous colorant.
Dans le groups tra ite , 7 (13 .7% ) anas­
tomoses se sont bouchees comparative- 
m ent a 20 (37 .0% ) dans le groupe 
temoin (x2 =  5.99, 1 dl, p <  0 .025 ).
Les taux de throm boxane B2 seriques 
chez cinq rats a qui on avait administre 
de I'acide acetylsalicylique par voie orale 
(33.1 ± 6 . 1  ng/ml) etaient sign ificative- 
m ent (p < 0 .0 01 ) inferieurs a ceux de 
cinq rats tem oins (86 .6  ± 49.1 ng/m l).
Les auteurs concluent que I'acide 
acetylsalicylique administre dans I'eau de 
breuvage a des rats Sprague-Dawley a 
ameliore la permSabilite des anastomoses 
d'arteres fym orales, vraisemblablement 
par une dim inution de I'agregation pla­
quettaire. L 'acide acetylsalicylique adm i­
nistre par voie orale pourrait beneficier 
cliniquement aux patients qui subissent 
une anastomose de petits vaisseaux.
Platelet aggregation has been shown by 
histologic and electron microscopic 
studies to be the critical initial step in 
anastom otic throm boses.1 In the 
m ajority  o f cases, throm bosis o f 
microvascular anastomoses is attributed 
to technical error.2 In the hands of an 
experienced microvascular surgeon, tech­
nical errors are minimized. The sleeve 
technique3 is associated with a higher 
rate o f thrombosis (16%) than a standard 
end-to-end anastomosis (4% to 6% ). We 
chose to use the sleeve technique in this 
study to demonstrate a difference in 
patency rates with and without the oral 
administration of acetylsalicylic acid 
(ASA).
Although platelet inhibitors are fre­
quently used to protect vascular 
anastomoses, there is little experimental 
evidence to support this practice. We 
believe that patency o f small-vessel 
anastomoses can be improved by inhibit­
ing platelet aggregation.
Material and Methods
Male Sprague-Dawley rats, weighing 
between 268 and 567 g, were anesthetized 
with xylazine (6.5 mg/kg) and ketamine 
(100 mg/kg) intraperitoneally. The thigh 
of each was shaved and the skin prepared 
with 7.5%  povidone-iodine detergent. 
Under clean conditions, a 4-cm longitu­
dinal incision was made in the thigh. The 
superficial femoral artery was isolated 
and stripped of its sheath for 1 cm, then 
clamped with microclamps, divided shar­
ply and reanastomosed using an operat­
ing microscope (25 X magnification). 
Before dividing the artery, 2%  xylocaine 
solution was applied to relieve vessel 
spasm. After division, the vessel ends 
were irrigated with a 1:200 solution of 
heparinized saline. With the sleeve tech­
nique of anastomosis two sutures of 10-0 
nylon were placed, one anteriorly and the 
other posteriorly. When they are tied the 
proximal end telescopes into the distal end 
o f the artery (Fig. 1).
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To assess technical proficiency a stan­
dard end-to-end anastomosis with inter­
rupted sutures (Fig. 2) was performed on 
the opposite leg in the first 76 animals.
The experimental group of 51 rats 
selected randomly by coin toss, received 
ASA in drinking water (Table I) 24 hours 
preoperatively and for 7 days postopera- 
tively, in addition to a full laboratory diet. 
The control group of 54 rats was matched 
for weight (Table II), water intake (Table 
III) and duration of vessel occlusion 
(Table IV).
Vessel patency was assessed by dye 
angiography at sacrifice (carbon dioxide 
chamber), on day 7. Through a transverse 
lower abdominal incision, the distal aorta 
was isolated and clamped below the renal 
arteries before injecting 2 ml of Wright’s 
stain. Patency was indicated by the pas­
sage of dye beyond the anastomosis.
Serum thromboxane B2 studies were 
performed on a separate group of 10 rats 
matched for weight and water intake 
(Table V). Blood was obtained by cardiac 
puncture in anesthetized rats. The sam­
ples were withdrawn into heparinized 
syringes, placed in tubes containing
FIG. 1—Placement of sutures in sleeve 
anastomosis (top) and completed anastomosis 
(bottom).
FIG. 2—Standard end-to-end anastomosis 
with interrupted sutures.
Table 1-Daily Acetylsalicylic Acid (ASA) Intake
Mean water intake, ml/rat 52.17
Average weight of rats, kg 
ASA solution* used
0.42
(325 mg ASA dissolved 
in 300 ml water [25°C]I, mg/ml 1.08
Daily ASA ingestion
mg/d 56.52
mg/kg 135.25
*1 g dissolves completely in 300 ml of water
at 25°C.
ethylenediamine tetra-acetic acid (EDTA) 
and frozen until assayed. Thromboxane 
B2 was measured by radioimmunoassay 
in a liquid scintillation counter.
The animals were handled according to 
the guidelines of The Canadian Council 
on Animal Care.4 The data were ana­
lysed using the unpaired Student’s r-test 
and x2 test.
Results
In the preliminary phases of the study, 
a standard end-to-end anastomosis with 
interrupted sutures (Fig. 2) was per­
formed to monitor for technical errors. 
Figure 3 shows the thrombosis rate versus 
the number of rats operated upon over 
time using the standard end-to-end tech­
nique. Each point on the graph represents 
the mean thrombosis rate per group of 
five rats operated upon. The graph indi­
cates that as operative experience 
increases, there is a corresponding 
decrease in thrombosis rate to a certain
level, after which the rate becomes sta­
ble. In order to minimize the contribution 
of technical error to the results, rats were 
included only after the thrombosis rate in 
both groups remained stable at less than 
10% .
With the sleeve technique (Table VI), 
7 (13.7%) anastomoses in the experimen­
tal group became occluded compared 
with 20 (37%) anastomoses in the control 
group (p < 0.025).
Serum thromboxane B2 levels (Table 
V) in five rats given ASA orally (33.1 ± 
6.1 ng/ml) were significantly (p < 0.001) 
lower than in the five control rats (86.6 
± 49.1 ng/ml).
Discussion
Platelet aggregation is the critical ini­
tial step in anastomotic thromboses. Cer­
tain metabolites of arachidonic acid play 
a key role in platelet function. In partic­
ular, thromboxane A2, the predominant 
metabolite of arachidonic acid in the
Table II—Weight of Rats
Technique No ASA ASA
End-to-end technique*
No. 46 30
Weight, g
Mean 368.7 396.9
Range 257.2 -  485.8 291.2 -  458.8
SO 51.6 47.0
Sleeve techniquet
No. 54 51
Weight, g
Mean 422.3 413.5
Range 266.5 -  568.2 291.2 -  510.7
SD 59.1 51.1
*t -  2.38, p >  0.01.
ft  = 0.80 p >  0.02.
Table III--Daily Water Consumption (ml/rat)
No ASA ASA
Water consumption In -  10) (n -  10)
Mean intake 52.2 52.2
Range 41.0 -  67.0 40.0 -  70.0
SD 7.5 8.8
t = 0.003, df -  18, p >  0.02.
Table IV-Period of Warm Ischemia
Technique No ASA ASA
End-to-end technique*
No. 46 30
Clamp time, min
Mean 37.8 24.7
Range 10 -  100 10 -  30
SD 19.4 5.7
Sleeve techniquet
No. 54 51
Clamp time, min
Mean 13.7 15.7
Range 8 - 3 0 10 -  25
SD 4.5 4.2
*t = 2.54, p >  0.01. 
tt  = 2.29, p >  0.05.
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platelet, is a potent vasoconstrictor and 
stimulates platelet aggregation. Prostacy­
clin, the principal metabolite of arachi- 
donic acid form ed in vascular 
endothelium, is also a potent vasodilator 
but inhibits platelet aggregation. There 
are three key enzymes in this pathway
FIG. 3—Thrombosis rate versus number of 
rats operated upon over time. N = 75. Each 
point equals group of five rats.
Table VI—Rate of Thrombosis Using 
Sleeve Technique
Status of No ASA ASA
anastomosis (n = 54) (n -  51)
Thrombosed 20 7
Patent 34 44
% thrombosed 37.0 13.7
X2 -  5.99, p <  C1.025.
(Fig. 4): cyclo-oxygenase, thromboxane 
synthetase and prostacyclin synthetase. 
One of the explanations for ASA’s action 
is that each of these enzymes has a differ­
ent sensitivity to inhibition by ASA, such 
that at any dose of ASA, thromboxane 
synthetase is more sensitive to inhibition 
by ASA than prostacyclin synthetase. The 
net result of ASA therapy would be a net 
production of prostacyclin over throm­
boxane, resulting in net vasodilation and 
inhibition of platelet aggregation.5
In this study, the experimental group 
of rats received 56 mg of ASA daily 
(Table I) or 135 mg/kg body weight. The 
human equivalent of this dose appears 
very large (9.45 g/d). Acetylsalicylic acid 
is relatively unstable in water, so we could 
not determine how much was actually 
absorbed. The group receiving ASA in 
their drinking water did have a signifi­
cantly lower rate of thrombosis than the 
control rats, demonstrating a definite 
benefit of the ASA. There may also be 
a large difference in reaction to ASA 
among species.
Patency was determined on postoper­
ative day 7 by angiography using a 
supravital dye technique. With this tech­
nique, we could show only those 
anastomoses that were either completely 
patent or totally occluded. Should one 
wish to determine partial occlusions, such 
techniques as radiographic angiography 
or radiolabelled microsphere flow meas­
urements could be used. Such determina­
tions would likely increase the difference 
between the two experimental groups.
From previous studies using the sleeve 
technique we know that recanalization of 
small arteries does not occur for 36 to 
48 days.3 The patency in all our 
anastomoses was studied at day 7 to 
exclude recanalization.
Although thromboxane A2 is the 
metabolite of arachidonic acid responsi­
ble for platelet aggregation and vasocon­
striction, thromboxane B2, the immedi­
ate product of thromboxane A2, is 
routinely measured. The reason for this 
is that thromboxane A2 is extremely
FIG. 4—Arachidonic acid metabolism indicates key enzymes inhibited by acetylsalicylic 
acid. PG = prostaglandin, Tx = thromboxane, HPETE = 12-hydroxyperoxy arachidonic acid, 
HETE = hydroxyarachidonic acid.
unstable with a half-life of 30 seconds 
compared with thromboxane B2 which is 
much more stable, having a half-life of 
20 minutes.6
Conclusions
We conclude from this study that in 
male Sprague-Dawley rats, orally 
administered ASA improves the patency 
of small-vessel anastomoses — probably 
through a reduction in platelet aggrega­
tion. Thromboxane B2 levels were also 
lowered. In our opinion it is also impor­
tant to administer ASA preoperatively, so 
that the inhibition of platelet aggregation 
is maximal at the time of surgery, when 
endothelial damage is also at its 
maximum.
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Fine-Needle Aspiration Cytology 
in Breast Lumps
The authors reviewed retrospectively 
368 breast lumps subjected to fine- 
needle aspiration cytology alone or to open 
biopsy as well.
Of those lumps for which the results 
of both studies were available, there 
were 39 true-positive results, 32 true­
negative, 1 false-positive and 7 false­
negative results when the definitive find­
ings of fine-needle aspiration biopsy 
were compared with the histologic fea­
tures. Also, in the 40 patients in whom 
the aspirate was suggestive of malig­
nancy or the findings were atypical, 22 
had malignant disease on open biopsy 
and 18 had benign disease.
These results are consistent with 
those reported in the literature and point 
to the importance of a positive or sug­
gestive report and the current unreliabil­
ity of a negative report.
Les auteurs font une revue retrospective 
de 368 tumeurs du sein qui ont ete sou- 
mises h une cytologie par aspiration a 
I'aiguille fine, soit seule ou accompagnee 
d'une biopsie ouverte.
Dans les cas de tumeurs pour lesquel- 
les on possede les resultats des deux 
examens, on observe 39 vrais positifs,
32 vrais negatifs, 1 faux positif et 7 
faux negatifs quand on compare les 
resultats definitifs de la biopsie par aspi­
ration h I'aiguille fine aux caracteristiques 
histologiques. De plus, chez 40 patientes 
dont la biopsie a I'aiguille indiquait la 
possibility d'un cancer ou dont les resul­
tats etaient atypiques, 22 presentaient 
un cancer a la biopsie ouverte et 18 
avaient une maladie benigne.
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Ces resultats coincident avec ceux qui 
ont ete signales dans la presse medicate 
et indiquent I'importance d'un rapport 
positif ou douteux, et le manque de fiabi- 
lite d'un rapport negatif.
Fine-needle aspiration biopsy is being 
promoted as an important step in the 
management of breast lumps. Its propo­
nents list the advantages of the technique 
as follows: it is a simple office procedure, 
leaves no scar and is psychologically 
acceptable to most patients; necessary 
equipment is minimal, the technique is 
easy to master and the result rapidly avail­
able; if confidence exists about the results, 
many open biopsies can be avoided, 
resulting in substantial savings of money 
and operating time. Dixon and asso­
ciates1 have addressed the issue with the 
following comment: “ If no technique 
other than history, physical examination 
and mammography were available in the 
diagnosis of breast lumps, it would be 
necessary to biopsy all solid lesions to 
ensure that no malignant lesions are 
missed; this approach is standard prac­
tice in many centres.”
The current literature abounds with 
reports of the high accuracy, sensitivity 
and specificity of the technique; indeed, 
more than 50 reports have appeared in the 
past 4 years.2 The results have shown 
considerable variation, with a general 
trend toward greater accuracy with 
increasing experience of both aspirator 
(usually a surgeon) and cytopathologist.
With this background, we undertook 
a review of the recent use of fine-needle 
aspiration biopsy in our hospital to 
address two questions; (a) can a positive 
result from fine-needle aspiration biopsy 
be grounds for a decision on the defini­
tive management of a breast lesion? and 
(b) can a negative result be sufficient to 
rule out the possibility of carcinoma in 
a breast mass?
Technique and Material
Fine-needle aspiration is carried out in 
the surgeon’s office. A 22-gauge needle, 
attached to a 10-ml syringe, is inserted 
into the mass which is fixed by the fingers
of the free hand. Once the needle is in the 
mass, suction is applied to the syringe. If 
fluid is encountered, it is all removed. If 
any mass remains, or if the lesion does 
not contain fluid, several passes are made 
through the mass, then suction is released 
and the needle withdrawn. Early in the 
series, the aspirate was expelled onto a 
glass slide, smeared and immediately 
fixed in 95% alcohol. More recently, to 
improve cell yield, the aspirate has been 
lavaged into a small amount of 50% alco­
hol, then filtered preparations have been 
made and stained using the Papincolaou 
technique. The slides are screened by a 
cytotechnologist and read by a pathol­
ogist.
The reporting system uses four 
categories:
• No reading — acellular or unsatis­
factory samples.
• Benign — epithelial cells with nor­
mal nuclear size and chromatin pattern.
• Malignant — a highly cellular 
aspirate with cellular dissociation, marked
FIG. 1—Positive cytologic finding from 
fine-needle aspiration biopsy showing high cel- 
lularity, cellular dissociation, irregular nuclei 
and mitosis (arrow) (Papanicolaou stain, origi­
nal magnification x 250).
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variation in nuclear size and shape, 
irregularity of the chromatin pattern and, 
rarely, a mitosis (Fig. 1).
• Other — epithelial cells that are 
atypical (variation in nuclear size but no 
significant change in chromatin pattern) 
or suggestive of malignancy (irregular 
nuclei and coarse chromatin pattern). A 
report in this category is usually accom­
panied by a recommendation for open 
biopsy.
The cytology records for the period 
Jan. 1, 1983 to Dec. 31, 1985 were 
screened and all aspirations of breast 
lumps noted. These were then used to 
screen the histology computer files to 
identify those patients who had also 
undergone open biopsy of the lesion con­
cerned.
During the study period, 368 breast 
masses were subjected to fine-needle aspi­
ration biopsy. In 135 patients open biopsy 
was subsequently performed. Of the other 
233 masses, the majority were cysts that 
disappeared after aspiration of the fluid.
Findings
This report concentrates on the 135 
masses for which data on both fine-needle 
aspiration and paraffin section were avail­
able. Of these, 71 masses were proven to 
be carcinoma on microscopic examina­
tion of the biopsy specimen and 64 
benign. Thirty-nine of the malignant 
lesions were considered malignant from 
the findings of fine-needle aspiration 
biopsy. A further 22 had been labelled 
suggestive and open biopsy recom­
mended. Seven biopsies were interpreted 
as benign but carcinoma was present at 
open biopsy and three patients with 
cancer had aspirates that were unsatisfac­
tory and categorized as “ no reading” on 
the cytology report.
Of the 64 masses that were histologi­
cally benign, 32 were also cytologically 
benign, in 18 the cytologic findings were 
atypical or suggestive of a malignant 
lesion, 1 was categorized as malignant and 
in 13 the aspiration specimens were 
unsatisfactory (Table I).
Our one false-positive result occurred 
in a 47-year-old woman who had aspira­
tion of a left breast mass. Fluid was 
obtained and there was no residual mass. 
The aspirate was sent for cytologic exami­
nation, and when it was categorized as 
malignant the patient was recalled. Clin­
ical examination revealed a small mass 
that was subjected to open biopsy. Histo­
logic examination showed marked 
epitheliosis, which some pathologists may 
have labelled atypical hyperplasia.
We initially had a second false-positive 
result in a 70-year-old woman who under­
went fine-needle aspiration of a solid 
lesion in her left breast. The cytologic 
findings were unequivocally in the malig­
nant category; however, subsequent 
biopsy showed only florid papillomato­
sis. The patient was followed up for about 
6 months, then underwent repeat open 
biopsy because of local recurrence of the 
mass. This biopsy confirmed a well- 
differentiated cancer with vascular inva­
sion, therefore we classified her result as 
a true positive.
The sensitivity of the method was 55% 
if only a positive label is considered a 
marker of malignancy; however, this rate 
increases to 86% if suggestive findings are 
included, based on the consideration that 
a suggestive finding will lead to an open 
biopsy and the correct diagnosis.
The specificity is 78% if suggestive 
findings are included with the negative 
group, but it drops to 50% if the sugges­
tive cytologic findings are included with 
the positive group.
If we look only at cases in which a 
definitive cytology report (malignant or 
benign) is made on fine-needle aspiration 
biopsy, then the sensitivity is 85% and the 
specificity is 97%.
More important to the goals of our 
study, the positive predictive value of the 
method is 97.5%, the negative predictive 
value is 82% and the accuracy 90% for 
a definitive cytology report. The false­
positive and false-negative rates were 
2.5% and 18% respectively.
Discussion
The use of fine-needle aspiration cytol­
ogy in the management of breast lesions 
was first reported by Martin and Ellis in 
1934.3 Little attention was paid to the 
technique until the 1970s when Zajicek4 
reported his use of the technique. Since 
then, it has become quite popular in 
Europe, with slower acceptance in Britain 
and North America.5
A summary of the recent literature6 
reported the following data on fine-needle 
aspiration cytology in breast lesions: 
accuracy in diagnosing malignant lesions 
77% to 96%, false-positive rate 0.1% to 
1.8%, false-negative rate 3.6% to 17%. 
Much of the variation comes from the 
method of reporting results; for example, 
some authors1'7,8 include suggestive find­
ings with the positive results, others8'10 
include them with the negative results and 
others11 ignore them.
The positive predictive value is the key
to the question of whether a positive fine- 
needle aspiration cytology report can 
form the basis for definitive therapy, 
which will vary in form but does include 
the possibility of mastectomy.
The gold standard against which cyto­
logic results must be weighed is histologic 
findings, which are assumed to be 100% 
accurate. Frozen-section diagnosis com­
pares favourably with this standard;5'12 
thus, definitive therapy can be chosen on 
the basis of a frozen-section report. 
Several centres report a similar reliance 
on a positive result from fine-needle aspi­
ration biopsy. On the basis of our current 
results — with a false-positive rate of 
2.5% — we do not yet believe that we can 
use the cytologic diagnosis to determine 
definitive therapy. Also, because of the 
current technique for measuring hormone 
receptors, and their present prominence, 
an open biopsy is still considered neces­
sary. A number of studies are under way 
on methods for measuring hormonal 
receptors directly from histologic sections 
and aspiration biopsy smears, that, if suc­
cessful, will weaken this argument.
In spite of these facts, we do modify 
our management of a breast lesion if the 
cytologic findings indicate a malignant 
lesion. We use the information inthe psy­
chological preparation of the patient; we 
attach some urgency to the timing of 
biopsy and often perform it as an inpa­
tient procedure in one stage, usually with 
frozen section and definitive treatment. 
If the patient is a candidate for lumpec­
tomy and axillary dissection as definitive 
treatment, we modify the biopsy to an 
appropriate segmental resection, aiming 
for tumour-free margins and the most 
cosmetically pleasing result.
The negative predictive value is the key 
to the question of whether a definitive 
negative aspiration result is sufficiently 
reliable to omit biopsy of a solid lesion. 
There is considerable debate on this issue: 
some authors2,9 rely on the aspiration 
result and apparently do not miss breast 
cancers.2 Just as many, however, 
disagree6,7,9 because of the average false­
negative rate of 10%. Those who support 
the use of fine-needle aspiration biopsy 
in this role cite a diagnostic accuracy for 
the triad of physical examination, mam­
mography and fine-needle aspiration 
approaching 99%. But they do state that 
whenever the clinical or mammographic
Table 1--Com parison of Cytologic and Histologic Findings
Fine-needle aspiration  
cytology category
Histologic findings 
M alignant Benign Totals
No reading (unsatisfactory) 3 13 16
Benign 7 32 39
Suggestivefatypical 22 18 4 0
M alignant 3 9 1 4 0
Totals 71 6 4 135
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findings do not agree with the cytology 
report, a biopsy is indicated. Most 
authors agree that the probable cause of 
a false-negative result is sampling error.
Our own false-negative rate of 18% has 
led us to side with those who demand that 
all solid lesions be biopsied. However, 
negative cytologic findings influence our 
approach in ways similar to those 
described for a positive aspiration result; 
that is psychological preparation, urgency 
for biopsy (which is usually done as an 
outpatient procedure) and extent of the 
biopsy.
Summary
This retrospective review of a small ser­
ies does not allow us to commit ourselves 
to total reliance on fine-needle aspiration 
biopsy in the management of patients 
with breast lumps. There currently are no 
definitive studies in the literature, 
although there is certainly a wealth of 
data suggesting that, with increasing 
experience, this goal may eventually be 
achieved. Our hospital uses many aspira­
tors and many pathologists instead of a 
single aspirator and pathologist, as in 
many of the reporting centres. That our 
results are comparable to those in the cur­
rent literature bodes well for the general 
use of the technique. Since diagnosis from 
paraffin sections is the current gold stan­
dard, what is needed is a prospective 
study of a large number of patients, com­
paring fine-needle aspiration cytology to 
paraffin section in a situation where car­
cinoma cannot be excluded on clinical 
grounds alone.
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Clinical Experience With Biliopancreatic Bypass 
and Gastrectomy or Selective Vagotomy 
for Morbid Obesity
In 1980 Scopinaro described biliopan­
creatic bypass for the treatment of 
obesity. This procedure was aimed at 
selective malabsorption. The authors 
used Scopinaro's procedure in 33 
patients, but in 17 they modified it by 
doing selective vagotomy with closure of 
the duodenum in continuity instead of a 
subtotal gastrectomy.
Eighteen months after the operation, 
88%  of the patients had what the 
authors considered was a good to excel­
lent result, that is a loss of more than 
25% of the patient's initial weight.
Morbidity of many kinds was encoun­
tered but most was self-limiting or easily 
corrected by medical means. From their 
experience the authors conclude that 
biliopancreatic bypass as a procedure for 
the treatment of morbid obesity should 
continue to be performed and evaluated.
L'exclusion bilio pancreatic est une nou- 
velle forme de traitement de I'obesite 
morbide. La technique fut decrite par 
Scopinaro en 1980. La physiologie sous- 
entendant cette intervention est celle de 
creer une mal-absorption selective et 
I'absence d'anse exclue.
Les auteurs ont modifie la technique 
originale en pratiquant une vagotomie 
selective avec fermeture du duodenum 
en continuity au lieu d'une gastrectomie 
subtotale chez la moitie de leurs 
patients.
Depuis janvier 1984, ils ont pratique 
33 bypass bilio-pancr£atiques. Ils £va- 
luent un resultat comme bon ou excel­
lent lorsque le patient a perdu 25% ou 
30% de son poids initial. Quatre-ving-
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huit pourcent des patients 6 18 mois 
franchissent ce niveau qui se maintient a 
24 mois.
Cette intervention produit une morbi­
dity certaine. Celle-ci est souvent limitee 
ou facilement corrigible par des moyens 
medicaux. Chacune des complications 
est dycrite. Les auteurs concluent que 
ces interventions doivent continuer a 
etre pratiquees et gvaluees.
Because the causes, and thus the ideal 
treatment, of obesity remain obscure, sur­
gical procedures were introduced more 
than two decades ago to manage this con­
dition. The surgical history of morbid 
obesity is one of multiple surgical varia­
tions on two themes: malabsorption — 
procedures designed to prevent ingested 
food being absorbed — and restriction — 
those designed to minimize the amount 
of food ingested.
As a malabsorptive procedure, jejuno­
ileal bypass produced satisfactory weight 
loss but was almost completely abando­
ned because it was often followed by 
serious, and sometimes fatal, complica­
tions. Most of these complications can be 
ascribed to two main defects of the clas­
sic operation.1
The first is the indiscriminate malab­
sorption caused by the short bowel and 
the interruption of enterohepatic bile-salt 
circulation. The second is the presence of 
a long section of excluded intestinal tract, 
which may play a substantial role in the 
pathogenesis of liver damage.
Restrictive procedures have evolved 
through a number of technical variations. 
Despite their technical ease, they are asso­
ciated with high failure rates.
In the search for a better procedure, 
Scopinaro and colleagues1 reported their 
technique of biliopancreatic bypass in 
1980. In this operation they recognized 
three separate parts of the intestinal tract: 
the alimentary tract from the stomach to 
the jejunoileostomy; the biliopancreatic 
tract from the duodenal stump to the jeju­
noileostomy; and the common tract from 
the jejunoileostomy to the ileocecal valve. 
Theoretically, biliopancreatic bypass has
the following advantages: it produces a 
selective rather than indiscriminate 
malabsorption; the enterohepatic bile-salt 
circulation remains intact; and there is no 
long, excluded intestinal loop. It was anti­
cipated that this procedure would over­
come the complications associated with 
the classic operation of jejunoileal bypass.
As described, this procedure is similar 
to the Mann-Williamson operation for 
the experimental production of peptic 
ulcer. To avoid this complication, 
Scopinaro recommended the addition of 
a 75% distal gastric resection. Since then 
highly selective vagotomy has been widely 
recognized as the treatment of choice for 
peptic ulcer disease. Because of our 
experience2 with highly selective vagot­
omy, we feel that we can rely on a selec­
tive vagotomy to protect the anastomo­
sis from peptic ulcer formation. So, based 
on Scopinaro’s clinical experience with 
biliopancreatic bypass and on our clini­
cal experience with highly selective vagot­
omy, we decided, more than 2 years ago, 
to offer two new options to morbidly 
obese patients seeking help in our insti­
tution.
Patients and Methods
From January 1984 to May 1986, 33 
patients (27 women, 6 men, ranging in age 
from 21 to 53 years [mean 36 years]) 
underwent a biliopancreatic bypass for 
obesity in our hospital. Informed consent 
for the procedure was obtained from all 
of them. All were either twice their ideal 
weight or had medical complications 
related to their obesity. All had under­
gone multiple medical treatments without 
success and had suffered from obesity for 
more than 5 years. An extensive medical 
work-up preoperatively failed to show 
any endocrine disorders. Five of the 33 
patients had already undergone a gastric 
partition procedure that had failed.
Sixteen patients (10 women and 6 men) 
underwent biliopancreatic bypass with 
gastrectomy and the other 17 women 
underwent biliopancreatic bypass with 
selective vagotomy.
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In four patients the biliopancreatic 
bypass was Scopinaro’s type III (i.e., the
FIG. 1—Biliopancreatic bypass with gas­
trectomy.
FIG. 2—Biliopancreatic bypass with closure 
of duodenum and selective vagotomy.
FIG. 3—Weight loss curves up to 24 months 
for all patients (squares), group with gastrec­
tomy (circles) and with vagotomy (triangles).
common tract is 50 cm long and the 
biliopancreatic and alimentary tracts are 
of equal length). In the other cases we 
transected the small bowel 250 cm from 
the ileocecal junction. The proximal loop 
was then anastomosed end-to-side 50 cm 
from the ileocecal junction. The small 
bowel was measured along its mesenteric 
border. The distal loop was anastomosed 
to the stomach after subtotal gastrectomy 
or selective vagotomy with closure of the 
first part of the duodenum (Figs. 1 and 2).
Wedge biopsy of the liver was per­
formed in 29 cases. When present, the 
gallbladder was removed with one excep­
tion. In two of the five patients with a 
failed gastric partition procedure we 
found it necessary to do a gastrogas- 
trostomy to facilitate normal alimen­
tation.
Most patients were instructed to take 
a liquid diet from the time of discharge 
until follow-up 3 weeks after operation. 
Then, their diet was returned to normal 
as tolerated. Follow-up visits were at 3 
and 6 months after operation and every 
6 months thereafter. Blood tests were per­
formed routinely at 6 and 12 months.
At each visit, the dietician recorded the 
patient’s food intake and gave advice. 
Weight, bowel habits, level of activities 
and any problems were recorded.
A few patients did not return at some 
of the follow-up times, but we were able 
to see them or reach them by phone to 
question them about their degree of satis­
faction, quality of life and bowel habits.
The results of operation were evaluated 
using three measurements: weight in kilo­
grams, body mass index (weight divided
by height in square metres) and percen­
tage over the ideal weight.
Results
Because bariatric surgery carries high 
risk of morbidity we were concerned not 
only with the amount of weight lost but 
also the number and type of complica­
tions, length of hospital stay, quality of 
life and bowel habits.
Weight Loss
The mean initial weight was 123 kg (116 
kg for women, 155 kg for men). It ranged 
from 88 to 179 kg. The mean body mass 
index was 46 (45 for women and 50 for 
men) and ranged from 37 to 64. Mean 
average percentage over the ideal weight 
was 124 (120 for women and 135 for 
men), ranging from 73 to 211.
Weight loss was quite rapid for the first 
12 months and continued, though more 
slowly, up to 24 months (Fig. 3). Weight 
loss expressed as a percentage of the ini­
tial weight reached 30% at 12 months and 
almost 40% at 24 months (Table I). At 
18 months the mean weight loss was the 
same for both operations (Table II) and 
was similar to Scopinaro’s results.1
Freeman3 recommended grouping the 
results as “ excellent”  (30% weight loss 
or over), “ good” (25% to 29% weight 
lost) and “ poor” (under 25% weight 
lost). Using these criteria we had excel­
lent results at 18 months in 64.7% of 
patients, good results in 23.5% and a 
poor result in the remaining 11% (Table 
III).
Table 1-Percentage Weight Loss (Mean ± SD) After Operation
Follow up, mo
6 12 18 24
Weight loss, % (n = 261 (n = 19) (n = 17) (n -  7)
Initial weight 22.6 ± 6.9 30.0 ± 11.1 35.2 ± 12.7 38.3 ± 15.0
Initial weight
over ideal 43.3 ± 16.1 57.6 ± 18.9 65.4 ± 19.0 66.1 ± 20.7
Table II—Percentage Weight Loss (Mean ± SD) at 
18 Months According to Type of Surgery
Biliopancreatic bypass with
Gastrectomy Vagotomy
Weight loss, % (n -  9) (n = 8)
Initial weight 
Initial weight
36.7 ± 17.0 33.6 ± 5.9
over ideal 64.4 ± 24.5 66.5 ± 1 1 . 5
Table Ill-Grading of Results According to 
Percentage Loss of Initial Weight Over 24 Months
Result
Follow-up, mo
12
(n = 19)
18
(n -  17)
24
(n -  7)
Excellent >  30%) 9 11 5
Good (25% -  29%) 2 4 1
Poor ( <  25%) 8 2 1
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Hospital Stay and Follow-up
The mean postoperative hospital stay 
was 10 days overall (12 days for those 
with gastrectomy, 8 days for those with 
selective vagotomy). The mean follow-up 
was 14 months (range from 1 to 28 
months).
Complications
The overall early complication rate was 
42% (14 of 33). One patient (3.03%) died 
of necrotizing hepatitis.
There was one case of a blown duo­
denal stump. On postoperative day 7, 
laparotomy was performed to secure bet­
ter drainage. One patient needed reintu­
bation because of pulmonary insuffi­
ciency. She was the only one who had to 
be kept on a respirator for more than 2 
hours after operation.
Other postoperative complications 
included ileus, which subsided rapidly 
when a nasogastric tube was inserted, 
fever from atelectasis, urinary tract infec­
tion and a minor wound infection in two 
patients.
Late complications were of many 
kinds. Three patients had anastomotic 
ulcers: in two (one in each operative
group) first symptoms appeared within 1 
month of operation and eventually 
required surgical revision of the gastroen­
terostomy; the third patient experienced 
epigastric pain 7 months after operation 
(she was in the vagotomy group). She 
responded well to cimetidine and is now 
free of symptoms.
Six patients (18%) were found to have 
an incisional hernia at follow-up. Three 
(9%) had to be readmitted because of 
malnutrition. The striking feature in these 
cases was that they had almost stopped 
eating to accelerate their weight loss. With 
dietary counselling all were able to regain 
a near-normal nutritional status without 
operation. Two of these patients were in 
the group of five with failure of a gastric 
partition procedure.
One patient had continuous colicky 
abdominal pain and multiple episodes of 
small-bowel obstruction. We finally 
decided to re-establish small-bowel con­
tinuity. She was another of the five with 
failure of a gastric partition procedure.
Bowel Habits
Nine patients complained of loose 
stool. In two, all bowel movements were 
loose and frequent (four to six a day). The
others had two to four formed stools fol­
lowed by a loose one.
The change of bowel habits most often 
mentioned was the early morning stool. 
Many patients had to get up at around 5 
or 6 in the morning to have a bowel 
movement.
Comments
Biliopancreatic bypass is a major 
procedure that may have a spectacular 
effect on body weight. There are major 
side effects but these can usually be 
managed medically. Patient acceptance is 
greater than professional acceptance.
It is our opinion that biliopancreatic 
bypass with gastrectomy or vagotomy 
should continue to be evaluated. Bariatric 
surgery will continue to be performed 
until we have the medical capability to 
influence the basic metabolic problems.
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The Virgin, Modified, Human, Umbilical Vein Graft: 
Morphologic Characteristics and Mechanical Properties
The authors used m acrophotography, 
endoscopy, roentgenography, lig h t m icro­
scopy, and transm ission and scanning 
electron m icroscopy to  assess the mor­
phologic characteristics o f 37 virgin, 
human, umbilical vein grafts. The speci­
mens showed deep longitudinal folds 
(22% ) and m ultip le  transverse fo lds of 
the intim al surface (27% ), irregularity of 
wall th ickness (41% ) and in tim al break­
down exposing throm bogenic layers of 
the vein w all to  blood (19% ).
The m echanical properties also studied 
were dynam ic compliance, Young 's 
modulus, breaking strength and breaking 
strain. The mean dynam ic compliance 
was 6 .4 4  x 1 0 -4  mm H g ~ 1 (SD =
2 .02  x 1 0 “ 4 mm H g ~ \  i.e., 31% ), 
w hich is in agreement w ith  results of 
others. The specimens showed great 
variability in Young 's  m odulus, breaking 
strength and breaking strain.
The structura l deficiencies and variable 
mechanical properties o f human umbilical 
vein g ra fts require investigation to  deter­
mine their e ffe c t on patency rates due to  
increased throm bogen ic ity  and thus to 
establish w hether there are potentia l haz­
ards associated w ith  the ir use.
Les auteurs ont a na lys t les caracteristi- 
ques m orphologiques et les propri£t6s 
mScaniques de 37 segments de prothfe-
From the Hopital St-Frangois d ’Assise, 
Hopital de VEnfant-Jisus, Hotel-Dieu de 
Quebec and University Laval, Quebec, PQ
Presented at the 90th annual meeting of the 
Canadian Association o f Clinical Surgeons, 
eastern division, Quebec, PQ, May 31,
1986
Supported by grant MT-7879 from the 
Medical Research Council o f Canada and a 
grant from l ’Hopital St-Frangois d ’Assise, 
Quebec
Accepted for publication June 18, 1986
* Visiting professor
Reprint requests to: Dr. R. Guidoin, 
Laboratoire de Chirurgie Exp6rimentale, 
Pavilion de Services, University Laval, City 
Universitaire, Quybec, PQ G1K 7P4
ses art6rielles D ardik-B iograft vierges.
Leur m orphologie a 6t6 pr6cis6e par 
une s6rie d'exam ens: observation 
m acroscopique, endoscopie, angiogra- 
phie, m icroscopie optique, m icroscopie 
glectronique & balayage et microscopie 
dlectronique a transm ission. Les veines 
pr6sentent frSquem m ent des depressions 
longitudinales (22% ) et de multiple plis 
de la surface luminale (27% ). Les parois 
son t d '6paisseurs variables (41%) et la 
surface luminale pr6sente des ruptures 
qui exposent les couches internes de la 
paroi au sang (19% ).
Les propri6t£s m6caniques S tu d ie s  
on t 6t6 la com pliance dynamique, le 
m odule d 'Young, la contrainte de rupture 
e t I'a llongem ent 6 la rupture. La com ­
pliance dynamique s '6 ta b lit a 6 .44  x 
1 0 ~ 4 mm H g " 1 (SD =  2 .0 2  x 1 0 ~ 4 
mm H g - 1 , i.e., 31% ), ce qui corrobore 
les rgsulta ts obtenus par d'autres 
auteurs. Le module d ’Young, la con­
tra in te  de rupture et I'allongement d la 
rupture sont extrdm em ent variables.
Les consequences des faiblesses struc- 
turales et des propri6t6s mecaniques 
variables sur la perm abilite in-vivo des 
proth6se art6rielles do ivent etre etablies 
en con fron tan t ces observations aux 
resultats cliniques. Les im perfections 
co n s titu te n t des sites privil£gi£s de 
throm bose bien que la surface luminale 
des veines ombilicales humaines traitees 
so it throm bor£sistante.
Although the human umbilical vein 
(HUV) graft has given satisfactory per­
form ance in fem oropopliteal and 
femorodistal arterial bypass,1'3 its dura­
bility requires further assessment. Bio­
degradation and aneurysm formation 
have been reported,614 but the deficien­
cies predisposing to these complications 
have not been emphasized.15
Because of their biologic origin, the 
glutaraldehyde-stabilized HUV prostheses 
would not be expected to demonstrate 
homogeneous mechanical and morpho­
logic characteristics. The purpose of this 
study was to analyse the variability of 
these characteristics in a group of virgin,
modified, HUV grafts processed by Mea- 
dox Medicals Inc. (Oakland, NJ) and sold 
as the Dardik-Biograft.
The morphologic characteristics of 
these grafts were assessed by macro­
photography, endoscopy, roentgenogra­
phy, light microscopy and scanning and 
transmission electron microscopy. The 
linear density (weight per unit length) 
gave a gross index for comparing the 
general structure. The mechanical proper­
ties — compliance and stress-strain be­
haviour — were also studied because of 
the importance of the viscoelastic proper­
ties o f an arterial substitute for success­
ful grafting.16'20
Compliance (Cde) is defined as the 
relative change in volume (AV) per unit 
change in pressure as follows:
c = = ?ad
dc VAP DAP
where A D  is the change in external 
diameter for a change in pressure AP, 
and D is the mean external diameter. As 
we used external diameters, the dynamic 
compliance is identified by Cde.
Material and Methods
Thirty-seven specimens of HUV grafts 
were obtained at the time o f surgery per­
formed at three local hospitals (St- 
Franyois d ’Assise, l’Enfant-Jesus and 
PHotel-Dieu). The excess segments o f the 
grafts were removed at the time of 
implant and used for this study. Segments 
traumatized by clamps were rejected. 
Blood contact with the endothelial surface 
had occurred in some specimens. The 
specimens were preserved in 1.5% 
buffered glutaraldehyde solution. They 
were rinsed in distilled water twice and 
then immersed in graded solutions of 
ethanol up to 40%.
M orphologic and Pathological Studies
The specimens were weighed and meas­
ured to determine their linear density.
Seventeen specimens longer than 2.5 
cm were investigated by endoscopy, using
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a 4-mm outer diameter endoscope with a 
fibre light “ cold” light unit (Edward 
Fletcher and Partners, Richmond, UK).
Twelve HUV prostheses longer than 8 
cm were subjected to roentgenography 
with Hypaque-M 30% (Winthrop Labor­
atories, Aurora, Ont.), containing 30 
mg/ml meglumine diatrizoate and 141 
m g/m l bound iodine. Views were 
obtained in two planes at right angles. 
The specimens were then rinsed with 
0.9% saline and stored overnight in 
saline. They were rinsed again with 0.9% 
saline and put back in 40% ethanol ready 
for further investigation.
With a Tessovar macrophotography 
optical system (Carl Zeiss, Oberkochen, 
West Germany), the HUV grafts were 
examined externally and short segments 
were opened longitudinally for examina­
tion of the luminal surface.
Each sample was then divided in three 
parts for pathological investigation.
Light microscopy.— After postfixation 
in formalin and routine processing, the 
slides of all the samples were stained with 
Weigert’s resorcin-fuchsin and Masson’s 
trichrome to facilitate the observation of 
collagen. Some samples were postfixed in 
1% aqueous osmium tetroxide solution 
with a phosphate buffer at pH 7.2 to 7.3, 
dehydrated through graded ethanol solu­
tions and then embedded in Epon 812 
acrylic resin. Semi-thin sections were 
made, stained with paraphenylenediamine 
(PPD) or with toluidine blue and 
observed in a light microscope with and 
without phase contrast.
Scanning electron microscopy.—All 
samples were postfixed in 1 % thiocarbo- 
hydrazide and 1% osmium tetroxide, 
rinsed twice in distilled water and 
dehydrated in graded solutions of 
ethanol. After critical point drying in a 
Bomar SPC 1500 apparatus (Bomar Co., 
Tacoma, Wash.) using liquid carbon 
dioxide as the transfer medium, the sam­
ples were coated with gold under vacuum 
using Humer V sputter equipment (Tech­
nics Inc., Alexandria, Va). A Jeol JSM 
35CF scanning electron microscope 
(Soquelec Ltee, Montreal, PQ) was used 
at a 15 to 25 kV accelerating voltage.
Transmission electron microscopy.— 
These observations were limited to speci­
mens prepared in semi-thin sections. Con­
trasting of selected areas was achieved 
with uranyl acetate and lead citrate stains 
before observation in a Philips 300 trans­
mission electron microscope (Philips Elec­
tronics Ltd., Montreal, PQ).
Mechanical Tests
Fifteen samples from 13 HUV grafts 
more than 7 cm long were used to deter­
mine the dynamic compliance of the vir­
gin HUV prostheses. The specimens were 
fixed on the test bench,21 elongated to an
additional 10% of their resting length and 
subjected to a pulsatile flow of physio­
logical saline at a mean pressure of 
100 ± 6 mm Hg. The pulse amplitude was 
approximately 40 + 6 mm Hg with a fre­
quency of 1 Hz. The pressure inside the 
specimen was measured with a Millar 
Mikro-Tip catheter pressure transducer 
PC-671 (M illar Instrum ents Inc., 
Houston, Tex.). The diameter was meas­
ured with a cantilever transducer.21 The 
specimens stabilized in a few minutes, 
then the pressure variation, mean pressure 
and diameter variation were recorded on 
a Dynograph recorder R511A (Beckman 
Instruments Inc., Schiller Park, 111.).
Stress-strain tests were carried out on 
test samples from 26 longitudinally 
opened prostheses. The samples were 32 
x 5 mm with their long axes along the 
longitudinal axes of the vein. The thick­
ness of the specimens was measured with 
a micrometer model CS-49-055 (Custom 
Scientific Instruments Inc., Whippany, 
NJ). Three measurements were taken for 
each test sample. The tests were per­
formed with a model 1130 tensiometer 
(Instron Corp., Canton, Mass.) When 
possible, several samples were taken from 
the same graft. Stress-strain curves were 
obtained for grafts with and without their 
polyester mesh and for the mesh alone.
Results
Linear Density
The linear density measured on 60 sam­
ples from the 37 specimens (with their 
polyester mesh) ranged from 0.21 g/cm 
to 0.70 g/cm. The mean linear density 
was0.38±0.09g/cm (i.e., 23% standard 
deviation). The values of linear density 
for the 17 grafts in which more than one 
sample was measured are shown in Fig. 
1. The variability in linear density was 
related to wall-thickness variations as 
confirmed by angiography (Fig. 2).
Morphologic Studies
Macroscopically, the surrounding 
Dacron mesh appeared to separate from 
and slide off the vein readily since the two 
were not attached. Furthermore, the mesh 
had been knitted in a very open construc­
tion which easily stretched.
When examined by Tessovar macro­
photography nearly all the 37 specimens 
had two longitudinal folds on their flow 
surface running the full length of the 
graft. In many grafts these folds were 
shallow, but in eight (22%) specimens 
they were deep (Fig. 3A). In 10 cases 
(27%) the intimal surface had multiple 
transverse folds (Fig. 3B) that may cor­
respond to the places where the cord had 
been straightened during processing. 
These specimens showed either numerous 
individual folds or their intima looked 
crumpled. Fifteen prostheses (41%) 
showed irregular wall thickness around 
their circumference (Fig. 3C). Of these, 
six (16%) showed serious thinning of the 
wall (Fig. 3D). In one case, we found a 
gelatinous deposit inside the graft. It
FIG. 2—Angiography of grafts taken in two 
planes at right angles. Wall thickness varies 
along length of graft.
P rosthesis
No
FIG. 1—Linear density o f 17 grafts measured on two or more samples from each graft. 
Horizontal bars represent samples with maximum and minimum linear densities for each 
prosthesis.
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FIG. 3—Tessovar observations. (A) Inside view of longitudinally opened graft with deep fold running full length of specimen. (B) Lon­
gitudinally opened graft shows multiple transverse folds of inner surface. (C) Irregularity of wall thickness. (D) Thinning of graft wall which 
becomes translucent.
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seemed poorly adherent to the intima and 
reduced the inner diameter of the graft.
Pathological Studies
The basement membrane of the 37 
specimens was relatively smooth, with fre­
quent ruptures and occasionally some 
remnants of endothelial cells (Fig. 4). The 
internal elastic lamina had been disrupted 
in places as a result of mandrel insertion 
(Fig. 5A). Seven (19%) of our human 
umbilical vein grafts showed intimal 
breakdown. The underlying layers of the 
vein wall were visible and accessible to 
blood. Some of our specimens had their 
flow surfaces exposed to blood before 
being harvested. Even if this exposure to 
blood flow was very short, the defects 
noted above had time to induce acute 
thrombotic debris in some instances (Fig. 
5B).
Cross-sectional views of the wall again 
showed an absence of endothelial cells. 
The elastic lamina had a corrugated 
appearance close to the luminal surface 
indicating a certain degree of contraction. 
The subintimal layer showed fascicles of 
smooth-muscle cells, most with a longitu­
dinal orientation. In some sections a 
different orientation was evident and 
large areas of Warton’s jelly continuous 
with the external perimuscular layer were
observed separating the fascicles of 
smooth-muscle cells (Fig. 6). Transmis­
sion electron microscopy facilitated the 
observation of amorphous areas of elastin 
surrounded by microfibrils located 
between the lumen and the subjacent 
layers of collagen and smooth-muscle 
cells (Fig. 7). The ultrastructure of these 
cells showed some variability in the degree 
of preservation. The cell nuclei were 
indented and their perinuclear cisternae 
dilated, indicating some cell contraction. 
Some cytoplasm ic filaments were 
observed, together with rough endoplas­
mic reticulum and some dense bodies. No 
nerves or vasa vasorum were evident in 
the stroma (Fig. 8).
Mechanical Properties
The dynamic compliance of the 15 sam­
ples tested (13 specimens) ranged from 
3.75 to 11.77 x 10"4 mm Hg'1. The aver­
age value was 6.44 x 10'4 ± 2.02 x 10'4 
mm Hg'1 (31% SD). Our results did not 
show any dependence of compliance on 
the diameter of the graft.
In the two grafts for which two sam­
ples were tested, the compliance values 
were 8.71 and 5.90 X 10'4 mm Hg'1 for 
one graft and 7.31 and 5.53 x 10'4 mm 
Hg'1 for the other.
A typical stress-strain curve is shown
in Fig. 9. The Young’s modulus* was cal­
culated in the quasilinear region before 
vein rupture.21 For the HUV graft with 
its polyester mesh, the breaking strength 
and the breaking strain were determined 
by the point of vein rupture (Fig. 9).
The Young’s modulus, breaking 
strength and breaking strain for the HUV 
grafts with and without their mesh and 
for the mesh alone are presented in Table 
I .
In some specimens, we made two 
stress-strain measurements. Figure 10 
shows the values obtained for each sam­
ple from each specimen.
Discussion
Failures of the modified HUV graft 
due to biodegradation and aneurysm for­
mation, to intimal breakdown and sus­
ceptibility to bacteremic colonization have 
been reported.7,Ui13'14 The 41% of speci­
mens demonstrating variable wall thick­
ness in our morphologic studies and the 
considerable variation of linear density
•Young’s modulus (E) is the ratio of stress (a) 
present in the material (the applied force per 
unit area) to the strain (e) resulting from it and 
can be represented by the form ula
FIG. 4— (A) Luminal surface is relatively smooth. Endothelium 
generally is no longer visible: basement membrane only remains with 
some disruption (bar = 100 nm). (B) Exceptionally, small islands of 
dead endothelial cells are still visible (bar = 10 nm).
FIG. 5—Graft damaged during processing. Luminal surface has 
deteriorated and internal elastic lamina is ruptured as result of man­
drel insertion (A, bar = 100 nm). This traumatized area is more likely 
to trap blood elements when exposed to blood (B, bar = 10 nm).
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FIG. 6—Phase contrast photomicrograph from Epon-embedded graft stained with paraphenylenediamine. No endothelial cells were observed 
in this specimen. Note pleated and sharply outlined elastic lamina (EL), wide extracellular space (arrows) in subjacent muscular layers (M). 
Perimuscular collagenous fibrous layer is to lower right (original magnification x 400).
A
FIG. 7—Transmission electron micrograph of stabilized graft. Partial view of subendothelial elements separating lumen from subjacent 
muscle cells of media and collagen fibres. Elastic lamina (arrows) appears as electronlucent amorphous areas of eiastin surrounded bv microfibrils 
(original magnification x 3000).
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between different specimens and between 
samples from the same specimen under­
line the irregularities in structure of this 
biomaterial. Such irregularities are espe­
cially important in the very thin wall 
specimens (16%) which, when submitted 
to blood pressure, will become even thin­
ner,3’14 perhaps leading to graft break­
down.
Intimal breakdown is a serious defect. 
It was present in a substantial proportion 
(19%) of our specimens and has been 
associated with cases of early graft 
failure.11'21 It may be caused by manipu­
lation during processing of the graft or 
during implantation.
FIG. 8—Transmission electron micrograph 
of stabilized graft. Partial view of medial layer 
which exhibits different degrees of ultrastruc- 
tural preservation. Note indented nucleus (N), 
well-preserved nucleolus (N u), dilated  
perinuclear cisterna (arrows). D ilated, 
perinuclear, rough, endoplasmic reticulum 
(RE) profiles are seen in fibrillar cytoplasmic 
areas (original magnification x 4500).
Breakdown of the fragile intima will 
expose the thrombogenic layer of the 
graft.22 Other irregularities of the flow 
surface may lead to turbulence and to 
thrombus formation thus explaining 
thrombosis even with a theoretically 
thromboresistant intimal surface.23,24 
Added to the increased thromboxane B2 
production in the umbilical graft com­
pared with host artery (indicating a low 
resistance to platelet adhesion and aggre­
gation),25 these phenomena, together 
with poor run-off, may cause graft 
thrombosis.
The serious implications of bacterial 
penetration due to intimal tearing have 
been discussed elsewhere.13 This may, in 
part, account for the documented high 
bacteremic entrapping of the HUV 
graft.26
There are many ways of determining 
and expressing the viscoelastic properties 
of conduits as arteries and arterial 
prostheses.20’27-36 Despite some draw­
backs, compliance has the advantage of 
being an easily determined index of the
or
FIG. 9—Typical stress-strain curve obtained 
from graft with its polyester mesh demonstrat­
ing point of rupture of vein and numerous rup­
tures of polyester fibres of mesh, a =  stress, 
e = strain.
viscoelastic properties of the wall; it is 
simply a relative volume change per unit 
pressure change. Because we wanted to 
work in the physiologic range, the need 
to specify the mean operating pressure 
was not bothersome. Likewise the use of 
external diameters was not of major con­
cern since we were merely comparing our 
specimens and did not want absolute 
values.
Many workers have used external 
diameters in their calculations of compli­
ance of arteries or prostheses. Our results 
are compared with those of others in 
Table II;17'20,34-36 the compliance of 
human arteries and saphenous vein is also 
given.
Compliance characterized the circum­
ferential viscoelastic properties of the 
HUV graft. The longitudinal properties 
were characterized by Young’s modulus. 
It is important to note the great variation 
in mechanical properties from graft to 
graft and between samples from the same 
specimen. Rigid prostheses are prone to 
occclusion. On the other hand, it is not 
unreasonable to speculate that very plia­
ble prostheses (great compliance or low 
Young’s modulus) may have a tendency 
towards dilatation and aneurysm forma­
tion. This needs to be investigated, and 
we have established an information 
retrieval program that will permit such 
clinical correlation between morphologic 
and mechanical characteristics before 
implantation and the fate of the 
implanted grafts.
Microscopic studies showed various 
alterations of the structure of HUV grafts 
and varying degrees of preservation of 
cells. The importance of these findings 
needs to be further explored.
Table 1—Stress-Strain Characteristics of Human Umbilical Vein Grafts (HUV)
Measurement
Young's modulus 
(E), MPa
Breaking strength 
K ) ,  MPa
Breaking strain
(£„), MPa
HUV 
+ mesh HUV Mesh
HUV 
+ mesh HUV Mesh
HUV 
+ mesh HUV Mesh
No. of
measurements 30 12 5 23 11 5 23 11 5
Mean 11.26 15.07 20.62 1.96 2.76 8.73 0.34 0.48 0.70
Standard deviation 3.52 17.60 6.19 0.64 2.43 2.51 0.12 0.29 0.25
% 31.3 116.8 30.0 32.7 88.0 28.8 35.3 60.4 35.7
Minimum 6.96 1.52 11.91 0.98 0.59 6.18 0.17 0.18 0.25
Maximum 19.48 57.55 28.52 3.08 7.05 12.41 0.60 1.21 0.85
Table II--Compliance of the Human Umbilical Vein (HUV), Human Saphenous 
Vein (HSV) and Human Arteries (HA) in 10~4 mm Hg-1*
Authors/year HUV HSV HA
Schu ltz and associates, 196736 _ - 4 .3 8 t (10)
Lye and associates, 19753S - 6.8 (20) -
Baird and associates, 197720 4.9 (6) - -
BouchierHayes, 197834 9.1 (22) — —
Walden and associates, 19 8 0 17 7.4 (16) 8.8 (5) 11.84 (8)
Present study 6.44 (15) - -
"R esu lts  have been adjusted to conform to our definition of compliance. The number of specimens tested is in parentheses, 
t  Right external iliac arteries free of atheroma but w ith plaques in aorta or common iliac arteries (autopsy specimens). 
TFemoral arteries (autopsy specimens).
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FIG. 10—Two samples of each of these prostheses were tested for: (a) Young’s modulus 
(E); (b) breaking strength (crb) and (c) breaking strain (eb). For each prothesis, two horizontal 
bars represent values obtained from two different samples.
Alterations of the intimal surface of the 
HUV grafts were frequent. These defi­
ciencies may explain the low resistance of 
the graft to platelet adhesion and aggre­
gation, in spite of its theoretically throm- 
boresistant flow surface. It could also 
play a role in the graft’s susceptibility to 
bacteremic colonization. In some speci­
mens, a thin wall may result in aneurysm 
formation.
There is considerable variation in the 
mechanical properties from graft to graft 
and between samples from the same graft. 
The clinical implications of this heter­
ogeneity have yet to be established.
We are indebted to the operating-room 
nurses for making graft harvesting possible. 
We acknowledge the technical assistance of J. 
Bastien, H. Desbiens, Y. Gourdeau, D. 
Lafreniere-Gagnon, G. Mongrain and D. 
Paquet and thank our colleagues D. Marceau, 
R. Paynter, J.C. Forest, D. Boyer, G. Drouin, 
G. Roy, S. Dube, C. Rouleau and J.F. Girard 
for fruitful discussions.
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Correction
In the article by A.A. Luoma, C.H. 
Scudamore and J.D. Longley entitled 
“ Experience with fine-wire localiza­
tion breast biopsies for nonpalpable 
breast lesions detected mammographi- 
cally” in the September 1986 issue, 
pages 315 to 318, there are two errors. 
On page 316, line 6 under the heading 
“ Fine-wire localization technique” 
should read “ into the suspicious area 
through a no. 20” and in Table I on 
page 317, in the right hand column, 
the number 11 should be followed by 
an asterisk indicating p < 0.005.
BOOKS REVIEWS
continued from  page 398
regarding anatomy and urethrography, (e.g., 
the parasympathetic, sympathetic and puden­
dal nerves all innervate the periurethral striated 
sphincter. In fact only the pudendal nerve 
innervates the external striated sphincter [Invest 
Urol 1982; 20: 415-416]). In addition, the 
described anatomy of the urinary sphincters is 
outdated, no mention being made of the intrin­
sic sphincter and the value of dynamic retro­
grade urethrography in the assessment of mem­
branous urethral stricture (Radiol Clin North 
A m  1979; 17: 227-243). Apart from these dis­
crepancies, the book is well written and illus­
trated, and is a comprehensive reference for 
the state-of-the-art radiologist and urologist. 
This book is recommended to every department 
of diagnostic imaging.
R .W . McC a l l u m , m b , f r c p c , facr
Professor of radiology,
St. Michael’s Hospital,
30 Bond St.,
Toronto, Ont.
M5B 1W8
ENDOCRINE ASPECTS OF ACUTE ILL­
NESS. Edited by Glenn W . Geelhoed and 
Bart Chernow. 350 pp. Illust. Churchill 
Livingstone, Edinburgh; Academic Press 
Canada, Don Mills, Ont., 1985. $52.75. 
ISBN 0-443-08309-6.
With some success, this book attempts to 
encompass the broad range of metabolic and 
hormonal difficulties producing and produced 
by acute illness. The overall quality is excel­
lent, but as usual in a text with many contri­
butors, there is variation in style and depth of 
coverage.
The two chapters on basic metabolism could 
be shortened by the use of more metabolic 
pathway drawings. There is much excellent 
information, although a serious omission is a 
review of lactate metabolism and the effect of 
unfitness on recovery, a serious problem in the 
elderly and chronically sick people.
The chapter on problems in younger patients 
is an excellent review for an “ adult” internist, 
but it does not provide sufficient detail for the 
practising pediatrician. The chapter on thyroid 
function is verbose and occasionally confus­
ing, covering too wide a range and presenting 
too little detail on the effects of the acute ill­
ness on thyroid function. The review of adrenal 
cortical function is clear and practical.
Prostaglandin metabolism is excellently 
covered, but since it is divided into two chap­
ters there is much overlap. The chapters on cal­
cium, phosphate and magnesium metabolism 
in the critically ill are excellent and a clear 
reminder that these are common disturbances 
in the seriously ill.
The chapters on management of hyperglyce­
mia, pheochromocytoma, diabetic and 
hyperosmolar coma, and nutrition are all 
useful.
Neuropeptides in shock and trauma is a 
masterful overview of the present state of the 
art, providing many insights into the possibil­
ities of manipulation of this system in the 
future.
Overall, the book could have been shortened 
and clarified by more ruthless editing. Despite
this it remains an excellent text with provoca­
tive ideas to promote further work. It would 
be of most value in an intensive care unit, par­
ticularly in a teaching hospital, not only for 
reference to those often-forgotten causes of 
hypocalcemia, but also as a stimulus for fur­
ther reading and research.
G. J on es , m b , bs, fr cpc
Director,
Intensive Care Unit,
Ottawa General Hospital,
Ottawa, Ont.,
K1H 8L6
H EM ATOPO RPHYRIN DERIVATIVE  
PHOTORADIATION THERAPY OF 
CANCER. Edited by Michael W. Berns. 
133 pp. Illust. Alan R. Liss, Inc., New 
York, 1984. $29.50 (U S). ISBN
0-8451-0237-0.
Although the idea behind this text originated 
25 years ago, for most of us this is a new and 
fascinating subject. The 14 contributions 
include an excellent introduction to the sub­
ject in the form of a preface by the editor. In 
addition to therapeutic applications there is a 
section describing the use of this modality in 
diagnosis. Excluding the exposure tables at the 
end of the book, there are 109 pages so that 
even the busiest physician or surgeon should 
have the time to read it. The articles are 
intended for experts, but are so well written 
they will be comprehensible to the beginner. 
Specific details of material and methods are 
included. The thickness of tumour that can be 
treated by this method is necessarily limited, 
but the range of interest by site includes lung, 
bladder, brain, prostate and skin. Different 
ways in which lasers can be used are described 
including frontal illumination, light diffusion 
media and embedding of the fiberoptic tip. 
Potential complications and precautions are 
dealt with in some detail.
I would recommend the book to all oncolo­
gists whether surgical, medical, radiation, or 
diagnostic. It will also be of interest to deter- 
matologists and ophthalmologists. One of the 
strongest impressions the book creates is that 
this is a field of potential research. For those 
already expert in this field, there is the attrac­
tion of material from China, not generally 
available.
David  F. R id eo u t , m b , fr c pc , frcr
Chief, Department of Diagnostic Radiology, 
Ontario Cancer Institute,
Toronto, Ont.
M4X 1K9
MANAGEMENT OF SPINAL DEFORMI­
TIES. Orthopaedics 2. Edited by Robert A. 
Dickson and David S. Bradford. 331 pp. 
Illust. Butterworth & Co. (Publishers) 
L td., B oston , 1984. $39.95. ISBN  
0-407-92347-X.
In recent years the treatment of spinal defor­
mities has undergone major advances. Surgi­
cal breakthroughs such as segmental spinal 
instrumentation and Zielke anterior instrumen­
tation, coupled with modern techniques in 
bracing and electrical stimulation have enabled 
continued on page 459
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Gastrointestinal Phytobezoars: 
Presentation and Management
A chart review from  1975  to  1985  at 
the Toronto W estern Hospital identified 
16 patients (9 wom en and 7 m en, 
between the ages o f 39  and 83  years) 
w ith  gastrointestinal phytobezoars. Nine 
had previously undergone vagotom y and 
drainage procedures. There w ere tw o  
d istinct clinical groups, dependent on the 
location o f the bezoar: nine patients w ith  
isolated gastric bezoars presented w ith 
chronic burning epigastric pain and 
nausea and vom iting in addition to  
anorexia and w e igh t loss. Six o f seven 
patients w ith  sm all-bowel bezoars had 
acute sm all-bowel obstruction, 
manifested by cram py abdom inal pain, 
vom iting and obstipation. In the  seventh 
patient the bezoar was found incidentally 
in an efferent loop during endoscopy. 
Gastric bezoars were all diagnosed by 
endoscopy; patients w ith  sm all-bowel 
bezoars had x-ray film s com patib le  w ith  
sm all-bowel obstruction. The obstructing 
sm all-bowel bezoars w ere found a t mid­
ileum and proximal je junum . Five patients 
underwent proximal en tero tom y w ith  
bezoar removal; in one the bezoar was 
milked distally into the cecum . One 
patient also had m ultip le nonobstructing 
small-bowel bezoars removed through 
the single enterotom y and another had a 
separate gastrotom y fo r rem oval o f a 
gastric bezoar. The postoperative 
courses were uncom plicated excep t for 
wound in fection in one patient. None of 
the patients w ith  an isolated gastric  
bezoar required surgery. Three patients 
were successfully treated w ith  gastric 
lavage and the others w ith  clear flu id 
diet.
Line etude des dossiers com piles de 
1975 a 1985 au Toronto W estern Hospi-
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ta l a permis d 'iden tifie r 16 patients (9 
femmes et 7 hommes ages de 39 a 83  
ans) porteurs de phytobezoards gastro- 
intestinaux. Neuf avaient prealablement 
subi des operations de vagotom ie et de 
drainage. Selon la localisation des 
bezoards on a identifie  deux groupes cli- 
niques distincts: neuf patients avec des 
bezoards gastriques isoles, qui ont et6 
vus souffrant de brulure epigastrique 
chronique, de nausees et de vomisse- 
ment, accompagnes d'anorexie et de 
perte de poids; six des sept patients po r­
teurs de bezoards dans I'in testin  grele 
avaient une obstruction  aigue du pe tit 
in testin  qui s 'est m anifests par des cram - 
pes abdominales, des vomissem ents et 
une constipation opiniatre. Chez le sep- 
tieme patient le bezoard a ete decouvert 
dans une anse efferente a I'occasion 
d 'une endoscopie. Les bezoards g astri­
ques ont tous ete diagnostiques a 
I'endoscopie; les patients porteurs de 
beozards de I'in testin  grele ont presente 
des radiographies com patib les avec une 
obstruction de I'in testin  grele. Les 
bezoards obstruant I'in tes tin  grele ont 
£te decouverts au niveau de I'ileon 
moyen et du je junum  proxim al. Cinq 
patients ont subi une enterotom ie pour 
enlever le bezoard; dans un cas, le 
bezoard a ete pousse dans le caecum. 
Chez un patient plusieurs bezoards situes 
dans I'in testin  grele mais qui ne cau- 
saient pas d 'obstruc tion  ont ete enleves 
a travers une enterotom ie unique; chez 
un autre, on a procede a une gastroto- 
mie separee pour I'en levem ent d 'un 
bezoard gastrique. A  I'exception d 'un  
patient qui a sou ffert d 'une infection de 
plaie, 1'evolution postoperatoire des 
patients a ete sans histoire. Aucun des 
patients qui avaient un bezoard gastrique 
isol6 n 'a necessity de chirurgie. Trois 
patients ont et6 tra ites avec succes par 
lavage gastrique, et les autres par une 
diete hydrique.
The term bezoar is derived from the Per­
sian word “ padzahr”  meaning “ to expel 
poison” .1’2 In ancient times, bezoars 
from goats and antelopes were ground up 
and ingested as remedies for disease and 
antidotes to poison. Bezoars may be one 
o f three types: trichobezoars (composed
o f hair), phytobezoars (made up o f fruit 
and vegetable fibres) and trichophyto- 
bezoars (a mixture o f the two).
Although rarely found in humans, 
phytobezoars can occur in the stomach or 
small intestine. We carried out a 10-year 
retrospective review o f  the clinical presen­
tation and management o f  phytobezoars 
in these two separate locations.
Methods
The charts o f patients admitted to the 
Toronto Western Hospital between 1975 
and 1985 with phytobezoars o f  the gas­
trointestinal tract were reviewed. The 
diagnosis was confirmed either by 
endoscopy or at laparotomy in 16 
patients.
The review sought information about 
the location o f  the phytobezoars, 
predisposing factors, presenting symp­
toms, endoscopic findings and the 
method and results o f therapy.
Findings
Nine patients had bezoars confined to 
the stomach and seven had small-bowel 
bezoars. One patient had concomitant 
small-bowel and gastric bezoars. There 
were nine women and seven men who 
ranged in age from 39 to 83 years (mean 
61.7 years).
Predisposing factors were identified in 
all patients (Table I). The presence o f den­
tures and previous vagotom y with 
drainage procedures were the most com­
mon findings. Eight patients had both 
causative factors. The average time from 
vagotomy and drainage to the develop­
ment o f symptomatic phytobezoars was 
7.5 years (range from 6 months to 14 
years). Three patients, with no related 
surgical or medical condition, had evi­
dence o f gastric stasis on barium contrast 
x-ray films or nuclear gastric-emptying 
scans.
Presenting symptoms varied with the 
anatomic location o f  the bezoar (Table 
II). Nine (56%) patients had isolated gas­
tric phytobezoars and complained o f 
long-term intermittent epigastric pain. 
Small-bowel phytobezoars were found in 
seven (44%) patients, six o f whom had 
symptoms o f acute small-bowel obstruc-
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tion. In the seventh patient, whose 
symptoms mimicked those of a patient 
with a gastric phytobezoar, the small- 
bowel bezoar was found incidentally in 
an efferent loop of a Billroth II gas­
trojejunostomy during endoscopy.
All gastric bezoars were diagnosed at 
endoscopy. Associated findings included 
gastritis (two patients), stomal ulcer (one) 
and gastric carcinoma (one). Obstructing 
small-bowel bezoars were diagnosed at 
laparotomy.
The gastric phytobezoars were all 
treated conservatively. Three patients 
underwent saline lavage during or after 
gastroscopy and five patients were given 
a clear fluid diet. All were free of bezoars 
within 7 days, as noted by repeat 
endoscopy or upper gastrointestinal 
series, and obtained relief of their symp­
toms. One patient with unresectable gas­
tric carcinoma received no treatment. Five 
patients were subsequently placed on 
long-term metoclopramide therapy.
Patients with obstructing small-bowel 
phytobezoars (mid-ileum in four, prox­
im al jejunum  in two) underwent 
laparotomy. In five, the bezoar was 
removed through a transverse enterotomy 
proximal to the site of obstruction, while 
in one patient it was milked distally into 
the cecum. One patient, in addition to the 
obstructing bezoar, had multiple small- 
bowel bezoars, which were removed 
through the same enterotomy. Another 
required a separate gastrotomy for the 
concomitant removal of a gastric bezoar. 
There was a single postoperative wound 
infection but no deaths. The patient with 
an efferent-loop small-bowel bezoar was 
treated successfully with a clear fluid diet.
Discussion
Phytobezoars have known predispos­
Table 1-Factors Predisposing to
Bezoar Formation
Factor No. (%)
Dentures 13(81)
Vagotomy with drainage 9(56]
Idiopathic gastric stasis 3(19)
H2 blocker therapy 2(12)
Type 1 diabetes mellitus 1 (6)
Carcinoma of the stomach 1 (6)
ing factors. A key element in the develop­
ment of nonpersimmon phytobezoars is 
gastric stasis,3’4 whether induced by gas­
tric surgery, related to an underlying med­
ical condition or idiopathic in nature.5 
Brady4 noted delayed gastric emptying in 
8 of 12 patients with phytobezoars. Con­
tributing factors in the postgastrectomy 
setting include reduced acid-pepsin secre­
tion, chronic gastritis leading to increased 
secretion of mucus and loss of pyloric 
function permitting large boluses to enter 
the intestine. A history of gastric surgery 
was present in 56% of our patients, and 
the average time from surgery to bezoar 
formation was 7.5 years, an interval simi­
lar to that reported by others.6 Medical 
conditions producing gastric stasis include 
insulin-dependent diabetes mellitus, as 
noted in one patient, and hypothy­
roidism.5 Idiopathic gastric stasis, con­
firmed radiologically or by nuclear scan­
ning was identified in three patients.
Other associated factors have been 
noted. Edentulous patients may be at risk 
due to inadequate mastication resulting 
in large boluses of food entering the 
stomach.5 Also reported7 is an associa­
tion between H2 blocker therapy in the 
elderly and phytobezoar formation, 
presumably related to lowered gastric 
secretion and reduced gastric emptying. 
Both our patients receiving H2 blocker 
therapy were over 80 years old, with no 
history of gastric surgery. Finally, intake 
of cellulose-rich fibrous fruits, frequently 
oranges, may contribute to phytobezoar 
formation in patients who have under­
gone gastric surgery.s’8'9 No specific 
dietary factors or persimmon bezoars 
were noted in our patients; they appear 
to have a different pathogenesis. Persim­
mons contain shiboul, a tannin that poly­
merizes in the presence of hydrochloric 
acid and produces a sticky mass.5*6 Per­
simmon bezoars may form regardless of 
whether a patient has undergone gastric 
surgery.
Chronic burning epigastric pain, 
associated with nausea, vomiting and 
weight loss constituted the major symp­
toms in patients with gastric bezoars. 
Diagnosis is made by endoscopy or upper 
gastrointestinal series, although it may be 
suspected by the appearance of a grossly 
distended stomach with particulate mat­
Table II—Presenting Symptoms
Gastric bezoar Small-bowel bezoar
Symptom (n -  9) In -  7)
Pain 8 6
(epigastric, burning) (central, crampy)
Nausea/vomiting 7 6
Anorexia 3 1
Weight loss 2 -
Obstipation - 4
Early satiety 2 1
Duration of symptoms chronic acute
(months) (hours)
ter on abdominal supine x-ray film.10
The treatment of choice for gastric 
phytobezoars is nonoperative, consisting 
of gastric lavage or clear fluid diet. Pro­
teolytic enzymes alone or combined with 
endoscopic removal have been used suc­
cessfully to dissolve the bezoar.5’8’11 The 
dissolution should be gradual, since intes­
tinal obstruction may occur after frag­
mentation and migration of the gastric 
bezoar.12 Ulceration, perforation, 
obstruction or gastritis can result from 
prolonged enzymatic or mechanical treat­
m ent.8 Rarely, gastrotomy may be 
required.
DeBakey and Ochsner2 reported that 
small-bowel obstruction was the most 
common complication of bezoars. 
Phytobezoars presenting as acute intesti­
nal obstruction require operative manage­
ment. In the absence of large-bowel stric­
tures, attempts should be made to milk 
the bezoar distally into the cecum. If this 
fails, proximal enterotomy is required; 
other small-bowel bezoars should be 
removed through the same enterotomy. 
DeBakey and Ochsner2 also recom­
mended that the stomach should be pal­
pated at surgery and if a gastric bezoar 
is present (as in one of our patients), it 
should be removed through a gastrotomy. 
Since phytobezoars may recur in up to 33% 
of patients,4,11 those with gastric stasis 
should be advised that raw fruits or 
stringy vegetables must be chewed 
thoroughly and eaten slowly. Drugs to 
stimulate gastric motility, such as 
metoclopramide, can be added in an 
effort to reduce the possibility of recur­
rence.3’13
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Long-Term Results of Hyperselective Vagotomy
for Duodenal Ulcer
Although considered by many as the 
operation of choice in the treatment of 
duodenal ulcer, hyperselective vagotomy 
without drainage is not unanimously 
accepted because little is known about 
its long-term efficiency in preventing 
ulcer recurrence.
The long-term results of 203 patients 
with duodenal ulcer, treated by hyper­
selective vagotomy between 1974 and 
1983 at the Hopital Laval, are reported. 
Patients were followed at yearly intervals 
and questionnaires were used to deter­
mine whatever benefits they perceived.
The procedure was found to be a safe 
one with an uncomplicated postoperative 
course. The overall recurrence rate was 
12% over a mean follow-up of 64 
months. Recurrences may occur 5 or 
more years after surgery. The operative 
technique is important in preventing 
recurrence. Dissection of the last 6 cm 
of esophagus lowered the recurrence 
rate at 5 years from 21%  to 9%.
Only four patients required reoperation. 
The majority of recurrences consisted of 
a single episode, the ulcer being easily 
controlled by short-course medical treat­
ment. The authors found that 94%  of 
patients were satisfied with the results 
of the operation.
Alors que la vagotomie hyperselective 
sans drainage est consideree par plu- 
sieurs comme I'opdration de choix dans 
le traitement de I'ulcere duodenal, son 
acceptation ne sera pas unanime aussi 
longtemps que les resultats a plus long 
terme ne seront pas mieux connus.
Le present rapport comporte les resul­
tats a long terme de 203 patients qui 
ont subi une vagotomie hyperselective
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pour ulcdre duodenal entre 1974 et 
1983. Ces patients ont ete suivis annuel- 
lement et des questionnaires ont ete 
employes pour mesurer le degre de satis­
faction des patients.
La vagotomie hyperselective est une 
procedure sure avec evolution postopera- 
toire simple. Le taux de recidive est de 
12% pour un suivi moyen de 64 mois. 
Les recidives peuvent survenir plus tard 
que 5 ans post-chirurgie. La technique 
de I'operation est importante pour preve­
n t la recidive. Une meilleure dissection 
de la partie inferieure de I'oesophage a 
fait chuter le taux de recidive a 5 ans de 
21% a 9%.
L'etude fait aussi ressortir revolution 
benigne des recidives. Seulement quatre 
patients ont du etre reoperes. La majorite 
des recidives a consists en un seul epi­
sode d'ulcere facilement controlable par 
un bref traitement medical. L'evaluation 
du degre de satisfaction des patients 
montre que pres de 94% d'entre eux 
sont satisfaits des resultats de I’ope- 
ration.
Hyperselective vagotomy without 
drainage is considered in many centres to 
be the operation of choice for duodenal 
ulcer. Its acceptance, however, is not 
unanimous because the long-term effica­
cy with respect to ulcer recurrence is not 
yet well documented.
Thus, many surgeons still do conven­
tional procedures despite increased oper­
ative morbidity and more long-term 
problems relating to disturbed gastric 
physiology.
This paper reflects our experience over 
the past 10 years with hyperselective 
vagotomy without drainage as the surgi­
cal treatment for complicated or uncom­
plicated duodenal ulcer. Operative mor­
bidity and recurrence rates during 
long-term follow-up are emphasized.
Patients and Method
Between 1974 and 1983, 203 patients 
(161 men, 42 women) underwent hyper­
selective vagotomy as treatment for duo­
denal ulcer. Ages ranged from 22 to 83 
years (mean 54 years).
Indications for surgery — ulcers resis­
tant to medical treatment (145) and ulcers 
with complication (58) — were identical 
throughout the period. In the former 
group, the period between diagnosis of 
the ulcer and surgical treatment averaged 
11.4 years. Among the whole group, 
81 (40%) patients received medical treat­
ment for more than 6 months before sur­
gery and 87 (43%) needed at least one 
period of hospitalization for their ulcer 
disease. In the latter group, surgery was 
indicated because of hemorrhage (36), 
pyloric stenosis (14) and ulcer perforation 
( 8).
With all elective cases, the preoperative 
studies included a gastric secretion test. 
(Basal acid output represents the sum of 
four 15-minute samples obtained before 
pentagastrin was given and maximal acid 
output represents the sum of the four 
15-minute acid output determinations 
after injection).
The original surgical technique, as 
described by Johnston and Wilkinson1 
and Goligher2 was used until 1977. Then 
special attention was paid to dissecting the 
last 6 to 7 cm of the esophagus. Others3 
had demonstrated that this improved the 
results.
In 50 (25%) patients concomitant 
procedures were added to the vagotomy 
(cholecystectomy in 25, hiatal hernia 
repair in 20, gastrostomy in 8 and closure 
of perforated ulcer in 8).
Follow-up
All 203 patients were followed-up 
annually as out-patients and were 
required to complete a questionnaire spe­
cifically designed to determine the 
benefits of the operation, as perceived by 
that patient. We classified patients as 
being totally satisfied, moderately satis­
fied or disappointed by the operation. We 
also inquired about recurrence of sym­
ptoms or the need for medication. If a 
patient had gastrointestinal complaints, 
the barium-swallow x-ray film or 
endoscopy was repeated.
The rate of ulcer recurrence was calcu­
lated from actuarial recurrence curves. 
Because of changes in technique we com-
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pared the results for patients who had sur­
gery before 1977 with the group who had 
surgery after that year. The probability 
of recurrence for each group was calcu­
lated and compared according to the one- 
tailed z value (p < 0.05) on a survival 
curve.4 Calculations were done using the 
time of symptom recurrence.
Findings
There were no operative deaths. The 
overall complication rate was 3% — 
esophageal fistula, gastrointestinal 
hemorrhage, evisceration and pulmonary 
embolus in one patient each and pulmo­
nary infections in two. There were four 
wound infections.
Among 153 patients who had hyper- 
selective vagotomy only, 72 (47%) left the 
hospital 4 days after operation and 125 
(82%) were home by postoperative day 
5. The average time between surgery and 
discharge was 5.5 days.
Twelve patients died of unrelated 
causes during the follow-up period. Of 
the 98% answering the questionnaire, 
80% were totally satisfied with the result 
while 14% were moderately satisfied and 
6% were disappointed. At the time of the 
last follow-up (excluding those who died 
[12] and those who had to be reoperated 
on [4]), 161 (88%) patients had either no 
gastrointestinal symptoms or minimal 
complaints that did not require medical 
attention. A further 16 (9%) had to take 
antacids or cimetidine for ulcer symptoms 
and 6 (3%) were under medical treatment 
for recurrence at the time they completed 
the questionnaire.
Recurrence
Twenty-four (12%) patients had 
documented recurrence of their ulcer dis­
ease during an average follow-up of 64 
months. The interval between operation 
and recurrence varied from 3 to 79 
months (mean 38.2 months).
In 13 of the 24 the recurrence consisted 
of a single episode that was successfully 
treated medically; in 7 medical treatment 
was required intermittently over the years 
and in 4 a second operation was neces­
sary. All second operations were per­
formed within 2 years of the original 
operation.
Three of the four patients had an 
antrectomy and one a pyloroplasty. No 
patient needed reoperation during the last 
7 years of follow-up. For 16 patients the 
recurrent ulcer was in the duodenum. Five 
patients had recurrent gastric ulcer and 
three a pyloric ulcer. There was no 
increased incidence of recurrence in 
patients who had pyloric or prepyloric 
ulcers (3 of 33) or in patients with pyloric 
obstruction (1 of 14).
A comparison was made of the recur­
rence rate in the 65 patients who under­
went operation before 1977 (original 
operation) and the 138 patients treated 
after 1977 (longer esophageal dissection). 
The probability of recurrence in each 
group is shown in Fig. 1. The refinement 
in technique resulted in a marked 
improvement in the recurrence rate at 5 
years. The probability of recurrence at 5 
years for those operated on before 1977 
was 21% compared with 9.3% for those 
treated after 1977.
Analysis of gastric secretions done 
preoperatively in 154 patients failed to 
show any significant difference between 
the number who eventually had recurrent 
ulcer and those who did not. This is in 
accordance with our previous report.5 In 
19 patients who had recurrent ulcer, the 
average base acidity was 7.2 mmol/L 
(ranging from 0.1 to 16.6 mmol/L) and 
28.2 mmol/L (ranging from 6 to 54 
mmol/L) for maximum acidity. Of the 
132 patients in this group who did not 
have recurrent ulcer, the mean base acidity 
was 5.2 mmol/L (ranging from 0.1 to 37 
mmol/L) and the mean maximum acidity 
was 24.8 mmol/L (ranging from 1.5 to 
70 mmol/L).
Discussion
The operation of hyperselective vagot­
omy is generally effective for short-term 
control of duodenal ulcer, but more long­
term evaluation is required. In that 
respect, it parallels previous experience 
with gastroenterostomy, which was 
thought to be an adequate procedure, but 
for which a high recurrence rate was 
found on long-term studies. In our opin­
ion the long-term results for hyperselec­
tive vagotomy are quite different.
In evaluating the results of surgical 
treatment of duodenal ulcer, it is impor­
tant to remember that the disease is 
benign and that, for most patients, med­
ical treatment is satisfactory. Therefore 
any kind of surgical approach must not 
create more problems for the patient than 
the disease itself. Surgery should be safe,
give excellent control of the disease and 
have minimal effects on the gastrointes­
tinal physiology.
This study shows that hyperselective 
vagotomy is a safe procedure associated 
with an uncomplicated postoperative 
course. Most patients have returned home 
5 days after operation and operative 
morbidity is comparable to or even lower 
than that for most other surgical proce­
dures for duodenal ulcer.
The overall recurrence rate of 12% is 
comparable to recent results.6-14 The 
data also suggest that recurrences may 
occur 5 or more years after surgery so that 
a long follow-up is necessary to obtain 
meaningful results. The technique of 
hyperselective vagotomy appears to be 
important in the incidence of recurrence. 
Dissection of the last 6 cm of the esopha­
gus has lowered the recurrence rate at 5 
years from 21% to 9.3%, and this is simi­
lar to the experience of others.2,3,9-11 The 
rate does not seem to be influenced by the 
anatomy of the ulcer or by the presence 
or absence of pyloric obstruction at the 
time of surgery.
The favourable presentation of recur­
rences after hyperselective vagotomy is 
well known8 and is emphasized in this 
series. Only 18% (4 of 24) of patients who 
had a recurrence needed reoperation; 
50% had only one episode that was eas­
ily controlled by a short course of medi­
cal therapy. These numbers differ some­
what from reported studies6,15 in which 
reoperation varied from 50% to 80% of 
all recurrences. There is no explanation 
for this apparent discrepancy.
Secondary effects of the procedure on 
the gastrointestinal tract are uncommon. 
We tried to evaluate these side effects by 
having the patients complete a question­
naire so that unsolicited answers could be 
obtained. The results showed that 94% 
of patients were totally or moderately 
satisfied by the operation. Dumping syn­
drome, diarrhea or food intolerance were 
infrequent, an important consideration 
when compared with other procedures for 
duodenal ulcer.
#N=* 65 60 55 53 51 46 43
N = « 138 133 105 83 66 43 23
0.07 0.06 0.03 0.01 0.05 0.18 0.18
FIG. 1—Duodenal ulcer recurrence rate after hyperselective vagotomy for patients oper­
ated on before (circles) and after (squares) 1977. * = number of patients available at end of 
each period.
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Conclusions
This procedure has minimal operative 
morbidity and the postoperative course is 
usually uncomplicated. Most patients are 
satisfied with the result of their operation, 
and have a feeling of well-being; gastroin­
testinal side effects are infrequent. 
The rate of recurrence is low and in most 
cases can be treated effectively by medi­
cal therapy. The operative technique is 
important in that it should include dissec­
tion of the last 6 cm of the esophagus.
It is important to evaluate the overall 
improvement of the patient as well as the 
rate of recurrence of ulcer disease when 
assessing the results of surgery. Hyper- 
selective vagotomy provides improvement 
in gastrointestinal symptoms and an 
acceptable rate of ulcer recurrence.
S ESA P  V  Question
33. Which of the following signifies the poorest prognosis for patients 
with pyogenic abscess of the liver?
(A) Anaerobic bacteria in the abscess
(B) Loculations within the abscess cavity
(C) Advanced age of the patient
(D) Jaundice
(E) Multiple abscesses
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Predicting Septic Related Mortality 
of the Individual Surgical Patient 
Based on Admission Host-Defence Measurements
In order to  assign a numerical probability 
o f septic related death fo r a given 
patient, the fo llow ing  data were recorded 
fo r 461 patients on admission to  the 
Royal V ic to ria  Hospital in M ontreal fo r 
m ajor surgical treatm ent: age; delayed- 
type  hypersensitiv ity  (DTH) skin-test 
score; to ta l serum protein level; serum 
albumin level; circu lating hemoglobin 
level; neutrophil adherence; polym or­
phonuclear chemotaxis; and sex. Logistic 
regression was used to generate a 
pred ic tive  equation o f the form :
P j  death | =  1 -  { 1 +  exp [1 .343  -  1 .372  
(album in) -  0 .1 73  In (DTH score) + 
0 .026(age) -  0 .522 (sex)]} - 1
(where P is the probability  o f death and 
exp is the exponentia l function) tha t 
could be used to  calculate the actual 
p robab ility  o f septic related death fo r an 
ind iv idua l patient. The predictive 
accuracy o f th is equation was tested on 
a separate, prospectively collected data 
base o f 6 2 5  surgical patients. There was 
an excellent f it  o f the model. There were 
6 8  septic related deaths w here 6 7 .2  
were predicted. It is now  possible to  cal­
cu late precisely the probability o f a sep­
tic  related death o f a given surgical 
pa tient upon admission to  the hospital. 
This should prove useful in clinical 
decision-m aking.
From the Department o f Surgery and 
Department o f Microbiology, McGill 
University and the Royal Victoria Hospital, 
Montreal, PQ
Presented at the 54th annual meeting o f the 
Royal College o f  Physicians and Surgeons 
o f  Canada, Vancouver, BC, Sept. 12, 1985
*Medalist in Surgery, Royal College of 
Physicians and Surgeons o f  Canada, 1985
Reprint requests to: Dr. N. V. Christou,
Rm. S10.30, Royal Victoria Hospital, 687 
Pine Ave. W, Montreal, PQ H3A 1A1
Dans le but d'assigner une probability 
numerique de deces par sepsie, les don- 
nees qui su ivent ont ete enregistrees pour 
461 paients lors de leur admission a 
I'H opita l Royal V ictoria  de Montreal pour 
une in tervention chirurgicale majeure: 
age; score cutane d 'hypersensibilite 
retarde (DTH); taux serique de proteines 
tota les; taux serique d 'album ine; taux 
d 'hem oglobine circulante; adherence des 
polynucleaires neutrophiles; chim iotaxie 
des polymorphonucleaires; e t sexe. Une 
analyse de regression logistique a ete uti- 
lisee pour generer une equation previ- 
sionnelle ayant la form e suivante
P | deces | =  1 -  {1 + exp [1 .343  -  
1 .372  (albumine) -  0 .1 73  In (score DTH) 
+ 0 .0 26  (age) -  0 .5 22  (sexe)]}-1 
(ou p est la probability de dyces et exp est 
la fonction  exponentielle). Cette equation 
pourrait etre utilisee pour calculer la pro­
bability de dyces par in fection d ’un 
patient donne. Lexactitude  previsionnelle 
de cette equation a ete mise a I'epreuve 
sur une serie independante de donnees 
ceuillies de facon prospective chez 625 
patients de chirurgie. Le modele mathe- 
matique a o ffe rt une exceliente correla­
tion . On a enregistre 68 dyces par in fec­
tion  alors qu 'on  en avait prevu 67 .2 . II 
est m aintenant possible de calculer de 
facon precise la probability de deces par 
in fection d 'un  patient lors de son admis­
sion a I'hop ita l. Ceci devra it facilite r les 
prises de decision clinique.
There are three determinants of infection: 
environment, such as an intact skin or 
bowel mucosa; bacteria; and host-defence 
mechanisms. The environment must be 
disturbed during a surgical procedure. 
Surgical attitudes and techniques, such as 
operating with minimal tissue damage, 
have reduced the risk of this determinant. 
Bacteria can be minimized with adequate 
skin disinfection, bowel preparation and
preoperative administration of antibi­
otics. What remains is to understand and 
improve host-defence mechanisms. A 
means of globally assessing host-defence 
was introduced 10 years ago by MacLean 
and associates.1 They used the delayed- 
type hypersensitivity (DTH) skin-test 
response to recall antigens2 as a predic­
tor of clinical outcome in surgical 
patients. Anergic patients (those with no 
response to any antigen) had higher rates 
of sepsis and death compared with reac­
tive patients. This work has been con­
firmed by others,3-10 although there are 
some contrary views.11
The difficulty in accepting these find­
ings and, more important, their use in 
clinical practice, suffers from the inabil­
ity to apply them to the individual patient. 
For example, if one is presented with 100 
anergic patients on admission to the 
hospital, one can deduce, based on previ­
ous findings in 2202 patients,12 that 33 
of them will die of septic related compli­
cations during their hospital stay. 
However, one cannot point out which 
particular patient will die. What a surgeon 
needs is a means of assigning a probabil­
ity of a septic related death to an 
individual patient on whose condition he 
must make a clinical decision. By having 
this information, he can then take 
appropriate measures to minimize the 
risk.
The purpose of this study was twofold: 
(a) to develop a predictive model that 
could assign a probability of septic related 
death to an individual surgical patient on 
admission to hospital, using those meas­
ures of host defence that have been shown 
previously to affect clinical outcome; (b) 
to test the validity of the predictive model 
on a separate, prospectively collected, 
surgical patient population.
The outcome of most importance fol­
lowing hospitalization is death, which was 
chosen as the dependent variable in this
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analysis, since it is irreversible and must 
be prevented. Previous data have 
associated septic and nonseptic related 
complications with depressed host 
resistance. Such outcomes can be equivo­
cal. Major septic episodes such as bactere­
mias can be missed unless frequent, rou­
tine, blood cultures are performed in all 
patients. Intra-abdominal abscesses, 
although suspected, cannot always be 
proven. Death cannot be missed and can 
only occur once. With this outcome we 
could derive a prognostic equation that 
would satisfy all statistical assumptions 
and predict a clinically useful and une­
quivocal event.
Patients and Methods
Patient Population
To achieve the purpose of the study, 
that is, to develop a predictive equation 
in a large number of surgical patients that 
can be applied to all major surgical 
admissions, a heterogeneous group of 
patients was purposely studied. In the 
first part of the study, we evaluated 499 
patients who were admitted to the wards 
and the surgical intensive care unit of the 
Royal Victoria Hospital over 1.5 years. 
The study was approved by the hospital 
ethics review board concerning human 
experimentation. All patients were 
assessed within 24 hours of admission. 
This included patients admitted for major 
surgery (not such procedures as 
cholecystectomy and herniorrhaphy) and 
those who sustained traumatic injuries. 
Some patients were operated upon at 
other hospitals and were transferred to 
the Royal Victoria Hospital for tertiary 
care because of severe complications. A 
history and physical examination was 
done on all patients upon admission to 
the study, taking care to note the presence 
of sepsis.
Host-Defence Measurements
Skin tests were performed with five 
recall antigens1 using the upper arm or 
volar surface of the forearm. No skin test­
ing or blood investigations were carried 
out in the first 24 hours after surgery, in 
order to avoid the effect of anesthetic 
agents on these measurements. The anti­
gens used were Candida (candidin 1:100 
dilution), mumps skin-test antigen 
(undiluted), purified protein derivative (5 
TU), trichophytin and streptokinase- 
streptodornase (Varidase, 100 units/ml) 
and were injected intradermally in a 
volume of 0.1 ml. A saline control was 
also used. The two greatest diameters of 
the resulting induration at 24 or 48 hours 
were measured, summed and divided by 
two, and the resulting mean sum for each 
antigen was noted. The erythema sur­
rounding the induration was ignored. The 
final results were recorded as a delayed- 
type hypersensitivity (DTH) score, 
defined as the sum of the average 
diameters of each individual antigen 
response, minus the saline control, as 
measured above. Serum albumin (g/L) 
and total protein (g/L) levels were meas­
ured by serum electrophoresis. The cir­
culating hemoglobin level (g/L) was 
measured in the laboratory. Whole blood 
neutrophil adherence to nylon wool was 
measured by a modification of 
McGregor’s technique.13 The adherence 
results were expressed as a percentage of 
total leukocytes that adhered to the nylon- 
wool column. Polymorphonuclear neu­
trophil (PMN) chemotaxis was measured 
by a modification of Boyden’s tech­
nique.14 The PMN chemotactic migra­
tion to an attractant (casein or 10% 
zymosan-activated serum) was expressed 
as the distance of cell migration in 
microns.
Data Collection
All patients had the following data 
recorded: demographic information 
including sex, age, diagnosis, medical his­
tory, previous related surgery, the timing 
of surgical interventions, the organ oper­
ated upon, and whether the operation was 
a clean, clean-contaminated, contami­
nated or dirty one. Also recorded was the 
presence or subsequent development of 
major sepsis and the final outcome and 
cause of death if this occurred.
Definitions
Major sepsis was defined as a positive 
blood culture, an abscess identified at sur­
gery or autopsy or confirmed by per­
cutaneous aspiration using computerized 
tomography or ultrasonic guidance, or a 
proven ascending cholangitis. Based on 
the autopsy report, or the death certifi­
cate if no autopsy was done, deaths were 
defined as septic if sepsis was the stated 
cause of death, septic related, if sepsis 
contributed to but was not the stated 
cause of death, or nonseptic if major sep­
sis as defined above did not occur during 
hospitalization.
Variables and Statistical Analysis
The variables determined to be signifi­
cantly different between survivors and 
nonsurvivors in univariate analysis from 
a previous study12 are: age (years), DTH 
skin-test score (mm), total serum protein 
level (g/L), serum albumin level (g/L), 
circulating hemoglobin level (g/L), neu­
trophil adherence (%), PMN chemotaxis 
(mm) and patient sex. Furthermore, the 
DTH skin-test score was related in an 
exponential manner to septic related mor­
tality. Thus, the natural logarithm of the 
DTH skin-test score was used in the 
modelling equation, along with the other 
seven variables. Stepwise, forward, logis­
tic regressions, were fitted to obtain esti­
mates of the risk of septic related death, 
corrected for multiple factors that con­
tributed to its development. The logistic 
function takes the following form:15
P | outcome = death | = 1 — {1 + exp 
( - b o-b ,x , -  ... — bkxk)}_ 1
where P is the probability of death, exp 
is the exponential function (natural 
logarithm), b0, b, ... bk are the coeffi­
cients to be estimated and x1; x2 ... xk are 
the independent variables.
Starting with the constant model (i.e., 
b0 as the only parameter), a variable was 
entered into the equation only if its addi­
tion increased the likelihood of the model 
with a significant p value (p < 0.05) using 
two-tailed tests of significance. This anal­
ysis was carried out with the statistical 
software from the Statistical Analysis Sys­
tem (SAS) version 82.4 at the McGill 
University computing centre in close con­
sultation with the Department of 
Epidemiology and Health.
Once the predictive equation was 
obtained, the fit was assessed on a 
separate, prospectively collected data base 
of 625 patients. The probability of septic 
related death for each patient was calcu­
lated, using the logistic regression equa­
tion, by entering the host-defence varia­
bles measured on admission. The patients 
were then grouped into deciles of risk, 
based on these probabilities. The 
observed septic related deaths within each 
decile were then compared to the expected 
cases, the latter being determined by sum­
ming the individual probabilities of each 
patient within the decile.
Results
Of the 499 patients assessed in the first 
part of the study, 95 died; 38 of the deaths 
could not clearly be defined as septic or 
septic related. These 38 patients were thus 
excluded from the analysis, leaving 461 
patients. The admitting diagnosis of these 
patients is shown in Table I. A wide spec­
trum of surgical diseases is represented, 
including both acute and elective admis­
sions. Over 80% of the patients under­
went a major surgical procedure. The 
variables entered into the logistic regres­
sion analysis and some additional patient 
characteristics are shown in Table II. Of 
the 57 deaths, 35 were classified as clearly 
due to sepsis and 22 as septic related. This 
classification was based on autopsy find­
ings in 81% of the deaths.
The final multiple logistic regression 
model is shown in Table III. The varia-
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bles of serum albumin, DTH score and 
age, in that order, contributed signifi­
cantly to the model. Sex (p = 0.1085) was 
retained in the model because of a previ­
ous clinical observation that women had 
a lower mortality overall than men fol­
lowing serious surgical illness.16 The neu­
trophil adherence and PMN chemotaxis, 
although they were significantly related 
to septic mortality when analysed 
individually, did not contribute to the 
prediction of septic related mortality in 
this multivariate analysis. This is not an 
uncommon finding. Strong predictor 
variables often replace weaker ones in 
such analysis. The total protein levels also 
did not contribute, as they were highly 
correlated with the serum albumin value. 
Their contribution to mortality lost sig­
nificance when the albumin was ac­
counted for. Similarly, the hemoglobin 
level did not contribute significantly to the 
predictability of the model.
Using the coefficients shown in Table 
III, we could calculate the probability of
septic related death of a particular surgi­
cal patient admitted to hospital from the 
following equation:
P j death | = 1 -  {1 + exp[1.343 -  1.372 
(albumin) — 0.173 In (DTH score) + 
0.026(age) -  0.522(sex)]}“ >
substituting for sex, the value of 1 for 
men and 2 for women. Figure 1 shows a 
plot of the calculated probabilities of sep­
tic related death for the 461 patients used 
to generate this equation with 95% con­
fidence limits for each probability. The 
model has reasonably narrow 95% con­
fidence intervals especially at low proba­
bilities of death. In other words, one can 
be more certain of a favourable outcome 
based on this model as compared with an 
adverse outcome. Using this equation, 
and substituting values for each variable 
progressing from best to worst measure­
ments, the mortality probability curve has 
the shape shown in Fig. 2. If three of the 
variables are kept constant and the fourth
is varied from the best to the worst, then 
the contribution of the individual varia­
ble to the overall probability of death can 
be determined (Figs. 3, 4 and 5).
Such an equation for predicting the 
actual probability of death of an 
individual patient, needs validation using 
a group of patients that is different from 
the one used to generate the model. The 
second part of this study involved the col­
lection of such a data base of 625 surgi­
cal patients. Their admission diagnoses 
are shown in Table IV and additional data 
profile in Table V. The only notable 
difference from the previous 461 patients 
is a lower number of severe trauma cases 
in this group. The rates of surgery, type 
of surgery (clean-contaminated, contami­
nated or dirty) and the degree of surgery 
were not significantly different.
The values for each patient’s age, 
serum albumin, logarithm (DTH score) 
and sex, all collected on admission, were 
entered in the predictive equation and a 
probability of death was calculated for
T a b le  1— A d m itt in g  D ia g n o s is  o f th e  4 6 1  P a t ie n ts  
U s e d  t o  D e r iv e  t h e  P r e d ic t iv e  E q u a tio n
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C a n c e r
E s o p h a g u s 1 3
S to m a c h 2 7
P a n c re a s 1 2
C o lo r e c tu m 9 0
O th e r 1 3
In f la m m a t o r y  b o w e l d is e a s e 4 0
G a s t r o in te s t in a l  b le e d in g 3 6
P a n c r e a t ic o b i l ia r y  t r a c t  d is e a s e 1 7
In t r a -a b d o m in a l  s ep s is 7 0
M is c e lla n e o u s 6 0
T a b le  I I — A d d it io n a l V a r ia b le s  a n d  
C h a r a c te r is t ic s  o f  t h e  4 6 1  P a t ie n t s  U s e d  
t o  D e r iv e  th e  P r e d ic t iv e  E q u a tio n
V a r ia b le V a lu e  (±  S D )
A g e , y r 5 7 . 2  ±  1 8 . 8
D T H  s c o r e , m m 1 5 . 6  ±  1 6 .8
N e u t r o p h i l  a d h e re n c e , % 7 7 . 6  ±  9 .5
P M N  c h e m o ta x is , f im 1 1 0 . 9  ±  1 3 . 9
S e r u m  a lb u m in , g/L 3 1 . 8  ±  6 .9
S e r u m  p r o te in ,  g /L 5 9 . 6  ±  1 0 . 3
S e x
M e n 2 6 8
W o m e n 1 9 3
D e a th s 5 7
FIG. 1—Probabilities of septic related death 
for 461 patients used to generate logistic regres­
sion model. Upper and lower 95% confidence 
intervals of each probability value are also 
shown.
FIG. 2—Shape of probability curve of sep­
tic related mortality when all predictive host- 
defence measurements are varied from best to 
worst values. Serum albumin level is varied 
from highest measured value of 48 g/L to 
lowest measured value of 14 g/L. Similarly, 
delayed-type hypersentivity (DTH) skin-test 
score is varied from 86 to 0 mm. Age is varied 
from 16 to 90 years. Sex is kept constant at 1.5.
T a b le  II I — A n a ly s is  fo r  C o n s tr u c t in g  E q u a tio n  t o  C a lc u la te  
P r o b a b il i t y  o f  S e p t ic  R e la te d  O u tc o m e
V a r ia b le * C o e f f ic ie n t p v a lu e
In t e r c e p t  (b 0) - 1 . 3 4 3
S e r u m  a lb u m in 1 .3 7 2 0 . 0 0 0 1
L o g a r i th m  (D T H  s c o re ) 0 . 1 7 3 0 . 0 0 3 7
A g e - 0 . 0 2 6 0 . 0 0 4 0
S e x 0 . 5 2 2 0 . 1 0 8 5
M o d e l x 2 -  5 6 . 6 ,  d f  -  4 , p <  0 . 0 0 1 ,  r -  0 . 3 9 2
'V a r ia b l e s  e n te r e d  t h e  m o d e l w h e n  p <  0 . 0 5 ,  e x c e p t  f o r  sex  w h ic h  w a s  re ta in e d  on c lin ic a l g ro u n d s .
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FIG. 3—Contribution of serum albumin 
level alone to overall probability of septic 
related death in this model; DTH score, age 
and sex are kept constant at their mean values 
and serum albumin is varied as in Fig. 2.
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FIG. 4—Contribution of DTH score alone 
to overall probability of septic related death 
in this model; serum albumin, age and sex are 
kept constant at their mean values and DTH 
score is varied as in Fig. 2.
serum albumin, DTH score and sex are kept 
constant at their mean and age is varied as in 
Fig. 2.
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each patient. The lowest probability was 
0 and the highest was 0.77. The expected 
deaths were then calculated within each 
probability decile as already described. 
For example, in the probability decile 0 
to 0.1, there were 384 patients. The sum 
of the individual probabilities of death 
was 17.2 — the expected number of 
deaths within this decile. The observed 
number of deaths in this decile was 17, 
indicating a good fit of the model. Figure 
6 shows the observed and expected sep­
tic related deaths for all deciles. There is 
an excellent fit of the model in this large 
separate set of surgical patients. The 
model predicted a total of 67.2 septic 
related deaths, and 72 deaths were 
observed. This discrepancy, which was 
not statistically different, was due to four 
patients who died from hemorrhagic 
shock secondary to bleeding from 
esophageal varices, a condition that this 
model was not expected to predict.
Discussion
Previous studies have clearly demon­
strated the strong association between 
abnormal host defence, as indicated by 
a decreased delayed hypersensitivity skin- 
test response, and septic related 
death.3-10 This was true in all surgical 
patients stratified by the first skin-test 
response upon entry to the study, in the 
subgroups of strictly elective patients 
preoperatively or in those admitted to the 
intensive care u n it.12 Johnson and 
colleagues3 found a sepsis rate of 8% 
and a mortality of 2% in reactive patients,
Table IV-Admitting Diagnosis for the 
625 Patients Used to Test the Validity 
of the Predictive Equation
Diagnosis No.
Trauma 10
Cancer
Esophagus 10
Stomach 29
Pancreas 16
Colorectum 116
Other 36
Inflammatory bowel disease 54
Gastrointestinal bleeding 62
Pancreaticobiliary tract disease 60
Intra-abdominal sepsis 82
Miscellaneous 150
Table V—Additional Variables and 
Characteristics of the 625 Patients Used 
to Test the Validity of the Predictive Equation
Variable Value (± SD)
Age, yr 60.2 ± 16.0
DTH score, mm 23.1 ± 20.1
Serum albumin, g/L 
Sex
3.36 ± 0.65
Men 310
Women 315
Deaths 72
compared with 30% and 16% respectively 
in anergic patients.7 The study of 
Griffith and Ross17 of 50 patients 
preoperatively who then underwent colon 
surgery, found a sepsis rate of 9% in reac­
tive patients, compared with 28% in aner­
gic patients. Associations between DTH 
and sepsis were found by Mullen and 
associates,6 Morath and associates,7 
Harvey’s group,8 Casey and colleagues,9 
Tasseau and colleagues5 and Kienlen and 
colleagues.10
All these studies evaluated one risk fac­
tor (i.e., abnormal host defence as indi­
cated by failed DTH responses). Con­
founding variables such as age and sex, 
were not adjusted for. Also, the DTH 
response was analysed as an ordered vari­
able (i.e., reactive, relatively anergic or 
anergic). The approach presented here not 
only accounts for the confounding vari­
ables of age and sex, but also expresses 
the DTH response on a numerical discrete 
scale of measurement. This allows for a 
high degree of quantification of this 
response, compared with the previous 
ordered approach.
The serum albumin level is the stron­
gest of the predicting variables, with a 
contribution to the overall correlation 
coefficient of the model of r = 0.262. It 
is tempting to hypothesize that this is due 
to the effects of chronic malnutrition on 
these patients. This is not readily accept­
able for several reasons. First, the data 
are collected on admission and include 
acutely traumatized patients, who were 
well nourished at the time. Second, when 
a strictly elective, preoperative patient 
subgroup is analysed, the serum albumin 
level does not contribute significantly to 
their outcome, even though some of these 
patients have clinical “ chronic malnutri­
tion” (unpublished data). Third, in the 
face of acute sepsis or trauma, the 
immediate reduction of the serum albu­
min level may not indicate malnutrition. 
The inability to correct the serum albu­
min levels to normal, despite adequate 
parenteral nutrition, a common finding, 
indicates that liver function is abnormal. 
Recent evidence suggests that, in acute 
stress, there exists a condition of protein
FIG. 6—Observed deaths and predicted sep­
tic related deaths in 625 patients used to test 
predictive model. Discrepancy at 0.2 and 0.4 
deciles, although not statistically different, is 
due to four deaths from hemorrhagic shock, 
which model was not designed to predict.
mobilization and proteolysis, part of it 
mediated by the interleukins, especially 
interleukin-1, released by m acro­
phages.18 Patients with trauma or sepsis 
have high levels of “ proteolysis-inducing- 
factor” activity which is thought to 
be a stable circulating product of 
interleukin-1. The ability to generate this 
activity and achieve hepatic synthesis of 
protein is essential to survival.19 This 
defect may be compounded by the acute, 
short-term denutrition that most of these 
patients undergo, until the decision is 
made to support them with parenteral 
nutrition or until they resume oral feed­
ing. It is more than likely that the low 
serum albumin levels indicate such an 
altered state in these patients. The defects 
in host defence, as indicated by the low 
DTH scores, and the “ acute stress” situ­
ation reduce the ability of the host to 
combat major life-threatening sepsis.
The DTH response is the next strongest 
predictor variable contributing an r value 
of 0.114 to the overall correlation coeffi­
cient of the model. The DTH skin-test 
score measured in these patients indicates 
a transient, acquired, immunodeficiency 
consisting of failure(s) of the immune sys­
tem at various levels. Such failure(s) could 
involve specific cell-mediated immune 
function or nonspecific inflammation, or 
both. This leads to decreased mobiliza­
tion of sufficient phagocytes to an area 
of bacterial invasion. The decisive period 
for establishment or eradication of an 
infection is the first 2 hours after bacterial 
invasion.20 The weakened inflammatory 
response mounted by these patients facili­
tates the establishment of the initial 
infection. The infection, which is itself 
immunosuppressive, creates a vicious cir­
cle. If the invaders break through these 
“ first-line” defences, then a local infec­
tion is established usually in the form of 
an abscess. This abscess must be con­
tained, otherwise the infection can 
become invasive by local extension or sep­
ticemia. At this level of infection control 
other failures of host resistance, indicated 
by suppressed DTH response, could 
include depressed antibody synthesis,21 
decreased complement levels and abnor-
FIG. 7—Effect of developing major sepsis 
following hospitalization on probability of sep­
tic related death. Two curves show death prob­
abilities when sepsis does (upper curve) or does 
not (lower curve) occur, in relation to chang­
ing remaining variables from best to worst 
values.
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mal function of the reticuloendothelial 
system.
The above hypothesis can be supported 
by deriving a logistic model, where the 
development of sepsis after admission is 
entered into the model as an independent 
variable, in addition to the variables 
measured on admission. This analysis is 
shown in Fig. 7. A patient with “ worse” 
host-defence values who subsequently 
suffers major sepsis has an increase in the 
probability of septic related death from 
0.35 to 0.9 or 0.55 points, compared with 
the patient who never has life-threatening 
sepsis in whom the septic related mortal­
ity remains at 0.35.
The ability to calculate precisely the 
risk of septic related death may be used 
clinically in choosing the most appropri­
ate treatment for a surgical patient. For 
example, an 82-year-old man with a car­
cinoma of the esophagogastric junction, 
a DTH score of 0 mm and an albumin 
level of 20 g/L, has a probability of death 
of 0.6 if he were to undergo palliative 
resection. With such a high measurable 
risk, one may consider radiotherapy 
rather than surgical resection with the 
possibility of a leak. If an anastomotic 
leak occurred, his probability of death 
would increase to more than 0.9. He 
would not handle this septic challenge 
well and would die. On the other hand, 
if his DTH score were 34 mm and his 
albumin level 34 g/L  the probability of 
death would be less than 0.1 (not con­
sidering further septic complications). In 
this situation the development of a leak 
would only increase the probability of
death to 0.18 and he would handle this 
septic challenge quite well. Another 
approach, though not clearly proven, 
might be an attempt to correct the abnor­
malities preoperatively with a 2-week 
course of nutrition.
Similar decisions can be reached using 
evaluations based on clinical assessment. 
The DTH score can be available within 
24 hours of admission and this can now 
be done in the surgeon’s office, before 
admission, at reasonable cost.22 Meas­
urement of the serum albumin level is part 
of any preoperative assessment. With a 
hand-held calculator the probability of 
septic related death of any surgical patient 
can be determined by using the logistic 
equation presented here. This ability to 
determine precisely the septic related risk 
of a surgical patient, allows for proper 
clinical decision-making and identifies a 
group of patients who should be studied 
in the future with the view of correcting 
these abnormalities and improving their 
clinical outcome.
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SESAP V Critique
ITEM  33
Multiple abscesses of the liver more commonly result in mortality than single abscess because of the difficulty of 
achieving adequate drainage. Multiple abscesses frequently are the result of hematogeneous spread or severe biliary tract 
disease. Although single abscesses may contain loculations, they can easily be broken up surgically to achieve good drainage. 
Anaerobic organisms, although more resistant to antibiotic treatment, are more commonly found in single abscesses, which 
can be easily drained. Although more abscesses are found in the elderly because of their increased incidence of biliary 
tract disease, neoplasia, and other diseases decreasing their resistance to infection, they do not have a worse prognosis 
when age alone is the variable.
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1986 ROUSSEL' LECTURE
Introduction
The Southern Ontario Surgical Society 
was founded in 1974 after a “ Day in Sur­
gery” for general surgeons held at 
McMaster University Medical Centre in 
Hamilton. Dr. J.E. Mullens was proba­
bly the major moving force in the initia­
tion of the society, whose prime objec­
tive is to promote professional, clinical 
and social activities of general surgeons 
in southern Ontario. It was agreed that 
the society would pursue these objectives 
by providing a forum for the discussion 
of clinical and professional problems 
related to the day-to-day practice of 
general surgeons, fostering education in
the field of general surgery for its mem­
bers and acting as a professional resource 
body for the surgeons of the area.
Roussel Canada Inc. undertook to 
sponsor a visiting professor for the 
region, and in 1980, the first Roussel lec­
ture was given by Dr. Malcolm Veiden- 
heimer. Roussel Canada sponsors the 
visiting professor for 3 days — 2 days are 
spent in the region with the local hospi­
tal staff surgeons and interested health 
professionals, the third day is the 
Southern Ontario Surgical Society annual 
clinical meeting. The keynote address at 
that meeting is the Roussel lecture deli­
vered by the visiting professor. The Cana­
dian Journal o f  Surgery has agreed to
publish the manuscript of this lecture if 
it is acceptable for publication.
This concept of a community visiting 
professor fulfils the important aspects of 
the objectives of the Southern Ontario 
Surgical Society and the society is grate­
ful to the Roussel Canada Inc. for its con­
tinued involvement and sponsorship.
P.R. Kn ig h t , mb, bs, frcs, frcsc
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Controversies in Biliary Tract Surgery
There are many controversies regarding 
the surgical management of calculous 
gallbladder disease. Newer data in the 
surgical literature and competing medical 
treatments compound this confusion. In 
this guest lecture the author reviews cur­
rent data and provides an update in 
seven controversial areas: the timing of 
operation in acute cholecystitis, the 
management of the diabetic patient with 
gallstones, the treatment of the patient 
with asymptomatic gallstones, the medi­
cal treatment of gallstones, the use and
*Professor o f  surgery. Chief, Division 
o f General Surgery, Loyola University 
Stritch School o f Medicine, Maywood, III.
Presented as the Roussel Lecture at the 
annual meeting o f the Southern Ontario 
Surgical Society, Niagara-on-the-Lake,
Ont., May 30, 1986
Accepted for publication June 12, 1986
Reprint requests to: Dr. J. Pickleman, 
Chief, Division o f  General Surgery, Loyola 
University Stritch School o f  Medicine, 2160 
South First Avenue, Maywood, IL 60153, 
USA
abuse of operative cholangiography, the 
management of the patient with gall­
stone pancreatitis and management of 
the patient with acalculous 
cholecystopathy.
II existe plusieurs controverses concer- 
nant le traitement chirurgical des calculs 
biliaires. Les donnees les plus recentes 
apparues dans la presse chirurgicale et 
dans les articles portant sur les traite- 
ments medicaux concurrents, n’ont servi 
qu'a aggraver la confusion qui entoure le 
sujet. L'orateur invite passe en revue les 
donnees actuelles et propose une mise h 
jour de sept sujets controverses: le choix 
du moment d'operer dans les cas de 
cholecystite aigue, le traitement du 
patient diabetique souffrant de calculs 
biliaires, le traitement du patient porteur 
de calculs asymptomatiques, le traite­
ment medical des calculs biliaires. 
I'emploi et I'abus de la cholangiographie 
operatoire, le traitement du patient souf­
frant de pancreatite calculeuse et le trai­
tement du patient atteint de cholecysto- 
pathie acalculeuse.
Operations on the biliary tract are com­
monly performed in a variety of hospital 
settings, outcomes are excellent, and there 
is thus a certain complacency regard­
ing the ease of management of calculous 
gallbladder disease. This obscures the 
reality that morbidity and mortality after 
biliary tract surgery are substantial in cer­
tain circumstances and that a number of 
competing treatments are being advo­
cated. Because of this, the modern-day 
biliary tract surgeon must be conversant 
with and utilize the most up-to-date data 
and management techniques if he is to 
render state-of-the-art care to his patients.
In this lecture I will review and update 
several controversial areas in biliary tract 
surgery in an attempt to form a consensus 
for the ’90s in each area. The topics 
include the timing of operation in acute 
cholecystitis, the treatment of acute 
cholecystitis in the diabetic patient, the 
treatment of the patient with asympto­
matic gallstones, the current status of the 
medical treatment of gallstones, the use 
and abuse of operative cholangiography, 
the treatment of gallstone pancreatitis and
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the treatment of the patient with acal- 
culous cholecystopathy.
Timing of Operation
It is surprising tha t although 
cholecystectomy is the most common 
abdominal operation performed by 
general surgeons, there is still debate 
about the optimal time to treat the patient 
with acute cholecystitis. This is mainly 
because of old data, indicating that 
patient mortality following emergency 
cholecystectomy for acute cholecystitis is 
greater than that of elective cholecystec­
tomy.1-2 At the outset, it should be 
understood that acute cholecystitis refers 
to patients who present with acute right 
upper quadrant pain, tenderness, local 
peritoneal signs, fever and leukocytosis, 
not those merely presenting with biliary 
colic.
This belief ignores several factors, not 
the least of which is the unpredictability 
of response to antibiotic therapy alone. 
Patients over 60 years old and those with 
diabetes mellitus will often fail to 
improve, and therefore medical treatment 
should consist of only nasogastric suc­
tion, volume resuscitation and antibiotics 
followed by urgent cholecystectomy.1-3'5 
Overall, at least 25% of patients with 
acute cholecystitis will fail to improve and 
run a significant risk of gallbladder gan­
grene and perforation. Even younger, 
nondiabetic patients may become 
progressively more septic on medical 
treatment, making a trial of medical ther­
apy unwise in nearly all. Most patients 
who do recover from acute cholecystitis 
with medical therapy alone will require 
cholecystectomy subsequently for persis­
tent or recurrent symptoms, so medical 
treatment does not avoid the operation, 
but merely postpones it. Sometimes acute 
cholecystitis will recur during this wait­
ing period or, when the operation is 
finally carried out, there will still be evi­
dence of acute cholecystitis, making the 
operation technically no easier than it 
would have been initially.6-7 Lastly, the 
patient who fails to improve with medi­
cal management who is then urgently 
operated upon has been said to have a 
substantially greater chance of death and 
serious complications,7 although recent 
data from our hospital indicate that even 
in those patients whose operation was 
delayed for up to 6 days, morbidity was 
not increased, although, of course, the 
total duration of hospitalization was 
lengthened.8 This study disclosed no sig­
nificant differences in mortality among 
389 patients operated upon for either 
acute or chronic cholecystitis (Table I), 
further underscoring the changes in out­
come brought about by modern anes­
thetic techniques, improved perioperative 
monitoring and intensive care, and the 
judicious use of antibiotics.8
Acute Cholecystitis in the 
Diabetic Patient
For years, it has been accepted that 
morbidity is increased after cholecystec­
tomy for acute cholecystitis in the diabetic 
patient. Not only is this view common 
sense, but it was supported by several 
large studies.9-11 Because of this 
increased risk and the perception that dia­
betic patients who undergo even elective 
cholecystectomy for cholelithiasis are at 
increased risk, various medical authori­
ties still advocate cholecystectomy in dia­
betic patients with asymptomatic gall­
stones while at the same time not 
recommending cholecystectomy for 
asymptomatic nondiabetic patients.12 
These recommendations are made regard­
less of whether the diabetes is controlled 
by insulin, drugs or diet alone.
Recently, however, several studies have 
demonstrated no increase in complica­
tions or mortality in diabetic patients who 
underwent cholecystectomy for either 
acute or chronic cholecystitis, with the 
consequent recommendation that diabetic 
patients with gallstones be treated no 
differently from their nondiabetic coun­
terparts.8-13-14 This has been supported in 
at least one prominent gastroenterology 
text.15
In our own series8 of 19 diabetic and 
101 nondiabetic patients with acute 
cholecystitis, similar major complication 
rates of 5.3% and 6.9% respectively were 
noted, even though the diabetic group 
was on average 11 years older than the 
nondiabetic group (66 versus 55 years). 
The only two deaths in this group of 120 
patients were in the nondiabetic group.8 
Thus, there appear to be no valid reasons 
to regard diabetic and nondiabetic 
patients with gallstones or acute 
cholecystitis differently, and that the deci­
sion to operate should be made indepen­
dently of the factor of diabetes.
The Patient With 
Asymptomatic Gallstones
Of all the disputes in the adversarial 
relationship between physicians and sur­
geons, few generate as much heat (and as 
little light) as the management of the 
patient with asymptomatic gallstones. On 
the one hand, the physician will recall that 
up to 20% of people in the United States 
harbour asymptomatic stones at autopsy, 
and that most stones produce symptoms 
before causing complications. Added to
this will be the recollection of an occa­
sional patient who underwent elective 
cholecystectomy, only to sustain various 
complications, a bile-duct injury or death. 
And lastly, the physician will remember 
at least a few patients whose dyspepsia 
persisted or worsened postoperatively. 
Additional ammunition to justify a course 
of inaction is provided by the periodic 
reports16 of an increased rate of colonic 
carcinoma after cholecystectomy.
The surgeon in turn could look at pub­
lished statistics showing extremely low 
mortality after elective cholecystectomy, 
an increasing number of older patients 
with common-bile-duct stones complicat­
ing their cholelithiasis, increased death 
rate after cholecystectomy in the elderly 
and a litany of disasters centring around 
patients known to have stones who 
presented with acute cholecystitis, ascend­
ing cholangitis, gallstone pancreatitis, 
gallstone ileus or even gallbladder car­
cinoma.
Several studies17-20 have indicated that 
if patients with asymptomatic stones are 
followed up for long periods, approxi­
mately 30% to 50% will experience 
symptoms, and that in perhaps one-third, 
these are severe, usually consisting of 
acute cholecystitis, common-bile-duct 
stones or gallstone pancreatitis. In each 
of these series, patients over 60 years of 
age were at greater risk with death rates 
of 7% to 15%.
Recently, a number of articles have 
been published strongly recommending 
that “ the silent gallstone” be allowed to 
requiescat in pace, indicating that perhaps 
only 20% to 30% of patients with stones 
ever experience symptoms. What has been 
overlooked is that most of these studies 
are by one group of investigators who 
looked mainly at small numbers of white 
professional men.21-24 Whether their con­
clusion supporting a nonoperative stance 
in all patients with asymptomatic stones 
is valid should await larger, more- 
representative studies.
What, then, should we recommend to 
patients with asymptomatic stones? Cur­
rent death rates for patients younger than 
60 years who undergo elective chole­
cystectomy are 0% to 0.2%,2-8-25 so it 
seems reasonable to recommend opera­
tion to any such person who is in good 
health and has a 10 to 15-year life expec­
tancy. Awaiting the onset of symptoms 
would not be supported by data from our 
institution, which showed that in 77% (92 
of 120) of our patients with acute
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cholecystitis, this was the first evidence 
of their disease.8 Also, early operation 
will decrease the number of operations on 
elderly patients and those requiring 
common-bile-duct exploration, with its 
increased morbidity, and will surely 
diminish the number of patients with gall­
bladder carcinoma, a condition that is 
rarely curable and is associated with gall­
stones 70% to 90% of the time.26-28
Medical Treatment of Gallstones
In years past, physicians and surgeons 
agreed that the treatment of calculous dis­
ease of the biliary tract was the responsi­
bility of the surgeon alone, and the death 
rates following the surgical treatment of 
gallstones became low to the point of 
inconsequence in many large series. Now 
a determined group of interventional phy­
sicians and radiologists have promised 
still lower morbidity, equal success and, 
of course, lower costs. With a variety of 
drugs, instillations, manipulations and 
percutaneous excursions ever deeper into 
the biliary tree, a wide variety of 
“ options” is being presented to the pub­
lic and to practising physicians who have 
not had the opportunity to evaluate crit­
ically the conflicting sets of data. Predic­
tably, the gallbladder has rebelled against 
many of these planned (and sometimes 
unplanned) forays into its domain, and 
a collection of side effects, complications 
and misadventures has accumulated anec­
dotally which has conveniently been 
ignored or excused by the dubious expec­
tation that “ new is better” .
Currently, the most popular alternative 
to cholecystectomy for patients with 
stones is the administration of cheno- 
deoxycholic acid which decreases the 
hepatic synthesis and secretion of 
cholesterol, thereby desaturating the bile. 
Numerous studies of the efficacy and 
safety of this drug have been carried out, 
including the National Cooperative Gall­
stone Study.29 In this study after 2 years, 
complete dissolution of stones was noted 
in only 13% of participants, while 41% 
achieved partia l d issolution. For 
chenodeoxycholic acid to be effective, a 
patient must have a functioning gallblad­
der and radiolucent stones. This 
eliminates approxim ately 15% of 
patients. If only 13% of patients obtain 
complete dissolution then only 11% of 
the total number may benefit assuming 
that the 41% of patients with smaller 
stones represent a failure of the treat­
ment. Furthermore, the drug must be 
continued indefinitely as there is a high 
risk of stone recurrence after the drug is 
withdrawn. If one considers the diarrhea 
that occurs in some patients, the 3% rate 
of serious liver toxicity and the approxi­
mate 10% increase in serum level of low- 
density-lipoprotein cholesterol, it is clear
that chenodeoxycholic acid is no 
panacea.29' 31
Because of these considerations, a bet­
ter dissolving agent is being sought. Cur­
rently, ursodeoxycholic acid is being 
investigated, with preliminary reports of 
equal effectiveness (or ineffectiveness) but 
decreased side effects.32 Ursodeoxycholic 
acid is not currently approved for use in 
the US.
Recently, a highly innovative method 
of stone dissolution has been attempted 
at the Mayo Clinic. This involves per­
cutaneous transhepatic puncture of the 
gallbladder with subsequent instillation of 
methyl tert-butyl ether; cholesterol gall­
stone may be dissolved within hours;33 
so far, approximately 25 patients have 
been safely treated, but obviously it is 
premature to speculate on the usefulness 
of this therapy (Thistle JL: Personal com­
munication, 1986). Lastly, encouraged by 
the urologists’ success with extracorporeal 
shock-wave lithotripsy in fragmenting 
renal calculi, some investigators are using 
the technique for gallstone fragmentation 
with modest success. But because of the 
expense of the machine, the need for 
general anesthesia and the problem of 
stone fragments being flushed into the 
common duct, it is unlikely that this mode 
of treatment will ever be popular.34
All the above treatments must be com­
pared with the standard treatment — elec­
tive cholecystectomy — which, for 
patients under 50 years of age, carries a 
death rate of approximately 0.05% to 
0.1%.2,3,8,25 It is a dubious proposition at 
best, that current nonsurgical alternatives 
will succeed in lowering the overall death 
rate over the lifetime of the patient, when 
stone recurrences, need for multiple treat­
ment sessions and the complications of 
treatment and subsequent stone disease 
are taken into consideration.
Use and Abuse of 
Operative Cholangiography
Many surgeons believe that operative 
cholangiography is an integral part of 
cholecystectomy. Numerous early papers 
attest to its safety and advantages, which 
include a decrease in the number of 
unnecessary common-bile-duct explora­
tions in patients with clinical or labora­
tory indications for duct exploration and 
the detection of unsuspected common- 
bile-duct stones.35-38 Another argument 
has recently been put forth to support 
routine cholangiography, namely a 
medicolegal one in which it may be con­
sidered deviant surgical practice not to 
perform cholangiography.
The recent surgical literature argues for 
a different stance. In patients with no 
clinical or laboratory indications of 
common-bile-duct stones, unsuspected 
stones are actually present in less than
1%.39-41 Moreover, it is clear that many 
common-bile-duct stones either remain 
silent or pass spontaneously. With the 
advent of endoscopic sphincterotomy, a 
missed common-bile-duct stone is no 
longer the problem it once was.
Added to these arguments must be the 
disadvantages of operative cholangiogra­
phy: increased operating and anesthesia 
time (up to 30 minutes in some series),42 
increased surgical and anesthesia fees, 
charges for radiologic studies, increased 
operating-room supplies, false-positive x- 
ray films leading to unnecessary common- 
bile-duct exploration and technical 
problems at the time of cholangiography 
that lead to duct injury or the need for 
placement of a T-tube.43
Taking all these issues into considera­
tion, I would favour the implementation 
of nonroutine operative cholangiography 
in patients who undergo cholecystectomy, 
a position supported by surgeons.39-45 I 
favour operative cholangiography if there 
is a history of pancreatitis or jaundice, a 
substantial elevation in any of the liver 
function test values, operative findings of 
an enlarged common bile duct (greater 
than 1 cm), an enlarged cystic duct or pal­
pable common-bile-duct stones. In these 
circumstances use of operative cholan­
giography should prove cost-effective and 
should minimize the number of over­
looked common-bile-duct stones.
Treatment of Gallstone Pancreatitis
There are perhaps only two areas of 
universal agreement regarding patients 
with gallstone pancreatitis. First, the con­
dition is caused by passage of gallstones 
into the common bile duct resulting in 
temporary obstruction of the pancreatic 
duct. This has been proven by the recov­
ery of stones in the stools of such patients 
in contrast to the absence of stones in the 
stools of patients with other forms of 
pancreatitis.46,47 Second, that after an 
attack of pancreatitis in a patient with 
gallstones, cholecystectomy must be per­
formed to prevent future attacks, which 
will occur in up to 60% of patients within 
6 months.48,49
There are two schools of thought 
regarding the management of patients 
presenting with gallstone pancreatitis: 
those favouring operation within 24 hours 
of an attack and those favouring initial 
treatment with fluids and nasogastric suc­
tion, then cholecystectomy as soon as 
symptoms subside and the serum amylase 
level returns to normal. Those who 
favour operation within 24 hours claim 
an improved outcome, the finding of 
common-bile-duct stones in up to 75% of 
patients,50,51 the elimination of impacted 
common-bile-duct stones and continuing 
severe pancreatitis, and concomitant
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acute cholecystitis in 14% to 31% of 
patients.49,51
The latter group, however, is in the 
majority. It has been repeatedly noted 
that 85% to 95% of patients with gall­
stone pancreatitis will recover after 
nasogastric suction and fluid replacement 
so elective cholecystectomy can be under­
taken.48,49,52 If such a protocol is fol­
lowed, less than 15% of patients will be 
found to harbour common-bile-duct 
stones at operation, compared with the 
65% to 75% noted when earlier opera­
tion is undertaken; therefore fewer 
patients will require common-bile-duct 
exploration and possible manipulation 
and instrumentation of the sphincter of 
Oddi. Lastly, operation within 48 hours 
of the onset of symptoms has been 
associated with death rates ranging from 
12% to 31% in three published 
series.48,52,53
In summary, the weight of opinion 
favours cholecystectomy and operative 
cholangiography in all patients with gall­
stone pancreatitis after symptoms have 
subsided and before hospital discharge. 
For patients exhibiting persistent or wor­
sening symptoms, endoscopic papil­
lotomy may be performed.54 If symp­
toms worsen or if papillotomy cannot be 
performed, cholecystectomy should be 
undertaken immediately.
Acalculous Cholecystopathy
Despite considerable evidence to the 
contrary, many surgeons are sceptical of 
the existence of such an entity as acal­
culous cholecystopathy.55'57 Yet all 
experienced clinicians have seen patients 
with biliary colic and normal findings on 
conventional radiologic studies of the 
gallbladder who were cured by chole­
cystectomy. Although one of the major 
problems regarding this condition is the 
lack of a specific diagnostic test, other 
problems such as tissue-committee con­
siderations, difficulties of informed con­
sent, the frequently normal histologic 
findings and the surgeon’s natural reluc­
tance to remove a “ normal” organ all 
complicate the clinical situation. The 
results of cholecystectomy for vague 
upper abdominal pains or dyspepsia are 
predictable in that the symptoms may 
often persist postoperatively. But if only 
patients with classic recurrent biliary colic 
disease are considered, and if other gas­
trointestinal disease has been ruled out, 
over 90% of patients will be completely 
relieved of their symptoms. Often, these 
patients will have seen many physicians, 
including psychiatrists, and will repeat­
edly have had normal findings on oral 
cholecystography and ultrasonography. 
Biliary colic is often present for years 
before cholecystectomy is recommended.
In the search for a useful diagnostic
test, endoscopic retrograde cholangiopan­
creatography, duodenal drainage and 
cholecystokinin-stimulated oral chole­
cystography have all been used with varied 
success.56,58,59 Recently, we have begun 
using sincalide cholescintigraphy, stand­
ard radioisotope biliary excretion scan­
ning coupled with sincalide (cholesystoki- 
nin) administration to stimulate gallblad­
der emptying.55 The percentage of iso­
tope cleared from the gallbladder can then 
be expressed as the gallbladder “ ejection 
fraction” , and less than 50% emptying 
is considered abnormal. Although this 
test will not be abnormal in all patients 
with this syndrome, it can provide the 
doctor and the patient with added reas­
surance that biliary tract disease may be 
present. Figures 1 and 2 show, respec­
tively, a normal and abnormal response 
to sincalide administration in two patients 
with acalculous cholecystopathy.
Until a definitive test is available, the 
history of classic recurrent biliary colic in 
a patient with normal results from con­
ventional biliary tract studies and an 
upper gastrointestinal series is sufficient 
to recommend cholecystectomy. If facil­
ities are available, Sincalide cholescintig­
raphy can be carried out if the patient 
wishes additional reassurance. The histo­
logic findings of the resected gallbladder 
will often be normal,55,56 but nearly all 
patients will be relieved of their symp­
toms. Over the past 13 years, I have 
studied over 100 such patients; 65 have
no4 GfltiflJDOfS
FIG. 1—Sincalide cholescintigraphy. Nor­
mal gallbladder response with 88% ejection 
fraction (EF).
FIG. 2—Sincalide cholescintigraphy. Abnor­
mal gallbladder response with 19% ejection 
fraction (EF).
undergone cholecystectomy and all but 2 
were relieved of their pain. Other series 
in the literature have noted comparable 
success, and so whatever name one wishes 
to attach to this entity, there is no longer 
any reason to doubt its existence.57,60'62
Conclusions
Although the seven topics I have 
covered are by no means the only areas 
of controversy in biliary tract surgery, I 
hope this review has proven useful in 
attempting to resolve some of the conflict­
ing data in the medical and surgical liter­
ature, particularly with regard to compet­
ing therapies. Before these are accepted 
as the standard of care, we must insist on 
the same careful studies and critical evalu­
ation of results that surgeons have con­
tributed to the literature over the past 50 
years. Although some of the current alter­
natives may ultimately prove to have 
merit, most will likely go the way of other 
highly acclaimed medical memorabilia 
such as the iron lung, gastric freezing and 
bloodletting.
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including piperacillin. These reactions have sometimes been associated w ith  abnormalities of coagulation tests 
such as clotting tim e, platelet aggregation and prothrombin time and are more likely to occur in patients w ith 
renal failure.
If bleeding manifestations or significant leukopenia occur, PIPRACIL* should be discontinued and appropriate 
therapy instituted.
The possibility o f the emergence of resistant organisms and the development of superinfections should be kept in 
mind, particularly during prolonged treatment. As w ith  other penicillins, patients may experience neuromuscular 
excitability or convulsions if higher than recommended doses are given intravenously.
Dosage adjustment should be made in renal insufficiency.
PIPRACIL* is a monosodium compound containing 1.98 milliequivalents (45.5 mg) of Na +  per gram based on 
vial content which includes the U.S.P. allowed average. The calculated value, based on molecular weight is 1.85 
mEq/g (42.55 mg). Periodic electrolyte determinations should be made in patients w ith  low potassium reserves 
and the possibility of hypokalemia should be kept in mind w ith  patients who have potentially low potassium 
reserves, receiving cytotoxic therapy or diuretics. Electrolyte and cardiac status should also be monitored during 
prolonged-treatment in patients w ith  impaired cardiac function.
Prior to treatment, patients w ith gonorrhea should also be evaluated for syphilis. Specimens for darkfield 
examination should be obtained from patients w ith  any suspected primary lesions, and serologic tests should be 
performed. In all cases where concomitant syphilis is suspected, monthly serological tests should be made for a 
minimum of 4 months.
The use of penicillins lampicillin, amoxicillin) has been associated w ith  morbilli form rashes in some cases of 
infectious mononucleosis. PIPRACIL* should be used w ith caution in the treatment of patients w ith  infectious 
mononucleosis.
Drug Interactions: The mixing of PIPRACIL* w ith  an aminoglycoside in vitro can result in substantial inactivation 
of the aminoglycosides.
Usage During Pregnancy or Lactation: Safety of PIPRACIL* use in pregnant women has not been determined. 
Because animal reproduction studies are not always predictive of human response, this drug should be used 
during pregnancy only if clearly needed. It has been found to cross the placenta in rats. Caution should be 
exercised when PIPRACIL* is administered to nursing mothers. It is excreted in low  concentrations in milk. 
Pediatric Use: Dosages for children under the age of 12 have not been established.
ADVERSE REACTIONS: PIPRACIL’  is generally well tolerated. The most common adverse reactions have been 
local in nature, fo llow ing intravenous or intramuscular injection. The following adverse reactions may occur:
Local Reactions-ln clinical trials thrombophlebitis was noted in 3.8% of patients. Pain, erythema, and/or 
induration at the injection site in 1.9% of patients. Less frequent reactions: ecchymosis, deep vein thrombosis 
and hematomas. Hypersensitivity Reactions-Rash was noted in 1.9% of patients. Drug fever 2.1%. Less 
frequent findings: Pruritus, vesicular eruptions, positive Coombs tests. Gastrointestinal-Diarrhea and loose 
stools were noted in 2.8% of patients. Less frequent reactions: vomiting, nausea, bloody diarrhea. 
Hepatic-Increases in liver enzymes (LDH, SGOT, SGPT), hyperbilirubinemia. Rarely, cholestatic hepatitis. 
Renal-Elevations o f creatinine or BUN. Central Nervous System-Headache, dizziness, fatigue Hemic and 
Lym phatic-Reversible leukopenia, thrombocytopenia and/or eosinophilia, bleeding and decreases in prothrombin 
time have been reported. Reversible leukopenia (neutropenia) is more apt to occur in patients receiving prolonged 
therapy at high dosages or in association w ith drugs known to cause this reaction. Serum Electrolytes-lndividualt 
w ith  liver disease or individuals receiving cytotoxic therapy or diuretics, were reported rarely to demonstrate a 
decrease in serum potassium concentrations w ith  high doses of PIPRACIL*. Musculo-Skeletal-Rarely, prolonged 
muscle relaxation. Other-Superinfection, including candidiasis.
ADMINISTRATION
Intramuscular: When indicated by clinical and bacteriological findings, intramuscular adminstration of 6 to 8 g 
daily of PIPRACIL* in divided doses, may be utilized for initiation of therapy and this route may be considered for 
maintenance therapy after clinical and bacteriologic improvement has been obtained w ith  intravenous piperacillin 
sodium treatment. Administration should not exceed 2 g per injection at any one site. This route has been used 
primarily in the treatm ent of patients w ith  uncomplicated gonorrhea and urinary tract infections.
Adults and Children More Than 12 Years of Age: The reconstituted solution is given by deep intramuscular 
injection. The preferred site of injection is the upper outer quadrant of the buttock li.e. gluteus maximusl. Also 
may be given in the mid-lateral muscles of the thigh. The deltoid area should be used only if well developed, and 
then only w ith  caution to avoid radial nerve injury. Intramuscular injection should not be made into the lower or 
mid-third of the upper arm.
Intravenous: The intravenous route should be used in the treatment of serious infections.
Direct Intravenous (Bolus) Injection: The vials should be reconstituted w ith  5 mL of suitable diluent listed below 
and the resulting solution should be injected slowly over a period of 3 to 5 minutes to help avoid vein irritation. 
Intravenous Infusion: A dilution of at least 15 mL per gram is recommended to reduce potential for vein 
irritation. The reconstituted and diluted solution may be administered by interm ittent or continuous drip.
Intermittent infusion should be administered over a period of about 30 minutes. During intermittent infusion it is 
desirable to discontinue the primary intravenous solution. Any unused portion must be discarded. For continuous 
infusion the solution may be administered over a longer period of time 
RECONSTITUTION
For Intramuscular Use: Solutions for Reconstitution: Sterile Water for injection, or if required Bacteriostatic 
Water for Injection, Lidocaine HC1 0.5 or 1% (without epinephrinel-For Intramuscular Use Only 
For Intravenous Use: Solutions for Reconstitution: Sterile Water for Injection, or if required, Bacteriostatic Water 
for Injection. Either parabens or benzyl alcohol. Lidocaine HC1 is contraindicated in patients w ith  a known history 
of hypersensitivity to local anesthetics of the amide type.
RECONSTITUTION TABLE
Product Size
Volume of Diluent 
to be added
Approximate Available 
Volume
Approximate Average 
Concentration
Vials 2 g 4.0 mL 5.0 mL 1 g/2.5 mL
39 6.0 mL 7.5 mL 1 g/2.5 mL
4g 7.8 mL 10.0 mL 1 g/2.5 mL
Infusion Bottles
3g 15 mL 17 mL
4g 20 mL 23 mL
The prepared solution may be further diluted to the desired volume w ith any of the solutions for intravenous 
infusion listed below.
The contents of the 3 and 4 g infusion bottles should be diluted to at least 15 mL per gram.
The appropriate quantity of reconstituted solution may be added to an intravenous bottle or bag containing any 
of the solutions for intravenous infusion listed below.
Solutions for Intravenous Infusion:
Intravenous Solutions:
5% Dextrose in Water (DsW).
0.9% Sodium Chloride (Normal Saline) (NS). 
Dextrose 5% and 0,9% Sodium Chloride (D&NS) 
Lactated Ringer's Injection, U.S.P.
Dextran 6% in 0.9% Sodium Chloride
Intravenous Admixtures:
Normal Saline I +  KCL 40 mEq.)
5% Dextrose/Water (Dr.WI I +  KCL 40 mEq).
5% Dextrose/Normal Saline ID«.NS) ( +  KCL 40 mEq). 
Ringer's Injection, U.S.P. I +  KCL 40 mEq).
Lactated Ringer's Injection, U.S.P. ( +  KCL 40 mEq).
STABILITY OF SOLUTIONS: PIPRACIL’  is stable in both glass and plastic containers when reconstituted w ith 
recommended diluents and further diluted w ith  the indicated intravenous solution and intravenous admixtures. 
Stability studies have demonstrated chemical stability (pH, potency and clarity) through 24 hours at room tern 
perature and up to 72 hours refrigerated. Appropriate consideration of aseptic technique, however, recommends 
discarding unused portions after storage for 24 hours at room temperature or 48 hours refrigerated. If used as a 
multi-dose container, the vials must be reconstituted only w ith the bacteriostatic diluents noted above 
INCOMPATIBILITY: Because of chemical instability, PIPRACIL* should not be used for intravenous 
administration w ith solutions containing sodium bicarbonate.
PIPRACIL* should not be added to blood products, protein hydrolysates or ammo acids.
When PIPRACIL* is given concurrently w ith  aminoglycosides, it is recommended that both drugs be used in full 
therapeutic doses, but administered separately. PIPRACIL* should not be mixed w ith an aminoglycoside in a 
syringe or infusion bottle, since this can result in inactivation to the aminoglycoside.
DOSAGE FORMS: PIPRACIL* (sterile, lyophilized piperacillin sodium) is available in vials containing amounts of 
piperacillin sodium equivalent to 2, 3 and 4 grams of piperacillin. Available in boxes of 12 vials.
Product Numbers: 2 g/vial-3879-48 3 g/vial-3882 49 4 g/vial-3880-50.
Available in 100 mL size infusion ("piggyback") bottles, containing sterile, freeze-dried piperacillin sodium powder 
equivalent to 3 and 4 grams of piperacillin. Boxes of 12 infusion bottles.
Product Numbers: 3 g/bottles-3882-41 4 g/bottles-3880-42.
Pipercillin Sensitivity Discs impregnated w ith  100 jzg of piperacillin are also available.
Storage: PIPRACIL'vials and infusion bottles should be stored at controlled room temperatures of 15 30°C 
(59-86°FI.
Pipercillin Sensitivity Discs should be refrigerated upon receipt. Product Monograph available on request. 
DOSAGE AND ADMINISTRATION: PIPRACIL* may be administered by the intramuscular route or intravenously 
by injection or infusion. Dosage and route of administration should be determined by the severity of the infection 
and condition of the patient. The usual dosage for serious infections is 3 to 4 grams given every 4 to 6 hours as a 
20 to 30 minute infusion administered intravenously. The maximum daily dose usually administered to adults is 
24 g/day, although higher doses have been used.
DOSAGE
Type of Infection Usual Total Daily Dosage Frequency of Administration
Serious infections such as septicemia, nosocomial 12-18 9 1.V. Every 4 to 6 hours
pneumonia, intra-abdominal infections, aerobic (200-300 mg/kql
and anaerobic gynecologic infections, and skin
soft-tissue infections.
Complicated urinary tract infections. 8-16 g I.V. (125-200 mq/kq) Every 6 to 8 hours
Uncomplicated urinary tract infections and most 6-8 g I.M. or I.V. Every 6 to 12 hours
community-acquired pneumonia. 1100-125 mg/kg)
Uncomplicated gonococcal urethritis. 2 g I.M.* Single dose
* 0 ne gram of probenecid given orally 1/2 hour prior to injection.
Dosage in Renal Impairment
Creatinine Clearance 
mL/min.
Urinary Tract Infection Urinary Tract Infection 
(uncomplicated) (complicated)
Serious Systemic 
Infection
> 4 0 No dosage adjustment necessary
20-40 No dosage adjustment necessary 9 g/day 3 g every 8 hrs. 12 g/day 4 g every 8 hrs.
< 2 0 B g/day 3 g every 12 hrs. 6 g/day 3 g every 12 hrs. 8 g/day 4 g every 12 hrs.
Patients on 
Hemodialysis*
•Hemodialysis removes 30-50% of piperacillin in 4 hours; 
1 g additional dose should be administered following 
each dialysis period.
6 g/day 2 g every 8 hrs.
additional guidance for adjusting dosage.
Infants and Children-Dosages in infants and children under 12 years of age have not been established.
The average duration of PIPRACIL* treatment is from 7 to 10 days, except for gynecologic infections, in which 
it is from 3 to 10 days; the duration should be guided by the patient's clinical and bacteriological progress. For 
most acute infections, treatment should be continued for at least 48 to 72 hours after the patient becomes 
asymptomatic. Therapy for Group A beta-hemolytic streptococcal infections should be maintained for at least 10 
days to reduce the risk of rheumatic fever of glomerulonephritis.
OBSTETRICS-GYNECOLOGY
1. Gilstrap LC III et al. Piperacillin versus clindamycin plus gentamicin for pelvic infections Obstet Gvnecol 
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Hepatic Resection for Metastatic Disease
Hepatic resection fo r m etasta tic disease 
is reviewed in 30 patients (mean age 
58 .9  years). The primary site w as the 
colorectum  in 25; the other primary 
tumours were leiomyosarcoma, plas­
macytoma, and adenocarcinoma (all of 
gastric origin), ocular melanoma and an 
unknow n primary. Operative procedures 
included 7 wedge resections, 5 segmen- 
tectom ies and 21 lobectom ies (11 right, 
4  extended right and 6 le ft). M ajor com ­
plications in seven patients included 
intraoperative hemorrhage in three, tw o  
o f whom died, bile-duct in jury in tw o , 
small-bowel in farction in one and 
cerebrovascular accident in one. Opera­
tive  death rate was 6 .7 %  (2 o f 30).
Thirteen patients were alive and free 
o f disease a mean o f 24  m onths after 
hepatic resection w hile  5 more were 
alive w ith  disease at a mean o f 36 .9  
months. Life-table analysis projected a 
5-year survival o f 50 .3%  for those w ith  
colorectal primaries, w ith  no apparent 
d ifference in survival between patients 
w ith  single (55 .0% ) and m ultiple 
(54 .0% ) metastases. Improved survival 
was projected fo r patients w ith  
metachronous (66 .6% ) versus syn­
chronous (45.0% ) tum ours, primary 
Dukes' class A or B (66 .1% ) versus 
Dukes' class C (46 .0% ) tum ours and 
those having wedge resection or seg- 
m entectomy (66 .6% ) versus lobectom y 
or extended lobectom y (48 .0% ).
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Hepatic resection fo r m etasta tic d is­
ease can be done w ith  acceptable m or­
b id ity and m orta lity  and the expectation 
o f substantia lly prolonged survival partic ­
ularly in patients w ith  m etachronous 
lesions or Dukes' A  or B colorectal 
primary lesions.
On a etudie les resultats de la resection 
de metastases hepatiques pratiquee chez 
30 patients (age moyen de 58 .9  ans). 
Dans 25 cas, le foyer tum oral p rim itif 
e ta it localise au colon ou au rectum ; les 
autres tumeurs prim itives etaient un 
leiomyosarcome, un plasmacytom e et un 
adenocarcinome (tous d 'orig ine gastri- 
que), un melanome oculaire et une d 'o r i­
gine inconnue. Les operations pratiquees 
comprennent 7 resections cuneiform es,
5 segmentectom ies et 21 lobectom ies 
(11 droites, 4 droites etendues e t 6 gau- 
ches). Des com plications majeures ont 
ete enregistrees chez sept patients: 
hemorragie operatoire dans trois cas, 
dont deux deces, lesion du choledoque 
dans deux cas, in farctus de I'in tes tin  
grele dans un cas et un accident cerebro- 
vasculaire. La m orta lite  operatoire a ete 
de 6 .7 %  (2 cas sur 30).
Treize patients v ivent toujours sans 
maladie apparente, 24  mois en moyenne 
apres resection hepatique; 5 autres sont 
v ivants mais malades apres 36 .9  mois 
en moyenne. Une analyse actuarielle a 
projete une survie a 5 ans de 5 0 .3%  
pour ceux qui ont des tumeurs co lorecta- 
les prim itives, sans d ifference apparente 
entre les patients porteurs de metastases 
uniques (55 .0% ) ou m ultiples (54 .0% ). 
Une amelioration de la survie a ete proje- 
tee pour les patients sou ffran t de 
tumeurs metachrones (66 .6% ) par rap­
port aux tum eurs synchrones (45 .0% ), 
pour les tumeurs prim itives de classe A 
ou B dans la c lassification de Dukes 
(66 .1% ) par rapport aux tumeurs de 
classe C (46 .0% ) et pour les patients qui 
ont subi une resection cuneiform e ou 
une sementectom ie (66 .6% ) par rapport
a une lobectom ie ou une lobectom ie 
etendue (48 .0% ).
La resection des m etastases hepati­
ques peut etre e ffectuee avec une m orb i­
d ity  et une m orta lite  acceptables, et avec 
I'esperance d 'une  survie ne ttem en t pro- 
longee, particu lie rem ent chez les patients 
sou ffran t de tum eurs m etachrones ou de 
lesions colorectales p rim itives de classe 
A  ou B dans la c lass ifica tion  de Dukes.
An aggressive approach to resection of 
solitary and multiple unilobar liver 
metastases from primary colorectal 
adenocarcinoma has been advocated 
recently by numerous authors.18 This 
recommendation has been based upon 
data that suggest improved length and 
quality of survival for patients who had 
resection compared with those in whom 
the natural history of metastatic liver dis­
ease was studied,9,10 and those who were 
treated without resection.11,12 Although 
less than 15% of patients with colorectal 
cancer and liver metastases will be can­
didates for resection, 5-year survival in 
the range of 20% to 25% has been 
reported.8,10,12,13
This report summarizes the McGill 
University experience with hepatic resec­
tion for metastatic disease over the last 
10 years; 80% (24 of 30) of the resections 
were carried out after 1980.
Patients and Methods
The charts of patients who underwent 
hepatic resection for metastatic disease at 
four McGill University teaching hospitals 
between 1974 and 1985 were reviewed. 
Although we believe that all major 
hepatic resections are included, an 
unknown number of wedge resections 
may have escaped review because of 
incomplete coding of the medical record 
for secondary surgical procedures. Most 
resections (85%) were done in two hospi­
tals by three of the coauthors (M.W., 
J.R., A.P.M.).
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In addition to general demographic 
information, data included the grade, 
stage and site of primary tumour, the size, 
number and interval to diagnosis of liver 
metastasis, and the relevant laboratory 
and diagnostic tests performed preoper- 
atively. The extent of surgery, morbidity, 
mortality, adjuvant therapy and survival 
status of each patient were also recorded. 
Life-table analysis was used to express 
survival.
Findings
Thirty patients, 15 men (mean age 60 
years) and 15 women (mean age 56.7 
years), underwent hepatic resection for 
metastatic disease. The site, stage and 
grade of the primary tumour is outlined 
in Table I. The site of primary tumour 
was predominantly the colorectum (25 
patients). The liver metastases were syn­
chronous in 17 patients and meta­
chronous in 13. Metachronous disease 
was diagnosed within 2 years of the 
primary tumour resection in two patients 
and a mean of 40 months after resection 
in the other 11.
Among the 25 patients with primary 
colorectal cancer, 14 had liver metastasis 
synchronous with their primary tumour 
and 11 had metachronous disease that 
was diagnosed a mean of 34 months after 
resection of the primary tumour in 9 and 
within 2 years in 2. Fifteen patients had 
solitary metastases, 10 had multiple
lesions. In eight patients, the multiple 
metastases were confined to one lobe; the 
other two had lesions in both lobes, 
requiring a right lobectomy and a left 
wedge resection in one and bilateral seg- 
mentectomies in the other. Relevant 
demographic data and tumour charac­
teristics for all patients with colorectal 
cancer are presented in Table II.
The alkaline phosphatase level was 
elevated in 10 (35.7%) of 28 patients in 
whom it was measured while the serum 
aspartate aminotransferase (SGOT) level 
was elevated in 4 (14.3%) of 28. The car- 
cinoembryonic antigen (CEA) value was 
elevated in 20 of 24 patients who had 
primary colorectal tumours. All four 
patients with a normal CEA value had 
synchronous metastases.
Ultrasonography of the liver revealed 
metastases in 23 of 24 patients, and liver 
and spleen scanning also demonstrated 
malignant lesions in 19 of the 20 patients 
in whom it was performed. Computerized 
axial tomography indicated malignant 
disease in 12 of 14, as did angiography 
in 18 of 19 patients. No patient had more 
than one false-negative test result 
although the number and size of 
metastases were occasionally underesti­
mated. With the exception of one false­
negative liver and spleen scan that missed 
a lesion 9 cm in size, all missed lesions 
were smaller than 4.5 cm in their greatest 
diameter.
Selected operative data are detailed in 
Table III. Operating time, estimated 
blood loss and the 24 hour perioperative
Table 1-Characteristics of Primary Tumour
Site
Total no. 
patients
Dukes'
stage
No.
patients
Broder's
grade*
No.
patients
Colorectum 25 A 3 1 5
B 7 2 6
C 14 3 5
Unknown 1 4 1
Unknown 8
Gastric - - - -
Leiomyosarcoma 1
Adenocarcinoma 1
Plasmacytoma 1
Melanoma (ocular! 1 — - -
Unknown primary 1 - - - —
'Grade 1 to grade 4, well differentiated to poorly differentiated.
Table II—Selected Demographic Data and Tumour Characteristics in 25 Patients With Colorectal Cancer
Age,
yr Sex
Tumour
site Stage' Gradet
Synchronous
or
metachronous
Size,
cm
Solitary
or
multiple Operation
Major
morbidity
Survival,
mo
Current
status
54 F Colon C — S 10 M L segmentectomy — 11 DWD
40 F Colon C - S 2 S R wedge resection — 33 AFD
27 F Colon c - S 24 S R lobectomy - 9 DWD
43 F Rectum c 1 s 8 M R lobectomy - 82 AFD
75 M Colon c 4 s 6 M R lobectomy HEM 16 DWD
46 F Colon c 3 s 5 M R lobectomy +
L wedge resection - 11 AFD
61 M Rectum c 2 s 9 S R segmentectomy - 1 AFD
51 F Rectum c 1 s 5 M R lobectomy - 4 AFD
61 F Rectum B 2 s 12 M R + L segmentectomy - 3 AFD
69 M Colon C - s 3 M R wedge resection CHD 36 DWD
59 F Colon C 3 s 2 S L wedge resection - 45 AWD
65 F Colon C 3 s 5 S R wedge resection — 29 AFD
48 M Colon C - s 10 s ER lobectomy - 13 DWD
64 M Rectum B 2 s 6 M ER lobectomy — 1 AFD
45 F Colon A 1 M 7 M ER lobectomy SBI 53 AFD
62 M Colon — 3 M 2 S L lobectomy - 20 DWD
68 M Colon B 2 M 17 s L lobectomy CVA 11 DWD
78 F Colon A 1 M 15 s R lobectomy CHD 30 AFD
47 M Colon B 2 M 6 M R lobectomy - 55 AFD
54 M Colon B 1 M 3 S R wedge resection — 61 AWD
59 M Colon B 3 M 6 S L lobectomy - 10 AFD
75 F Rectum A 2 M 3 S R lobectomy — 20 AWD
46 M Colon C — M 8 s R lobectomy HEM - ORD
62 F Colon B — M 5 s ER lobectomy — 36 DWD
66 F Colon C - M 10 s R lobectomy HEM - ORD
'Dukes' stage. 
tBroder's grade.
R = right, L * left, ER - extended right, HEM = hemorrhage, CHD - transection of common hepatic duct, SBI - small-bowel infarction, CVA - cerebrovascular 
accident, AFD - alive free of disease, AWD - alive with disease, DWD = dead with disease, ORD - operative death.
436 VOLUME 29, NO. 6, NOVEMBER 1986 /  THE CANADIAN JOURNAL OF SURGERY
transfusion requirements correlated well 
with the extent of hepatic resection.
\yT c» ir» r ---------------- ^  • “  ^ ^
patients. Three had hemorrhage 
intraoperatively and it proved fatal in 
two. In two patients transection of the 
common hepatic duct was satisfactorily 
repaired over stents at the time of occur­
rence. There was one case of small-bowel 
infarction and one cerebrovascular acci­
dent. Nine patients suffered minor com­
plications; atelectasis (four), phlebitis 
(two), lymph leak, bile leak, urinary tract 
infection and subphrenic fluid collection
(one patient each). The hospital stay aver­
aged 15 days postoperatively; 20 days for
u n u  u u j j  i u i  m u s t  w n n u u i
postoperative complications.
Two deaths accounted for the 30-day 
operative death rate of 6.7%. Both 
resulted from intraoperative exsanguina- 
tion in patients with primary colorectal 
cancer, when technical difficulties were 
encountered in attempting right hepatic 
lobectomy for solitary metastases larger 
than 8 cm in diameter.
Fourteen patients received no adjuvant 
therapy — 7 had chemotherapy, 2 radi­
T a b le  I I I - - O p e r a t iv e  D a ta
E x te n t  o f N o  o f O p e r a t in g U n its
re s e c t io n p r o c e d u r e s * t im e ,  m in E B L , m l t t r a n s fu s e d *
W e d g e 7 2 2 1 9 0 0 1
S e g m e n t 4 2 1 3 9 5 0 1 .5
L e f t  lo b e 6 2 9 0 2 8 4 0 5 .7
R ig h t  lo b e 11 3 1 5 2 9 6 2 7
E x te n d e d  r ig h t  lo b e 4 4 2 1 2 8 7 5 6 . 3
* 1  p a t ie n t  h a d  b i la te r a l  s e g m e n te c to m ie s , 1 h a d  a  w e d g e  re s e c t io n  a n d  r ig h t  lo b e c to m y .  
t E s t im a t e d  b lo o d  lo s s .
t N o .  o f  u n its  o f  p a c k e d  re d  b lo o d  c e lls  t r a n s fu s e d  in  1 s t  2 4  h.
T a b le  IV - - O b s e r v e d  S u r v iv a l (in  M o n t h s ) *
A ll p a t ie n ts  (N  = 3 0 ) C o lo r e c ta l g ro u p  (n = 2 5 )
N o . M e a n M e d ia n S ta t u s N o . M e a n M e d ia n
1 3 2 4 . 2 11 A F D 1 2 2 6 . 0 2 0 . 0
5 3 6 . 9 3 9 A W D 4 3 6 . 4 3 2 . 5
1 0 3 0 . 8 1 6 D W D 7 2 0 . 5 1 2 . 5
’ E x c lu d in g  2  p a t ie n ts  w h o  d ie d  w i t h in  3 0  d o f  o p e r a t io n .
MONTHS
FIG. 1—Projected 5-year survival after 
hepatic resection (life-table analysis) for all 
patients (black circles) and survivors of oper­
ation who had primary colorectal tumour 
(white circles).
FIG. 2—Projected 5-year survival (life-table 
analysis) for patients with colorectal primary 
who had single hepatic metastasis (white cir­
cles) and multiple metastases (black circles).
FIG. 3—Projected 5-year survival (life-table 
analysis) for patients with synchronous (white 
circles) and metachronous (black circles) 
metastases.
FIG. 4— Projected 5-year survival (life-table 
analysis) for patients with Dukes’ class A or 
B (black circles) and Dukes’ C (white circles) 
primary disease.
otherapy, 3 a combination of the two, 1 
had immunotherapy and 1 immuno- and 
c n c iu u iiie ra p y . A lt oi tne adjuvant 
chemotherapy was given to patients with 
synchronous disease, to control the 
primary tumour, except in two instances. 
The radiotherapy was directed at the 
pelvis in patients with Dukes’ C rectal 
cancer and synchronous liver metastases. 
Immunotherapy in the form of bacille 
Calmette Guerin scarification was origi­
nally administered in a 47-year-old man 
who had a metachronous liver metasta­
sis 3.5 years after resection of a Dukes’ 
B rectosigmoid tumour. Immunotherapy 
was also received by the patient with 
primary ocular melanoma that first 
metastasized to the liver 7 years after 
enuculeation of the primary tumour.
Table IV sets forth survival data for all 
patients and those with primary colorec­
tal carcinoma. Thirteen patients were 
alive and free of disease an average of 24 
months after liver resection. Of patients 
with recurrent disease, nine lived an aver­
age of 30.8 months, and those still living 
have survived a mean of 36 months.
Life-table analysis projected a 5-year 
survival of 56.0% for all patients and 
50.3% for the 23 operative survivors with 
primary colorectal tumours (Fig. 1). For 
patients with colorectal primaries, life- 
table analysis projected a 5-year survival 
of 55% for those with a single metastasis 
and 48% for those with multiple meta­
stases (Fig. 2); 45.0% for patients with 
synchronous and 66.6% for patients with 
metachronous tumour (Fig. 3); 65.6% for 
patients with primary Dukes’ A or B com­
pared with 43.5% for patients with 
Dukes’ C tumours (Fig. 4); and 66.1% for 
patients who underwent wedge resection 
or segmentectomy compared with 48.0% 
for those who underwent lobectomy or 
extended lobectomy (Fig. 5).
Five of six patients with metastases 
smaller than 4 cm in diameter were alive 
at a mean of 36 months (median 33 
months) postoperatively, the sixth patient 
died 36 months after operation. If the two 
operative deaths are excluded, 11 of 17 
patients with metastases larger than 4 cm
FIG. 5—Projected 5-year survival (life-table 
analysis) for patients who underwent wedge 
resection or segmentectomy (black circles) and 
lobectomy or extended lobectomy (white 
circles).
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in diameter were alive a mean of 25.4 
months (median 11 months) after opera­
tion, and 6 died of the disease at a mean 
of 16 months (median 12 months) (Table 
V).
The tumour grade was recorded in 17 
patients. Four of five patients with a 
grade 1 tumour were alive and disease free 
at a mean of 42.5 months. The fifth 
patient, with tumour recurrence, was alive 
at 61 months. Four of six patients with 
grade 2 tumours were alive and free of 
disease at a mean of 15 months postoper- 
atively. One was alive, with tumour recur­
rence at 20 months and the other died 11 
months after operation. Three of five 
patients with grade 3 tumours were alive 
and free of disease at a mean of 16.3 
months. One was alive with recurrence at 
45 months and the other died of the dis­
ease at 20 months. The only patient with 
a grade 4 tumour died 16 months after 
operation (Table VI). Women did not 
appear to do any better than men in this 
series (Table VI).
Discussion
Of the patients presenting with primary 
colorectal cancer, 15% to 25% will have 
synchronous liver metastases.8'9'n ’12'14’15 
Approximately 20% of these will be 
amenable to hepatic resection.10'15-17 
Foster and Berman2 estimated that resec­
table liver metastases will develop 
metachronously in an additional 5% to 
8% with previous resection of a colorec­
tal cancer. Thus, approximately 10% to 
15% of patients with colorectal cancer 
metastases may be candidates for hepa­
tic resection of metastatic tumour.
Fifty percent of patients with primary 
colorectal carcinoma die with or of liver 
metastases,15 and there has been no 
improvement in patient survival over the 
last 30 years.14 While trials of intra­
arterial chemotherapeutic agents have 
demonstrated response rates as high as 
80%, none have resulted in improved sur­
vival.15-19 Likewise, systemic chemother­
apy, hepatic artery ligation and 
immunotherapy trials have not demon­
strated improved patient survival when 
compared with the natural history of 
untreated m etastases,17'20-22 and no 
patient has been cured using these treat­
ment modalities.
Early studies that examined the natural 
history of untreated liver metastases 
reported mean survival rates of 6 to 9 
months.9'1‘'15'23'24 These rates represented 
the life expectancy of a heterogeneous 
group of patients, many of whom would 
never have qualified for hepatic resection. 
More recently, Wanebo and colleagues13 
demonstrated an average survival of 19 
months in 18 patients with an untreated 
solitary liver metastasis and 9.4 months 
in 149 patients with multiple metastases. 
Adson and colleagues10 reviewed the 
natural history of a potentially resectable 
liver metastasis, proven by biopsy, from 
a colorectal primary tumour and found 
the median 3-year survival to be 20% 
among 24 patients with solitary 
metastases. Survival data for patients 
with multiple but potentially resectable 
(unilobar) metastases are not available.
Recently an aggressive surgical 
approach to the treatment of hepatic 
metastases from primary colorectal 
cancer has been adopted at McGill 
University teaching hospitals, 80% of 
resections having been performed since 
1980. The major morbidity in this series 
of 23.3% compares favourably with that 
reported by Bengmark and associates,1 
and Taylor’s group.8 Likewise, the oper­
ative death rate of 6.7% is comparable 
to those of other reported series that 
range from 1.7% to n % .s'10'12'13'25 Our 
life-table analysis projected an overall 
5-year survival in patients with colorec­
tal primary tumours of 50.3%, compara­
ble to a 42.2% survival at 42 months 
projected by Taylor and colleagues,8 
given the small number of patients who 
have actually reached this stage. It sup­
ports the contention of numerous inves­
tigators that survival can be notably 
prolonged in some patients. Indeed, all 
of our survival curves levelled off at the 
24 to 30-month interval. This supports the 
view of Adson and colleagues10 that 2 
years is a reasonable interval in which to 
examine and predict survival benefit from 
hepatic resection for metastatic disease.
In our series, the presence of multiple 
metastatic lesions appeared to have no 
detrimental influence on survival as long 
as the lesions were confined to one hepatic 
lobe. This observation is corroborated in 
reports by Foster and Berman2 and Mor­
row and colleagues.26 Patients with syn­
chronous disease appeared to do less well 
than those with metachronous disease in 
our series, and in those of Wilson and 
Adson,25 F oster,12 Bengmark and 
colleagues1 and Wanebo and associ­
ates.13 Patients with Dukes’ class A or B 
primary tumours have a longer projected 
survival than those with Dukes’ C 
primaries. Although this observation is 
supported by Adson and colleagues,10 
neither Foster12 nor Logan and 
colleagues5 demonstrated such a benefit.
Meticulous patient selection for major 
resection of hepatic metastases cannot be 
overemphasized. The operation can be 
done with acceptable morbidity and mor­
tality in properly screened patients, but 
should be performed by surgeons with an 
interest and training in hepatic surgery. 
Both operative deaths in this series 
occurred in patients with extremely large 
lesions of dubious resectability. Major 
resection should be reserved for patients 
whose primary tumour is under control, 
who manifest no evidence of extrahepatic 
spread and those whose tumours are con­
fined to one hepatic lobe, especially a soli­
tary metastasis (synchronous or meta­
chronous). Our data also suggest that the 
simple wedging out of small metastatic 
deposits is of potential benefit, perhaps 
equivalent to major resection, and should 
be considered by all surgeons when 
appropriate. There is some debate regard­
ing patients with multiple metastatic 
deposits, especially in view of the recent 
finding by Adson and associates10 that 
patients with multiple, small, syn­
chronous metastases were not definitely 
helped by resection but that those with 
large metachronous metastases were 
helped. Although our data showed no sig­
nificant difference in survival between 
patients with single or multiple metastases 
there was a difference between syn­
chronous and metachronous lesions. 
Numbers were too small to permit scien­
tific analysis of patients with multiple, 
small, synchronous lesions. Of eight 
patients in this category, three died with 
disease while five were alive and disease 
free at the time of writing, but in only one 
was the follow-up longer than 1 year 
(Table II).
Table V—Survival Related to Diameter of Largest Metastasis
Durarion of survival, mo
metastasis, cm Status No. (%) Mean Median
<  4 In = 6) AFD 1 (16.7) 33
AWD 4 (66.6) 42 45
DWD 1 (16.7) 36
>  4 (n -  17) AFD 11 (64.7) 25.4 11
DWD 6 (35.3) 16 12
Table VI—Survival (in Months) Related to Tumour Grade and Sex 
Broder's grade (n = 17)__________  Sex (n -  23)
1 2 3 4 Status Male Female
42.5 (4) 15 (4) 16.3 (3) — AFD 30 (4) 24 (8)
61 (1) 20 (1) 45 (1) — AWD 61 (1) 32.5 (2)
11 (1) 20 (1) 16 (1) DWD 16.5 (4) 18.6 (4)
( ) -  no. of patients.
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Hepatic resection for metastatic lesions 
other than from a colorectal primary has 
been disappointing, although some suc­
cess has been reported with gastric 
leiomyosarcoma, Wilms’ tumour and 
ocular melanoma. Our small experience 
corroborates these findings.
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Iatrogenic Duodenocolic Fistula
Benign duodenocolic fistula is a rare, sur­
gically curable, but potentially lethal 
entity. Etiology, symptomatology, diag­
nosis and management are discussed.
The authors describe the fifth reported 
case of an iatrogenic cause and review 
the literature on benign duodenocolic 
fistula. Early diagnosis and aggressive 
nutritional and surgical management are 
necessary to avoid serious morbidity and 
malnutrition leading eventually to death.
La fistule duodeno-colique benigne est 
une entity rare, guerissable par chirurgie, 
mais qui peut neanmoins etre mortelle.
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Son etiologie, sa symptomatologie et son 
diagnostic sont commentes. Les auteurs 
font la description du cinquieme cas 
latrogene signale et font la revue des 
publications sur la fistule duodeno- 
colique benigne. Son diagnostic precoce 
et un traitement alimentaire et chirurgical 
agressif sont necessaires si I'on veut evi- 
ter la serieuse morbidity et la malnutri­
tion qui en decoulent et qui peuvent con­
duce a la mort.
Direct communication between two 
abdominal viscera is an uncommon com­
plication of gastrointestinal surgery com­
pared with external gastrointestinal 
fistulas that usually occur as a result of 
surgical complications.1'4 Communica­
tion between the duodenum and colon is 
most commonly the result o f cancer at the 
hepatic flexure of the colon and is often 
amenable only to palliation. On the other 
hand, when the fistula is from a benign 
cause, management is usually successful. 
If untreated, however, a benign duodeno­
colic fistula can result in considerable 
morbidity, progressive undernutrition 
and death.5 Among 62 cases o f benign 
nonbiliary etiology we identified only 
four instances in which gastrointestinal 
surgery resulted in iatrogenic duodeno­
colic fistula. We present an additional 
case to illustrate the importance o f early 
diagnosis with aggressive nutritional and 
surgical management of this rare, but 
curable, condition.
Case Report
A 59-year-old white woman was referred to 
the surgical service of the Montreal General 
Hospital with fever, prostration and bile 
drainage from an abdominal incision in the 
right upper quadrant. She had undergone a 
cholecystectomy for cholelithiasis, performed 
elsewhere 5 years earlier, but otherwise there 
was nothing of note in her medical history.
She had been well until 3 months before her 
referral, when pancreatitis and jaundice had 
developed secondary to choledocholithiasis. 
Common-bile-duct exploration at the time rev­
ealed a single stone, but a T-tube cholangio- 
gram obtained 2 weeks later revealed two addi-
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tional stones, one at the lower end of the 
common bile duct. At a second laparotc..,,, 
a duodenotomy and sphincteroplasty were per­
formed and the two remaining stones removed. 
During the procedure, the hepatic flexure of 
the colon was entered inadvertently and the 
resulting laceration closed in two layers. Her 
postoperative course was complicated by 
prolonged fever and ileus requiring a gas­
trostomy for continuous gastric drainage. One 
month after the second abdominal exploration, 
bilious drainage from the drain site in the right 
upper quadrant appeared spontaneously.
Upon admission to the Montreal General 
Hospital, the patient was gravely ill with a 
blood pressure of 90/50 mm Hg, a pulse rate 
of 110 beats/min, body temperature of 40°C 
and respiration rate of 25/min. The abdomen 
was tender in the right upper quadrant. 
Peristaltic bowel sounds were absent and bile 
drainage was evident from the previous drain 
site. The patient had been started on 
intravenous nutrition through a line placed in 
the right femoral vein.
The femoral line was removed and cultured. 
Blood cultures revealed Staphylococcus albus. 
After we had restored the fluid and electrolyte 
balance, given general supportive care and 
antibiotic therapy and had controlled the sep­
sis, we inserted a subclavian line to provide 
total parenteral nutrition. A sinogram obtained 
through the drainage site in the right upper 
quadrant revealed communication between the 
second portion of the duodenum and the 
hepatic flexure of the colon. The radiologic 
findings after barium enema identified the 
anatomy more clearly (Fig. 1). During the 
preoperative phase of intravenous nutrition, no 
change in bile output or size of fistula was 
noted; however, the nutritional measures were 
maintained and the nitrogen balance was 
positive.
Two weeks after admission, the patient’s 
abdomen was re-explored. Dense adhesions 
were found throughout the right upper quad­
rant making identification of anatomical struc­
tures difficult. The entire right colon was fore­
shortened and the cecum was adherent to the 
duodenum. Retroperitoneal exposure of the 
inferior vena cava and second portion of the 
duodenum, with identification of the right ure­
ter, permitted access to the fistula between the 
duodenum and colon. A right colectomy was 
performed and an end-to-end ileotransverse 
colonic anastomosis used in reconstruction. 
The duodenotomy was closed in two layers. 
Vagotomy and gastroenterostomy were per­
formed in an attempt to enhance healing of the 
difficult duodenal closure. A Stamm gas­
trostomy was fashioned and the right paraduo­
denal region drained with suction catheters 
(Fig. 2). Her recovery was uncomplicated and 
2 weeks after surgery she was eating a normal 
diet and was ready for discharge. She remains 
asymptomatic.
Discussion
Although identified by Haldane6 in a 
case of cancer o f  the cecum in 1862, the 
first report o f a benign duodenocolic 
fistula is credited to Sanderson7 who, in 
1863, reported on a case produced by a 
duodenal ulcer. The first successful 
preoperative diagnosis o f the condition is 
attributed to McPeak.8 Sporadic reports
continued to appear in the literature until 
1959 when Starzl and colleagues9 made 
an important contribution to the 
knowledge of the etiology, pathogenesis, 
clinical features and treatment of this con­
dition. Their report contained 19 cases 
o f communication, from nonbiliary 
causes.8-20 Since then, 27 well-docu­
mented reports containing 43 additional 
cases have appeared in the English liter­
ature.21-47
The etiology of this condition is largely 
related to benign processes originating in 
the duodenum or colon with very few 
cases having their origin outside both 
organs (Table I). Duodenal ulcer is by far 
the most common etiologic factor, being 
implicated in 14 o f the 62 cases reported. 
Although ulcerative colitis was reported 
in three instances prior to 1951, Crohn’s 
disease was probably responsible for the 
condition more often than realized, as evi­
denced by seven additional cases in the 
last three decades reported to have 
occurred secondary to regional ileitis. 
Spontaneous duodenocolic fistula occur-
F1G. 1—Barium enema obtained preopera- 
tively. Arrows show fistulous communication 
between right colon and third portion of 
duodenum.
ring as a result o f benign biliary tract 
disease has been excluded from the 
discussion because it invariably causes the 
formation of a triple fistula (cholecysto- 
duodenocolic). Duodenal diverticulum 
has been implicated in nine instances, and 
other embryologic anomalies account for 
four additional cases.
Since neonatal duodenocolic fistula has 
never been demonstrated, some5 have 
questioned embryologic anomalies as an 
etiologic factor. It is noteworthy that 
infectious processes such as tuberculosis, 
typhoid fever, amebiasis and appendici­
tis have played a role in the development 
of duodenocolic fistulas. Although exter­
nal injuries have never been implicated, 
at least one report suggests that a foreign 
body may have caused the fistula. Several 
authors were unable to find a plausible 
cause for nine reported cases.
Iatrogenic duodenocolic fistula  
accounts for a minority of reported cases. 
We could find only four authentic reports 
from the Western literature,10,21-23 but it 
is probable that an operative injury to one 
or both organs resulting in fistula forma­
tion occurs more frequently. In the cases 
reported by Clayton and Thornton,11 
Marinaccio and associates,13 Rife18 and 
Masters,47 patients had previous abdomi­
nal surgery, but the fistulas were related 
more clearly to underlying disease.
T a b le  1 -C a u s e s  o f  B e n ig n  D u o d e n o c o lic  F is tu la
C a u s e N o . o f  c a s e s
D u o d e n a l u lc e r 1 4
D u o d e n a l d iv e r t ic u lu m 9
T u b e rc u lo s is 8
R e g io n a l ile it is 7
Id io p a th y 6
E m b ry o lo g ic  a n o m a lie s 4
ia t ro g e n ic 4
A p p e n d ic it is 3
U lc e r a t iv e  c o lit is 3
T r a u m a 2
T y p h o id 1
A m e b ia s is 1
T o t a l 6 2
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Gastric or duodenal ulcer disease 
precipitated the course of events that led 
to iatrogenic fistula formation in three of 
the reported cases. Fistula formation 
between the duodenum and colon 
occurred 3 years after gastric resection in 
the case reported by Michell,21 represent­
ing a rare long-term complication of sur­
gery for peptic ulcer disease. It is 
noteworthy that no disease was found to 
explain the fistula formation. Internal 
fistula following gastric resection is most 
commonly related to recurrent anasto­
motic ulceration or recurrence of a malig­
nant lesion after gastric or colonic sur­
gery. Hardy48 reported 10 instances of 
internal fistula following gastric surgery 
for benign disease, representing less than 
1.7% of the postoperative complications 
in 604 cases; none of the fistulas occurred 
between the duodenum and colon. Duo­
denal stump leak was clearly the 
precipitating factor in two of these iatro­
genic cases, one occurring 3 years after 
the duodenal blow-out and the second 16 
days after gastric resection during the 
same hospitalization. It is evident that a 
chronic or an acute inflammatory process 
may produce a simultaneous erosion into 
the duodenum and colon. Duodenocolic 
fistula as a result of a duodenal stump 
blow-out was not reported to have 
occurred according to two large series that 
recorded a 3.3% incidence of stump 
leakage.48,49
Our case report has certain similarities 
to that of Bucaille10 in which operations 
upon the biliary tract resulted in recog­
nizable injury to the duodenum and 
colon. Fistula formation between two 
penetrated visci is not uncommon, par­
ticularly when the contaminated large 
bowel is entered. Diverting colostomy 
may have prevented this complication if 
gross contamination actually occurred, 
although this is speculative.
The symptoms of benign duodenocolic 
fistula are characteristic of an initial 
process in the right upper quadrant of the 
abdomen that may elicit fever, pain and 
crampy abdominal pain. Symptoms com­
mon to virtually every reported case 
include diarrhea that may be bloody, fecal 
vomiting or foul-smelling eructations and 
passage of undigested food per rectum. 
Weight loss, often resulting in severe mal­
nutrition, invariably occurs. This virtual 
bypass of the entire small intestine is not 
compatible with life.
Duodenocolic fistula is curable. With 
the availability of modern parenteral 
nutrition, it no longer represents an 
urgent surgical problem, particularly 
when sepsis is not present. Severe protein- 
calorie undernutrition is not only prevent­
able but is also reversible, thus decreas­
ing the risks of postoperative complica­
tions.
Barium enema examination will
demonstrate the fistula in the majority of 
cases. Since most benign duodenocolic 
fistulas are secondary to peptic ulcer dis­
ease and biliary lithiasis, upper gastroin­
testinal contrast studies may demonstrate 
air or contrast material in the biliary tree, 
when the fistula is secondary to lithiasis, 
or a normal colonic mucosal outline, 
when it is due to peptic ulcer disease. The 
anatomy of the upper gastrointestinal 
tract should be defined before surgery.
As Starzl and associates9 have sug­
gested, corrective surgery is performed 
either for direct closure of the fistula or 
to  enhance spontaneous closure. 
Although authors have used direct closure 
with total success, prevention of a lateral 
duodenal fistula can be achieved by duo­
denal diverticulization, as originally 
reported by Berne and colleagues50 in 
discussions of severe duodenal trauma. A 
variety of other procedures may be 
employed if primary duodenal closure is 
difficult; they include serosal patching, 
Roux-en-Y duodenojejunostomy or par­
tial duodenal exclusion with vagotomy 
and gastrojejunostomy, as in our case, 
although the last technique lacks suppor­
tive data and is not routinely recom­
mended.
The literature reviewed contains only 
two deaths among 61 reported cases. The 
natural tendency to report successful out­
comes may give a false impression and, 
indeed, this operation is a formidable one 
for the inexperienced surgeon. When the 
abdomen is entered, the right upper quad­
rant may best be exposed by a retro­
peritoneal approach with identification of 
the right renal vessels, inferior vena cava, 
right ureter and lower common bile duct, 
reflecting the right colon medially and 
gaining access to the retroperitoneal por­
tion of the duodenum. At this point, the 
fistula can be divided, avoiding sacrifice 
of excessive duodenal wall, to permit 
primary closure. A partial colectomy can 
then be performed, if needed. Since spon­
taneous closure of a benign duodenocolic 
fistula has been reported in only one 
instance,9 this condition remains a surgi­
cal entity.
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Campylobacter pyloridis Is Associated 
With Acid-Peptic Disease in Toronto
Campylobacter pyloridis has been 
associated with acid-peptic disease in 
centres outside Canada. The authors 
conducted a pilot study to see if this 
association existed in Toronto. Patients 
in whom esophagogastroscopy was indi­
cated on clinical grounds were arbitrarily 
selected for determination of the 
presence of C. pyloridis. Included in the 
study were 100 patients who underwent 
105 endoscopies. In 75 patients (80 
endoscopies) there was some form of 
acid-peptic disease (inflammation or 
ulceration of stomach or duodenum). Of 
those with acid-peptic disease, 34% had 
C. pyloridis compared with 4% among 
patients without acid-peptic disease (p 
<  0.01). Men with acid-peptic disease 
were more likely to harbour C. pyloridis 
than women (48% versus 16%, p <  
0.01). The organisms were curved gram­
negative rods that appeared as small 
colonies after 4 days of incubation under 
microaerobic conditions. They were 
strongly urease positive.
There was considerable heterogeneity 
of endoscopic diagnoses. Future clinical 
studies of C. pyloridis need careful 
endoscopic and histologic classification.
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Campylobacter pyloridis a ete, dans des 
centres situes hors du Canada, relie a la 
maladie ulcereuse de I'estomac. Les 
auteurs ont mene une etude pilote pour 
verifier Texistence d'une pareille associa­
tion a Toronto. Des patients dont le 
tableau clinique commandait une oeso- 
phagastroscopie ont ete choisis de facon 
arbitraire pour rechercher chez-eux la 
presence de C. pyloridis. On compte 
dans I'etude 100 patients qui ont subi 
105 endoscopies. II existait chez 75 
patients (80 endoscopies) une forme ou 
I'autre de la maladie ulcereuse (inflamma­
tion ou ulceration de I'estomac ou du 
duodenum). Parmi ceux qui souffrait de 
maladie ulcereuse, 34% etaient porteurs 
de C. pyloridis comparativement a 4%  
chez les patients sans maladie ulcereuse 
(p <  0.01). Les hommes souffrant de 
maladie ulcereuse etaient plus suscepti- 
bles que les femmes d'avoir du C. pylori­
dis (48% contre 16%, p <  0.01). Les 
microorganismes sont des batonnets 
gram negatifs qui apparaissent sous la 
forme de petites colonies apres 4 jours 
d'incubation sous conditions microaerobi- 
ques. Ms sont fortement urease positifs.
On a constate une heterogeneite consi­
derable de diagnostics endoscopiques.
Les prochaines etudes de C. pyloridis 
devraient porter une attention particuliere 
a la classification endoscopique et histo- 
logique.
Campylobacter sp. are a known cause of 
gastroenteritis. Recently Warren1 and 
Marshall2 found a new species, now clas­
sified as Campylobacter pyloridis,3 in 
the stomachs and duodenums of patients 
with acid-peptic disease. These findings 
prompted worldwide interest as the cause 
of acid-peptic disease is unknown. 
Although several other centres have 
reported a similar association,4-7 it has 
not been investigated in Canada. Since 
there are geographic variations in the 
natural history of acid-peptic diseases8 
we conducted a pilot study to determine 
if there is an association between these 
conditions and C. pyloridis in Toronto, 
Ont.
Methods
Patients
All patients who underwent upper gas­
trointestinal endoscopy performed by one 
of two gastroenterologists (J.A. and J.K.) 
between March 1984 and May 1985 at St. 
Joseph’s Health Centre were potential 
candidates for study. Endoscopy was 
indicated on clinical grounds. Patients 
were selected for investigation of C. 
pyloridis on the basis of convenience 
rather than by formal randomization. 
Most were included because of endoscop- 
ically visible disease, but enough patients 
with no endoscopic evidence of disease or 
with evidence of conditions other than 
acid-peptic disease were included to allow 
comparisons. For each patient we 
recorded the age, sex and endoscopy 
number of that day (e.g., second, third, 
and so on). Biopsies were not examined 
histologically.
The endoscopic diagnosis was 
recorded. When gastric disease was seen, 
a tissue biopsy of the abnormal region 
was sent for culture of C. pyloridis. When 
duodenal disease was found, brushings 
were taken from the area for culture. 
Similarly, when an esophageal lesion was 
found, brushings were taken for culture. 
When no disease was visible on 
endoscopy, brushings were taken from 
the duodenum and gastric antrum. All 
specimens were transported in 10 ml of 
normal saline and plated within 1 hour 
of arrival in the microbiology laboratory.
Microbiology
Specimens were plated on chocolate 
agar and 5% sheep’s blood agar at 37°C 
under microaerobic conditions (5% oxy­
gen, 10% carbon dioxide, 85% nitro­
gen).5 Campylobacter pyloridis was iden­
tified using tests for susceptibility to 
nalidixic acid and cephalothin, oxidase, 
catalase, nitrate reduction, hippurate 
hydrolysis, growth at 37°C but not 43°C 
and urease production in Christensen’s 
medium.5,9
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Data Analysis
For the sake of this study we defined 
acid-peptic disease as the presence of ulcer 
or gross inflammation in the stomach or 
duodenum but not esophagus. If a patient 
underwent gastroscopy twice and C. 
pyloridis was found only once, the results 
from both gastroscopies were still counted 
to avoid bias in favour of a connection 
between acid-peptic disease and C. 
pyloridis. However, in the analysis of fre­
quency of C. pyloridis by sex, each 
patient was counted only once. For com­
parisons of proportions, Fisher’s exact 
test and the x2 test with Yates’ correction 
were used, depending on sample size. For 
comparisons of mean ages, the two-tailed 
/-test was used.
Findings
We studied 100 patients; 5 were sub­
jected to gastroscopy twice. Their ages 
ranged from 15 to 88 years (mean 57 
years). There were 12 patients in whom 
the endoscopic findings were normal. 
They ranged in age from 15 to 68 years 
(mean 46 years). The other 88 patients (93 
endoscopies) in whom some type of dis­
ease was evident on endoscopy ranged in 
age from 20 to 88 years (mean 58 years). 
Seventy-five patients (80 endoscopies) had 
acid-peptic disease. Their mean age was 
59 years. Patients were arbitrarily divided 
into three groups: duodenal, gastric or 
other. Fifteen patients with gastritis, gas­
tric erosion and gastric atrophy were
found in both the duodenal and gastric 
groups.
The organisms identified as C. 
pyloridis were curved gram-negative rods 
that grew on chocolate agar at 37°C but 
not at 43°C. They appeared as 0.5 mm 
to 1 mm diameter transparent colonies 
after 4 days of incubation. They gave a 
rapid (less than 2 minutes), strongly posi­
tive urease reaction, were catalase and 
oxidase positive and gave a negative result 
for nitrate reduction and hippurate 
hydrolysis. The isolates were resistant to 
nalidixic acid (30 pg disc) and sensitive to 
cephalothin (30 pg disc).
A great heterogeneity of endoscopic 
diagnoses was encountered (Table I).
Campylobacter pyloridis was found in 
27 (34%) of 80 endoscopies that revealed 
acid-peptic disease compared with 1 (4%) 
of 25 endoscopies that showed no abnor­
mality or revealed disease other than acid- 
peptic (p < 0.01). Of the five patients 
who underwent two endoscopies, the 
specimens in one grew C. pyloridis on 
both occasions and another was negative 
for the organism at each endoscopy. 
Three patients had a specimen that was 
positive for C. pyloridis at one endoscopy 
and negative at the other.
Of the 75 patients with acid-peptic dis­
ease, 21 (48%) of 44 men harboured the 
organism, compared with 5 (16%) of 31 
women (p < 0.01). This sex difference 
was most striking in the gastric ulcer 
group in which 9 of 12 men versus 2 of 
12 women had specimens positive for C. 
pyloridis (p < 0.025). This trend was
present, but not statistically significant, 
in the duodenal ulcer and prepyloric ulcer 
groups; combining these two groups, 9 
(39%) of 23 men had C. pyloridis com­
pared with 1 (10%) of 10 women (p = 
0 . 1) .
In patients with acid-peptic disease 
there was no correlation between age and 
the finding of C. pyloridis, but in the duo­
denal ulcer group it was more common 
in younger patients. In duodenal ulcer 
patients the mean age of those with the 
organism was 42 years compared with 59 
years in patients who did not have the 
organism (p = 0.046). A similar trend in 
those with gastric ulcer was not statisti­
cally significant: those with a specimen 
positive for the organism had a mean age 
of 58 years and those without had a mean 
age of 65 years (p = 0.2). No age corre­
lation was found in patients with 
prepyloric ulcer.
One patient with a gastric ulcer 14 
months after a highly selective vagotomy 
was found to have C. pyloridis in the 
ulcer. Three patients, during short-term 
follow-up for gastric ulcers, were found 
to have C. pyloridis in biopsies of the 
healing ulcers. We did not find that 
patients who underwent gastroscopy later 
on the day’s list were more likely to have 
C. pyloridis.
Discussion
The cause of acid-peptic diseases is elu­
sive and probably multifactorial.10 Previ­
ous attempts to link ulcers with micro­
organisms have shown only spurious con­
nections.11-14 In 1983, W arren1 and 
Marshall2 reported a strong association 
between “ unidentified curved bacilli” and 
histologically confirmed gastritis and 
other types of acid-peptic disease. This 
association has been confirmed by inves­
tigators in other parts of the world.4-7 
The organism has recently been classified 
as C. pyloridis.3 We have now shown 
that C. pyloridis is associated with acid- 
peptic disease in at least one city in 
Canada.
Campylobacter pyloridis was not iso­
lated from stomachs in the past because 
it is a microaerophilic, slow-growing 
organism and conditions for growing 
such bacteria had not been used. 
However, curved rods were found in 
histologic sections of human gastric 
mucosa as early as 1940, and more 
recently by several investigators.5,15-17 In 
our pilot study we did not use this impor­
tant method of studying C. pyloridis.
Although there is clearly an association 
between C. pyloridis and acid-peptic dis­
ease, a cause-and-effect relationship has 
not been proven; however, evidence is 
beginning to accumulate. The presence of 
C. pyloridis does give rise to a host 
immune response.16,18 There is a correla­
tion between the degree of histologic gas-
Table 1—Endoscopic Diagnosis and Incidence of Campylobacter pyloridis
Total no. of No. with
Diagnosis patients C. pyloridis (%)
Acid-peptic disease 80 27 (34)
Duodenal ulcer 20 5 (25)
Prepyloric ulcer 13 5 (38)
Duodenal ulcer + gastric erosion 4 2
Duodenal ulcer + gastritis 1 0
Prepyloric ulcer + esophageal ulcer 1 0
Duodenitis 3 1
Duodenitis, gastritis, esophagitis 1 0
Duodenitis + gastritis 1 0
Duodenitis + gastric ulcer 2 1
Duodenal ulcer + gastric ulcer 1 0
Total 47 14 (30)
Gastric ulcer 24 11 (46)
Gastritis 2 0
Gastroesophageal ulcer 1 1
Gastric ulcer + gastric erosion 3 1
Gastric erosion 1 0
Gastric atrophy 1 0
Gastritis + esophageal stricture 1 0
Total 33 13 (39)
No acid-peptic disease 25 1 (4)
Esophagitis 6 0
Carcinoma of the stomach 3 0
Esophageal stricture 1 0
Esophageal ulcer 1 0
Duodenal polyp 1 0
Gastric polyp 1 0
Normal 12 1
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tritis and number of bacteria in the gas­
tric mucosa.5 In a remarkable sequence 
of events, an epidemic of gastritis with 
hypochlorhydria developed in a group of 
healthy volunteers who underwent gastric 
in tubations.19 After this event was 
reported a retrospective examination of 
the gastric biopsies revealed the presence 
of what appeared to be C. pyloridis.20 
Lastly, studies have shown that patients 
with duodenal ulcers are less likely to 
suffer relapse when treated with bismuth 
compounds, which kill C. pyloridis, than 
when treated with antacids or histamine 
blocking agents.21,22
Among patients with acid-peptic dis­
ease we found correlations between the 
presence o f  C. pyloridis and both youn­
ger age and the male gender. To our 
knowledge, similar associations have not 
been reported. The significance of these 
findings is unclear; they may be coin­
cidental. Our arbitrary method of select­
ing patients could have introduced 
unknown biases. The great heterogeneity 
of clinical diagnoses in our study empha­
sizes the need for histologic classification 
and rigorous stratifications in future ther­
apeutic trials.
Because Campylobacter- like organisms 
have been found to adhere to gastro- 
scopes,23 we investigated whether sam­
ples from patients who underwent
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endoscopy later in the day were more 
likely to contain C. pyloridis, but such 
was not the case.
An etiologic role for C. pyloridis in 
acid-peptic diseases would have tremen­
dous clinical importance. By directing 
medical therapy towards eradication of 
the organism, it may be possible to reduce 
the very high relapse rate associated with 
current therapies.24 The remote possibil­
ity o f carcinogenicity25 and the frequent 
need for long-term therapy with histamine 
blocking agents make other therapeutic 
approaches worth consideration.
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methoxazole (10-15 ml 'Bactrim ' for Infusion) every 6 ,8 or 12 
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Children: 5 to 10 mg trim ethoprim /kg/day +  25 to 50 mg 
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Not recommended if creatinine clearance ( C y  less than 
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Supply
Adult tablets: 80 mg trimethoprim and 400 mg sulfa­
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azole. Bottles of 100 and 250. Pediatric tablets: 20 mg 
trimethoprim and 100 mg sulfamethoxazole. Bottles of 100. 
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200 mg sulfamethoxazole, per 5 ml. Bottles of 20, 100 and 
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sulfamethoxazole and 16 mg trimethoprim, for infusion with 
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Product Monograph available on request.
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Thymostimulin Prophylaxis of 
Postoperative Infections in Anergic Patients
The rate of postoperative infections is 
significantly increased in anergic 
patients. The authors evaluated prospec­
tively, in a controlled, randomized and 
stratified study, the efficiency of 
thymostimulin in reducing postoperative 
infections in 42 such patients. Excluded 
were those who were malnourished in 
whom preoperative alimentation cor­
rected the anergy. The incidence of 
infections was significantly |p<0.05) 
reduced in thymostimulin-treated patients 
(4.8% versus 28.6%).
Le taux des infections postoperatoires 
est grandement augmente chez les 
patients anergiques. Les auteurs ont eva 
lue prospectivement dans une etude con- 
trolee, randomisee avec groupes strati­
fies, I'efficacite de la thymostimuline 
comme moyen de r^duire des infections 
postoperatoires chez 42 patients anergi­
ques. Exclus de cette etude etaient ceux 
qui souffraient de malnutrition et chez 
qui une alimentation preoperatoire a per- 
mis de corriger I'anergie. La frequence 
des infections a ete significativement 
reduite (p < 0.05) chez les patients trai- 
tes a la thymostimuline (4.8% contre 
28.6%).
Excluding patients in intensive care units, 
6% to 30% of the hospital population is 
anergic1-3 as verified by the skin-test 
response.4-6 In anergic surgical patients 
morbidity and mortality are greatly 
increased; postoperative infections have 
reportedly risen from 7% to 46%,7 8% 
to 50%3 and from 8% to 24%;6 death 
from infection, according to these same 
sources, rises from 2% to 31%, from 1% 
to 28% and from 4% to 20%.
Malnutrition is responsible for about 
one-third of immunoincompentence.8 
Anergy is also caused by advanced 
age,3'4 neoplasia,3’9'10 sepsis,4 drugs11 and 
severe hepatic insufficiency.3
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Immunocompetence can be restored by 
removing the cause of the anergy, while 
antibiotics should be administered to 
these patients only if required at the time 
of surgery. Although preoperative nutri­
tion programs may correct anergy due to 
malnutrition,12 it is not always possible 
to eliminate etiologic factors. It seems 
reasonable therefore to consider the use 
of an immunomodulator.13
Several reports have described the use 
of levamisole,7 bacterial derivatives2 and 
dithiocarbamate;3 and other substances, 
such as thiabendazole, muramyl dipeptide 
and tuftsin, have been used in animal 
experiments.
Thymostimulin is a thymic hormonal 
complex that can revive and potentiate 
host-defence mechanisms; its activity has 
been demonstrated in vitro14 and under 
diverse clinical conditions.15-18
We report the results of a trial of 
thymostimulin prophylaxis designed to 
reduce postoperative infections in aner­
gic but not malnourished patients.
Patients and Methods
The study was prospective, controlled, 
randomized and stratified. All patients 
awaiting elective surgery in whom anergy 
was identified by the Multitest C.M.I. 
(Institut Merieux, Lyon, France), which 
correlates well with the usual bacteria 
employed in skin tests,3'5’19 were admit­
ted to the study. An anergic patient was 
defined as one with less than two positive 
responses (diameter of induration equal 
to or greater than 2 mm).3 Excluded 
were patients less than 14 years old, those 
with signs of malnutrition according to 
the criteria of Mullen20 and patients who 
were to undergo minor surgery. Informed 
consent was obtained from all patients.
The trial was stratified into two levels 
according to the type of surgery: (a) clean 
and (b) clean-contaminated and contami­
nated (in these patients short-term antibi­
otic prophylaxis with mezlocillin was 
used).
Patients were randomly assigned either 
to the group receiving thymostimulin (1.5 
mg/kg daily intramuscularly, as a single 
dose, beginning 2 days before surgery and 
continuing after until day 7) or to a con­
trol group.
In all patients daily temperature records
were kept and blood chemistry studies 
and urine cultures were done preopera- 
tively and on day 7 postoperatively. In the 
case of respiratory infection a chest film 
was obtained, and for a wound infection 
the pus was cultured. All patients were 
observed until discharge and examined 
again 1 month after surgery.
Statistical analysis was performed using 
2 x 2  contingency tables with the Fisher’s 
exact test, and probability a posteriori 
was calculated according to Bayes’ 
theorem.
Findings
Forty-five anergic patients were admit­
ted to the study between Jan. 1 and Aug. 
31, 1985; 42 completed the study. Two 
patients were excluded from the trial for 
protocol deviations and one patient died 
from causes unrelated to infection (two 
belonged to the control group, one to the 
treated group).
Of the 42 patients, 21 were assigned to 
the control group and 21 received 
thymostimulin. There were no significant 
differences in patient characteristics 
between these groups.
Twenty patients underwent clean sur­
gery and 22 underwent clean-contamin­
ated or contaminated surgery. The con­
ditions found and the types of surgery are 
reported in Tables I and II.
The infections discovered were: wound 
infection (defined as discharge of puru­
lent material), peritoneal cavity infection 
(peritonitis or localized abscess not secon­
dary to dehiscence of an anastomosis), 
generalized sepsis, respiratory tract infec­
tions, urinary tract infections (urine cul­
ture with > 105 bacteria/ml, in the 
absence of a positive preoperative cul­
ture), hyperthermia (>38°C) for at least
Table 1-Diseases and Operations in Patients 
Who Had Clean Surgery
Disease/operation No. of patients
Neoplasms 6
Spleen 4
Thyroid 4
Gastrointestinal tract 2
Other 4
Laparotomy 12
Thyroidectomy 4
Mastectomy 1
Other 3
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2 days. There were seven infections — six 
(28.6%) in the control group and one 
(4.8%) in the thymostimulin-treated 
group (Table III). Table IV indicates divi­
sions among the two stratified groups and 
lists the infections found.
The lower incidence of postoperative 
infections in patients treated with 
thymostimulin (4.8% versus 28.6%) is 
significant (p = 0.046). We also exa­
mined the two stratified  groups 
separately; the percentage differences 
(0% versus 20% for clean surgery and 
9.1%  versus 36.4% for clean- 
contaminated and contaminated surgery) 
are not significant (p = 0.236 and 0.155 
respectively).
Discussion
Clean-contaminated and contaminated 
surgical procedures were grouped 
together because in our department both 
groups of patients received antibiotics 
prophylactically; therefore, a more 
homogeneous group than one formed by 
clean and clean-contaminated surgery was 
obtained.
The frequency of postoperative infec­
Table 11-Diseases and Operations in Patients 
Who Had Clean-Contaminated and 
Contaminated Surgery
□isease/operation No. of patients
Neoplasms 17
Colon/rectum 8
Gastric 7
Other 2
Biliary tract 3
Other 2
Resection 14
Large intestine 7
Gastric 7
Biliary tract 3
Laparotomy 3
Other 2
Table Ill-Infections, All Patients
Infection Control Treated
No 15 20
Yes 6 1
% 28.6 4.8
p -  0.046.
tions in the untreated group was 28.6%, 
20% for clean procedures and 36.4% for 
clean-contaminated and contaminated 
operations; these values are similar to 
those described by others for immunoin- 
competent patients. The number of infec­
tions in the treated group is similar to that 
for standard values reported for surgery 
in general.21,22
Four of the seven infections recorded 
involved the respiratory tract and three 
the wound. The lack of urinary tract 
infections, often the most common 
type,23 could be due to the restrictions 
we imposed and also because most of the 
catheterized patients (20 of 24) received 
antibiotics prophylactically.
Dehiscence of an anastomosis was not 
considered an infective complication 
because we believe that in almost all cases 
it is due to problems of surgical tech­
nique. In our series dehiscence did not 
occur.
Statistical analysis indicates fewer 
infections in those patients treated with 
thymostimulin (p < 0.05). This is con­
firmed by Bayes’ analysis which fur­
nishes, for each probability a prjori, prob­
ability a posteriori that is notably greater, 
producing a curve with pronounced in­
ferior concavity (Fig. 1). Also, separate 
analysis of the two stratified groups (clean 
surgery, p = 0.236 and clean-contami­
nated and contaminated surgery, p = 
0.155), gave curves with inferior but less- 
accentuated concavities. Therefore, in
FIG. 1—Bayes’ analysis: probability a pri­
ori (p.p.) and probability a posteriori (P.P.)
------------ =  all patients;------------- ---- clean
surgery g r o u p ; ----------------= clean-
contaminated and contaminated group.
Table IV—Infections in Two Stratified Groups
Clean* Clean-contaminated/contaminatedf
Infection Control Treated Control Treated
No 8 10 7 10
Yes 2 » 0 4 t*§ § 1§
% 20 0 36.4 9.1
*p -  0.236. 
tp -  0.155.
IRespiratory tract infection. 
§Wound infection.
each of these two groups (especially the 
latter) thymostimulin probably had a sub­
stantial action that was masked by the 
small numbers in these groups.
Conclusion
The results of this trial demonstrate the 
efficiency of thymostimulin, administered 
pre- and postoperatively, in reducing 
postoperative infections in anergic 
patients not suffering from malnutrition.
We thank Elizabeth M. Tully, MD, MS, for 
her translation of this manuscript.
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Ligation of the External Carotid 
and Anterior Ethmoidal Arteries for Severe or 
Unusual Epistaxis Resulting From Facial Fractures
From July 1980 to December 1983, 16 
patients with severe posterior epistaxis 
were treated by arterial ligation. The 
procedure was successful in all.
Two cases of life-threatening and 
unusual epistaxis resulting from maxillary 
fractures are presented in detail. The 
authors conclude that ligation of the 
external carotid and anterior ethmoidal 
arteries is a speedy, safe and highly suc­
cessful method of dealing with posterior 
epistaxis.
De juillet 1980 a decembre 1983,
16 cas d'epistaxis posterieur grave ont 
ete traites par ligature arterielle. Dans 
tous les cas, I'intervention fut couronnee 
de succes.
On decrit ici deux cas I'dpistaxis inha- 
bituel ayant menace la vie des patients 
et resultant de fractures du maxillaire.
Les auteurs concluent que la ligature de 
la carotide externe et des art&res ethrnoi- 
dales anterieures est une methode 
rapide, sOre et hautement efficace de 
traiter Tepistaxis posterieur.
Severe epistaxis often requires close col­
laboration between the otolaryngologist 
and internist. We describe our experience
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in 16 patients with severe posterior 
epistaxis — to make a plea for ligation 
of the external carotid and anterior eth­
moidal arteries as the procedure of choice 
for this condition. We include two case 
histories of young patients who required 
ligation of the external carotid artery 
secondary to complications of maxillary 
fractures. We found this an efficient and 
safe method of controlling severe or 
unusual epistaxis.
Patients and Methods
Our 16 patients (2 women, 14 men), 
ranged in age from 17 to 86 years 
(Fig. 1). In 12 patients the epistaxis was 
spontaneous, in 4 young men it occurred 
as a result of trauma.
Apart from the two cases presented in 
detail all patients requiring the ligation of 
external carotid and anterior ethmoidal 
arteries had an anterior and posterior 
packing or a nasostat inserted at least 
twice.
Patients referred from other hospitals 
with anterior and posterior packing or a 
nasostat in place were first observed while 
associated medical problems were cor­
rected. When bleeding persisted despite 
packing, the latter was removed and the 
bleeding site identified if possible. In the 
majority of patients with posterior 
epistaxis, the packing or nasostat was 
replaced. The external carotid and 
anterior ethmoidal arteries were ligated if 
the bleeding persisted or recurred despite 
adequate packing and medical 
management.
Patients who presented with epistaxis 
in our emergency department were 
assessed by our house-staff and the nose 
packed, if necessary. Again, when 
epistaxis continued, despite adequate 
sedation, bed rest and control of arterial 
hypertension, the packing was changed or 
the nasostat repositioned, and when 
bleeding persisted while the second pack­
ing was in place, or several days after its 
removal, then the arteries were ligated.
A similar method of treatment was fol­
lowed when the patient was admitted for 
observation without initial packing.
The technique of arterial ligation has 
been well described.1 We ligate the exter­
nal carotid artery twice with 0 silk, above 
the superior thyroid artery take-off. We 
do not divide the artery. Following this, 
one or two small Week clips (Division of 
Squibb Canada, Inc., Weston, Ont.) are 
applied to the anterior ethmoidal artery; 
it is divided only when there is an ade­
quate arterial cuff on each side.
Case Reports
Case 1
A 22-year-old man was admitted after a 
motor vehicle accident. On admission he had 
a Le Fort III fracture with an obvious 
cerebrospinal fluid leak, a “ rocker” fracture 
of his nasal bones and a fracture of the hard 
palate. In addition, he had a pneumothorax 
and a transverse fracture of the right femur. 
After stabilization in the intensive care unit, 
he underwent a tracheostomy, suspension of 
the Le Fort III fracture and reduction of the 
nasal fracture.
Five days later, while coughing he had a 
small amount of bleeding through the 
tracheostomy tube. That same day the 
tracheostomy tube was changed, and immedi­
ately he began to hemorrhage. Approximately 
2000 ml of venous blood drained from the 
tracheostomy tube, the mouth and nose.
Fortunately, the tracheostomy cuff was 
inflated immediately, the intermaxillary sus­
pension wires were cut and clots removed by 
suction and manually. This episode occurred 
with the patient in a supine position and on 
continuous leg traction.
A Foley catheter was inserted through the 
right nostril and inflated to stop what turned 
out to be a massive venous hemorrhage aris­
ing from the pterygoid plexus. At the same 
time, the right external carotid and anterior 
ethmoidal arteries were ligated and bron­
choscopy was performed, with suctioning of 
clots from the basal bronchi bilaterally.
Two days later, under local anesthesia, the 
intermaxillary wiring was repositioned. The 
patient suffered a pulmonary embolism and 
required anticoagulation but there was no 
recurrence of epistaxis. After 80 days in the 
hospital he was discharged. On follow-up (Fig.
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2) he had a large perforation of the bony nasal 
septum and right epiphora, successfully treated 
later with dacryocystorhinostomy.
Comment
This case demonstrates an unusal com­
plication of a Le Fort III fracture with a 
profuse venous epistaxis and hemoptysis 
originating from the pterygoid plexus.
Case 2
A 17-year-old man sustained a punch injury 
to the right maxilla. Three months later max­
illary sinusitis and right facial cellulitis deve­
loped (Fig. 3). Sinus x-ray films revealed right 
pansinusitis and an old fracture of the right 
maxillary sinus. Swabs obtained from an inci­
sion in the buccal fat pad and nasal pus rev­
ealed the presence of Haemophilus influenzae. 
The patient was given an adequate dosage of 
intravenous cefazolin, then amoxicillin, and 
discharged from hospital 5 days after admis­
sion. Follow-up sinus x-ray films showed a 
mucocyst nearly filling the right antrum. Later 
he underwent a right Caldwell-Luc antrostomy 
to remove the mucocyst. A longitudinal frac­
ture was seen on the lateral wall of the maxil­
lary sinus, close to its posterior wall. Upon 
exploration of the fracture site, which commu­
nicated with the infratemporal fossa, the inter­
nal maxillary artery was torn. Bleeding was 
partially controlled with packing and Week 
clips, followed immediately by external carotid 
artery ligation because of persistent bleeding.
There were no postoperative complications 
and when he was last seen there was no recur­
rence of sinusitis.
Results
All patients left the hospital in stable 
condition and none required further 
admission for epistaxis. One elderly man 
needed ligation of the right external 
carotid artery and anterior ethmoidal 
artery and then 4 days later, because of 
persistent bleeding, required ligation of 
the left external carotid artery.
The mean number of units transfused 
per patient was 5.25. None had an abnor­
mal platelet count or prolonged proth­
rombin time or partial thromboplastin 
time.
Complications o f  Treatment 
o f  Severe Epistaxis
The complications in this study resulted 
from either packing alone or arterial liga­
tion. Two patients suffered necrosis of the 
inferior aspect of the nostril at the point 
of maximum pressure from the metal 
clamp holding the catheter under tension. 
Regardless of anterior packing and gauze 
padding between the clamp and nose, this 
complication still occurred. After arterial 
ligation, we released the metal clamp and 
the necrotic area was covered with antibi­
otic ointment for several days, then left 
to dry and slough off on its own. The 
remaining scar could be seen only with 
difficulty.
One woman died of epistaxis. She was 
over 70 years old and had had a 
dacryocystorhinostomy done by an eye 
surgeon. She died while under sedation, 
with posterior and anterior packing in 
place. She had a long history of conges­
tive heart failure and required several 
blood transfusions, but she was alert and 
in stable condition when seen on morn­
ing rounds 2 hours before she died. Per­
mission for an autopsy was not granted. 
The only complication of external carotid 
artery ligation was weakness of the lower 
lip in one patient, resulting from division 
of a marginal branch of the facial nerve 
through the upper neck crease incision. 
The wound was re-explored and a divided 
nerve branch identified. Continuity could 
not be re-established because the distal 
portion of the nerve could not be located. 
At follow-up 6 months later the function 
of the lower lip was completely restored.
Discussion
The recent literature has placed empha­
sis on internal maxillary artery ligation as
the procedure of choice for severe, uncon­
trollable posterior epistaxis.2'4 However, 
because of restricted operating-room 
time, the two senior authors prefer liga­
tion of external carotid and anterior eth­
moidal arteries which is a much quicker 
procedure.
Ligation of the internal maxillary artery 
only was done in one case, a 25-year-old 
woman who had a punch injury to her 
face as the result of an assault. She had 
severe posterior epistaxis requiring three 
posterior packings on two different 
admissions. We elected to explore her 
maxillary sinus for possible fracture and 
then ligate the internal maxillary artery. 
There was no fracture and the bleeding
FIG. 2—Case 1. Six months after accident. 
Note hypertelorism and ocular slant that 
followed Le Fort III fracture.
FIG. 3—Case 2. During first hospital admis­
sion; there is right facial cellulitis and maxil­
lary sinusitis.
AGE ( years )
FIG. 1—Age range of 16 patients who underwent arterial ligations; youngest was 17 years 
and oldest 86.
448 VOLUME 29, NO. 6, NOVEMBER 1986 /  THE CANADIAN JOURNAL OF SURGERY
did not recur after ligation. In terms of 
choice between packing and surgery, all 
patients preferred the surgery.
Advantages of external carotid artery 
ligation are: expediency in an elderly 
patient with multiple medical problems, 
minimal morbidity because of constant 
anatomical landmarks, patient preference 
and no recurrence o f epistaxis in our ser­
ies. The procedure usually takes 1 hour 
and can be done under general, local, or 
neurolept anesthesia. Neurolept anesthe­
sia was used in one elderly woman with 
previous cervical spine fusion, in whom 
endotracheal intubation was not possible.
The disadvantages are: an external 
scar, the risk of facial nerve damage and 
of interference with collateral cerebral cir­
culation in a patient with cerebrovascu­
lar insufficiency from atheroma o f the 
internal carotid artery.
We thank Dr. Mohamed Nabile Abdel- 
Hamid from Thunder Bay, Ont. for drawing
up a questionnaire sent to patients on the treat­
ment of posterior epistaxis.
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Percutaneous Drainage of a 
Tuberculous Liver Abscess
The authors describe the management 
by percutaneous drainage of a rare soli­
tary tuberculous liver abscess in a 
37-year-old woman. Open surgical 
drainage of such abscesses can be 
avoided using percutaneous drainage 
combined with transcatheter infusions of 
antituberculous agents. For the safe and 
successful use of this method three 
criteria must be met: the abscess should 
be unilocular, there must be a safe 
access route and a previously sterile 
compartment must not be contaminated. 
In addition a small (22 or 23 gauge) nee­
dle should be used for the initial 
puncture.
Les auteurs decrivent le traitement par 
drainage percutane d'un abces tuber- 
culeux solitaire du foie, une affection 
rare, chez une femme de 37 ans. Le drai­
nage chirurgical ouvert de tels abces 
peut etre evite en ayant recours a un 
drainage percutane en association avec 
des perfusions transcatheter de substan-
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ces antituberculeuses. Pour s'assurer de 
Tinnocuite et du succes de cette 
methode, trois criteres doivent etre ren­
contres: I'abces doit etre uniloculaire, il 
doit exister une voie d'acces sure, et il 
faut eviter de contaminer un comparti- 
ment sterile auparavant. De plus, il y a 
lieu d'utiliser une petite aiguille (de cali­
bre 22 ou 23) pour la piqure initiate.
Tuberculous liver abscess is rare. 
Although the liver is commonly involved 
in pulmonary and extrapulmonary tuber­
culosis in the form of multiple granu­
lomas, these are seldom important clini­
cally and can readily be diagnosed by 
percutaneous liver biopsy. We present a 
case of extrapulmonary tuberculosis com­
plicated by a tuberculous liver abscess.
FIG. 1—Computerized tomogram shows well-defined cavity (arrow) in right lobe of liver. 
Lesion abuts abdominal wall and has enhancing rim.
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Case Report
A 37-year-old woman was admitted to The 
Wellesley Hospital in February 1980 for inves­
tigation of a 3-month history of hoarseness. 
She had emigrated from the Phillipines and was 
employed in Canada as a hospital laboratory 
technician. Suspension microlaryngoscopy and 
biopsy were carried out. The biopsy cultures 
grew Myobacterium tuberculosis var. hominis 
(sputum cultures were not done). Isoniazid 300 
mg, ethambutol 600 mg and rifampin 400 mg 
once a day were prescribed.
One month later she began to complain of 
right upper quadrant abdominal pain, aggra­
vated by deep breathing and coughing. This 
was associated with intermittent fever. Physi­
cal examination revealed mild to moderate 
tenderness in the right upper quadrant on pal-
FIG. 2—Sinogram through drainage 
catheter shows size of cavity in liver.
pation. Results of liver function studies, 
aminotransferase and alkaline phosphatase 
levels, were normal.
Oral cholecystography gave normal findings. 
An isotope study of the liver and spleen demon­
strated a vaguely defined defect in the liver. 
Computerized tomography (Fig. 1) demon­
strated a moderate-sized, ovoid, cystic lesion 
in the right lobe of the liver. It did not have 
the radiologic characteristics of a hydatid cyst, 
and a complement fixation test for echinococ­
cosis gave negative results. Amoebic serologic 
tests likewise were negative. A chest film 
appeared normal.
The patient was readmitted in September 
1980 for celiac angiography. This excluded 
hepatoma and adenoma as possible diagnoses. 
The cystic lesion was again demonstrated. 
Under computerized tomographic control, a 
20-gauge needle was introduced into the cavity 
and purulent material was aspirated, a sample 
of which was cultured. No fungi or bacteria 
were grown, but acid-fast bacilli were seen with 
Ziehl-Neelsen-stained preparations. Cultures 
did not reveal the presence of viable mycobac­
teria. Contrast was injected to outline the cavity 
and a no. 8.3 French pigtail catheter with mul­
tiple side-holes was placed into the cavity under 
fluoroscopic control (Fig. 2).1 The cavity was 
flushed with isoniazid (1 g) and rifampin (1 g) 
in 30 ml of normal saline. The abscess was 
flushed four times a day for 6 days with this 
solution. Following this, injection of contrast 
material demonstrated a small irregular cavity 
at the tip of the catheter, which was then 
removed.
The patient’s symptoms resolved over several 
weeks. A follow-up computerized tomogram 
in January 1981 demonstrated resolution of the 
cavity in the right hepatic lobe (Fig. 3). She 
continued on isoniazid, ethambutol and rifam­
pin therapy until May 1982. At a clinical 
follow-up in January 1986 there were no signs 
or symptoms of this abscess.
Discussion
The development of symptoms due to
a tuberculous liver abscess after the insti­
tution of treatment for tuberculosis, as in 
our patient, has been reported.2 In that 
case, the authors speculated that the 
cicatrix that formed around the coalesc­
ing tuberculoma prevented the antibiotics 
from entering the abscess cavity. Resolu­
tion of the abscess after the injection of 
antituberculous agents into the abscess 
cavity is in agreement with this hypothe­
sis although, while we did identify 
myocobacteria on direct smear, we were 
unable to culture them. This suggested 
that antituberculous agents had entered 
the cavity and rendered the bacilli non- 
viable and that the abscess had formed 
before therapy for the laryngeal tubercu­
losis was begun. The late appearance of 
symptoms after treatment o f the initial 
lesion remains unexplained.
Previous reports o f tuberculous 
abscesses of the liver have emphasized the 
importance o f open surgical drainage.2'3 
The development of reliable ultrasonog­
raphy and, more recently, computerized 
tomography, has allowed accurate locali­
zation of intravisceral lesions preopera- 
tively. This has permitted the radiologist 
to plan a safe route for percutaneous aspi­
ration of the intra-abdominal lesion.
The safety of diagnostic and therapeu­
tic needle aspiration has been greatly 
improved by the use of small (22 or 23 
gauge) needles for the initial puncture.
Percutaneous drainage of an abscess is 
usually curative when the following three 
basic criteria can be met: the abscess is 
unilocular; there is a safe access route, so 
that the large drainage catheters do not 
penetrate bowel or viscera other than the 
organ containing the abscess; a previously 
sterile compartment is not contami­
nated.4 If these criteria cannot be met, 
then open surgical drainage should be 
considered.
Drainage o f amoebic and pyogenic 
abscesses by the percutaneous route has 
been described previously.5 Our case 
demonstrates that this method is also 
applicable to tuberculous liver abscesses, 
so that when combined with transcatheter 
infusions4'6 o f antituberculous drugs, 
open surgical drainage can be avoided.
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Local Hepatic Tuberculosis, 
the Cause of a Painful Hepatic Mass: 
Case Report and Review of the Literature
Local hepatic tuberculosis is an unusual 
form of extrapulmonary tuberculosis. The 
authors describe the case of a 39-year- 
old woman with this disease who posed 
diagnostic difficulties. She presented 
with abdominal pain, minimal constitu­
tional symptoms, hepatomegaly and radi­
ologic findings of a focal hepatic lesion. 
Laparotomy was required for diagnosis.
A literature review revealed that most 
individuals with local hepatic tuberculosis 
have fever, night sweats and weight 
loss. Hepatomegaly is often the only 
abnormal physical sign. Minimally 
elevated serum bilirubin and alkaline 
phosphatase levels are common. 
Ultrasonography and computerized 
tomography will demonstrate a lobu- 
lated, hypoechoic liver mass. Definitive 
diagnosis requires demonstration of acid- 
fast bacilli in biopsy material obtained by 
percutaneous techniques or at 
laparotomy. Cultures of the diseased 
liver are usually negative. Antituber­
culous drug therapy appears to be the 
preferred method of treatment.
La tuberculose hepatique localisee est 
une forme inhabituelle de tuberculose 
extrapulmonaire. Les auteurs en decri- 
vent un cas dont le diagnostic a pose 
des difficultes. Le patient a ete recu pre- 
sentant des douleurs abdominales, des 
symptomes constitutionnels minimes, 
une hepatomegalie et ses radiographies 
montraient une lesion hepatique focale. 
Une laparotomie diagnostique a ete 
necessaire. Une revue de litterature 
revele que la plupart des malades souf- 
frant de tuberculose hepatique localisee 
ont de la fievre, des sueurs nocturnes et 
une perte de poids. L'hepatomegalie est 
souvent le seul signe physique anormal. 
Des augmentations discretes des taux de 
bilirubine et de phosphatase alcaline sont
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frequentes. L'echographie et la tomogra- 
phie par ordinateur demontrent la pre­
sence d'une masse hepatique lobulee. Le 
diagnostic ddfinitif exige la demonstra­
tion de bacilles acido-resistants dans les 
prelevements de biopsie obtenus par voie 
percutanee ou a la laparotomie. Les cultu­
res obtenues du foie malade sont habi- 
tuellement negatives. Une antibiotherapie 
antituberculeuse semble etre le mode de 
traitement prdfere.
Hepatic tuberculosis is a common find­
ing in patients with disseminated miliary 
tuberculosis.1-3 Even in autopsies of 
patients with nonmiliary pulmonary 
tuberculosis, miliary hepatic tuberculosis 
is found in 50% to 80% of cases.3 
However, local hepatic tuberculosis is 
rare and tuberculomas or tuberculous 
pseudotumours of the liver, in the absence 
of active extrahepatic tuberculosis, are 
extremely uncommon.
We describe a patient who had local 
hepatic tuberculosis without evidence of 
active extrahepatic tuberculosis, and we 
review the literature on this subject.
Case Report
A 39-year-old woman, native to the Philli- 
pines, was referred for evaluation of abdomi­
nal pain. Her symptoms had begun approxi­
mately 3 months before admission, becoming 
slightly more severe over the ensuing period. 
The pain was steady, predominantly in the right 
upper quadrant and epigastrium, and was 
aggravated by lying on the right side. The only 
other positive symptom was mild anorexia. She 
denied any weight loss, fever, chills or night 
sweats. The remainder of the medical history 
and functional enquiry were negative.
On physical examination she was a thin 
woman who appeared well and in no distress. 
Her body temperature was 37.5°C, the pulse 
rate 92 beats/min and the blood pressure 
130/70 mm Hg. The head and neck were nor­
mal on examination. There was slight dullness 
to percussion over the lower left lung field with 
good air entry bilaterally. The cardiovascular 
system was normal. The liver edge was palpa­
ble 8 cm below the right costal margin with a 
firm , nontender edge. There was no 
splenomegaly. Bowel sounds were present. 
Mild tenderness to deep palpation was present 
in the right upper quadrant. Rectal and pelvic
examinations gave normal results. Neurologic 
examination was unremarkable.
Serum electrolyte, urea, creatinine, calcium, 
magnesium and glucose levels were normal. 
The hemoglobin value was 110 g/L  and leu­
kocyte count 7.6 x 109/L  with a normal 
differential. Findings on urinalysis were nor­
mal. The total protein value was 83 g /L , albu­
min 40 g/L and total bilirubin 8.0 /tmol/L. The 
serum gamma glutamyl transferase level was 
93 U /L  (normal 5 to 30 U/L), alanine trans­
aminase level 36 U /L (normal 5 to 20 U /L) and 
lactate dehydrogenase level 62 U/L (normal 45 
to 85 U /L). Prothrombin and partial throm­
boplastin times were normal. Urine and spu­
tum cultures were sterile. Serologic tests for 
hydatid disease were negative. A Mantoux test 
was positive using 1 TU.
A small left pleural effusion was seen on a 
chest x-ray film. Tomograms of the left chest 
showed a poorly defined nodular density 2 to 
3 cm in dimension, anterior to the 8th thoracic 
vertebral body (Fig. 1). Bronchoscopic find­
ings were normal with negative bronchial wash­
ings and brushings. A limited (4 cm) left thora­
cotomy and pleuroscopy revealed pleural 
thickening with biopsies of the pleura show­
ing only dense fibrosis. On abdominal 
ultrasonography, the kidneys, spleen, pancreas 
and gallbladder appeared normal; however, a 
4-cm mass was noted in the posterior segment 
of the right hepatic lobe. The mass had the 
characteristics of a cyst filled with debris or 
necrotic tissue (i.e., echoes were reduced but
FIG. 1—Chest film shows nodular density 2 to 3 cm in diameter anterior to 8th thoracic vertebra.
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not absent). Computerized tomography of the 
liver showed that the mass was lobulated and 
nonenhancing (Fig. 2). It seemed to be made 
up of a cluster of spherical masses lying just 
beside the inferior vena cava in its intrahepatic 
portion. The tomographic density of the lesion 
indicated that it was solid and the radiologic 
interpretation was that of a tumour. Abdomi­
nal angiography was normal except for a 
hypovascular area in the posterior segment of 
the right lobe of the liver. Barium radiologic 
examinations of the upper and lower gastroin­
testinal tract showed no abnormalities. 
Intravenous pyelography revealed an irregular 
extrarenal calcification near the lower pole of 
the left kidney, but the right kidney appeared 
normal. Attempts to biopsy the liver lesion 
using percutaneous needle aspiration directed 
by computerized tomography were unsuccess­
ful on two occasions because of the superior 
and posterior location of the lesion in the right 
lobe.
At laparotomy, a lesion 4 cm in diameter was 
found on the posterior surface of the right lobe 
of the liver as well as a 0.5-cm lesion on the 
inferior surface of the right lobe. Similar 
lesions were present in the lateral segment of 
the left lobe of the liver. A needle biopsy of 
one of the lesions revealed caseating 
granulomatous inflammation. All other 
abdominal organs were normal. Ziehl-Neelsen 
stains of the liver biopsy showed acid-fast 
bacilli. Culture of the liver biopsy tissue did 
not grow tuberculous bacilli. The patient was 
treated with isoniazid, rifampin and etham- 
butol. She did well except for a transient, drug- 
related elevation in liver enzyme levels. Repeat 
computerized tomography at 4 months’ follow­
up revealed a rim of calcification surrounding 
the hepatic lesion. The patient is free of ab­
dominal pain and doing well at 1 'k  years. The 
liver is softer and considerably smaller.
Discussion
Since Bristowe’s4 original description 
of 12 cases of local hepatic tuberculosis 
in 1858, only a few more cases have been 
reported. Hersch5 found fewer than 100 
cases in a literature review up to 1964. 
Involvement of the liver in patients with 
tuberculosis is not uncommon, but the 
majority of patients with hepatic tuber­
culosis have the miliary type consisting of
FIG. 2—Computerized tomogram shows 
lobulated nonenhancing mass in posterior seg­
ment of right lobe of liver.
widespread multiple granulomas 0.6 to 2 
mm in diameter. Lesions larger than 2 
mm are classified as local tuberculo­
sis.2’5'6 These focal lesions present as 
conglomerate tubercles, granulomas, bile- 
duct tuberculosis or tuberculous 
abscesses.5
The histologic findings in local hepatic 
tuberculosis have been well described by 
Korn and associates.1 Large granulomas 
and conglomerate tubercles often have 
central caseation with Langhans giant 
cells. Occasionally, the caseous granula­
tion tissue breaks down and may dis­
charge into the bile ducts causing cholan­
gitis.2 In miliary hepatic tuberculosis, the 
granulomas appear concentrated near the 
heptic veins, while in the local form, the 
bacilli are usually found in the portal 
regions.2,5 The tubercle bacillus probably 
reaches the liver through the hepatic 
artery in cases of miliary tuberculosis and 
from the intestine, through the portal 
vein, in local hepatic tuberculosis.2’45 
The rarity of the local form of this dis­
ease may be because the liver is resistant 
to challenge with tubercle bacilli.7 This 
may be due to the relatively low tissue 
oxygen tension in the liver.5
Patients described in case reports of 
local hepatic tuberculosis have presented 
with fever, chills, night sweats and weight 
loss,5’6,8 but they may, as in our case, 
present without systemic manifesta­
tions.5,9 In a review of 20 cases of local 
hepatic tuberculosis, Hersch5 noted that 
the average age at presentation was 44 
years with 90% of the patients having 
fever, 75% weight loss and 55% anorexia.
Physical findings are variable. Patients 
may appear entirely well without the typi­
cal cachexia characteristic of disseminated 
miliary tuberculosis. Hepatomegaly is a 
consistent finding in individual case 
reports,6,9,10 and was described in 19 of 
Hersch’s 20 patients.5 The enlarged liver 
is often tender.5’10 Splenomegaly may 
also be present.5 The remainder of the 
physical examination is often un­
remarkable.
The results of liver function tests are 
occasionally normal,6’8 but serum liver 
enzyme levels, most commonly alkaline 
phosphatase, are usually minimally 
elevated. Hyperbilirubinemia, if present, 
is often mild.1’5 With modern imaging 
techniques such as ultrasonography and 
computerized tomography, local hepatic 
tuberculosis may become easier to diag­
nose than in the past. In their manage­
ment of a patient with a tuberculous pseu­
dotumour of the liver, Forward and 
colleagues10 used these two techniques to 
demonstrate the hypoechoic, lobulated 
mass, which was similar to the findings 
in our patient. In our case ultrasonogra­
phy suggested a cystic mass filled with 
debris, but computerized tomography 
suggested a tumour. The high-density 
number of the caseous material was mis­
leading in this case. Furthermore, lesions 
in the left lateral lobe were not visible on 
scanning or ultrasonography.
To diagnose local hepatic tuberculosis 
definitively, involved liver tissue must be 
obtained for histologic examination and 
culture. Percutaneous liver biopsy, when 
successful, is the least morbid approach 
and may be an adequate method of 
obtaining tissue; however, laparotomy 
may be required when the lesions are inac­
cessible as in our case. The presence of 
acid-fast bacilli in the biopsy is diagnos­
tic. Perhaps surprisingly, cultures of the 
liver biopsy often do not grow tubercle 
bacilli. In three of four recent 
reports,6'8-10 cultures of infected liver tis­
sue were negative as in our case.
The differential diagnosis of local 
hepatic tuberculosis includes benign 
hepatic neoplasms, primary and secon­
dary liver tumours and infective processes 
that produce focal hepatic lesions. 
Granulomatous diseases such as sarcoi­
dosis may make the histologic diagnosis 
difficult if acid-fast bacilli are not seen.11 
Antituberculous drug therapy is usually 
effective for localized hepatic tuberculo­
sis,6’8,9 although hepatic resection has 
been carried out successfully.9
Although our patient had minimal 
symptoms, she did have laboratory and 
radiologic findings consistent with local 
hepatic tuberculosis. Laparotomy was 
necessary for tissue diagnosis. The abnor­
mal chest x-ray film and perirenal calcifi­
cation suggest that she had tuberculosis 
at extrahepatic sites, but the liver 
appeared to be the only organ affected by 
active tuberculosis.
In summary, although local hepatic 
tuberculosis is rare, it should be consi­
dered in any patient presenting with fever, 
night sweats, weight loss, an enlarged 
liver and focal hepatic lesions.
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Ileal Perforation Due to 
Cytomegaloviral Enteritis
As the AIDS epidemic unfolds, many 
newly described clinical syndromes 
resulting from unusual manifestations of 
opportunistic infections are being seen. 
The authors report the clinical and patho­
logical features of intestinal perforation 
in an AIDS patient caused by extensive 
small-bowel ulcerations due to 
cytomegalovirus. The diagnosis was con­
firmed by ultrastructural and immuno- 
histochemical studies. It is suggested 
that infection and destruction of the 
muscularis propria by the virus contrib­
utes to intestinal perforation.
Au fur et & mesure qu'apparait I'ampleur 
de I'epidemie de SIDA, on observe plu- 
sieurs nouveaux syndromes cliniques 
resultant de manifestations inhabituelles 
d'infections opportunistes. Les auteurs 
presentent les caractdristiques cliniques 
et pathologiques d'une perforation de 
I'intestin chez une victime du SIDA, per­
foration provoqu6e par une ulceration 
etendue du petit intestin due au cytome­
galovirus. Le diagnostic fut confirme par 
des etudes d'ultrastructures et des exa- 
mens immunohistochimiques. II est pro­
pose que I'infection, puis la destruction 
de la muscularis propria par le virus a 
contribue a la perforation intestinale.
In the immunocompromised host, 
cytomegalovirus (CMV) infection is a 
major cause of morbidity and mortal­
ity.1 Patients with the acquired immune 
deficiency syndrome (AIDS) have a pro­
found defect of cell-mediated immunity 
and are susceptible to infection by fungi, 
viruses, protozoa and intracellular bac­
teria.2 These infections occur with 
devastating severity and in unusual loca-
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tions, resulting in a myriad o f hitherto 
unencountered clinical syndromes. We 
report a case in which ileal perforation 
due to CMV enteritis occurred in a 
homosexual man suffering from AIDS.
Case Report
A 22-year-old male homosexual was treated 
intravenously with acyclovir for a perianal 
ulceration due to herpes simplex virus that had 
not healed over 3 months. Investigation rev­
ealed cotton-wool exudates in the fundi, a leu­
kocyte count of 2.7 x  109/L  (0.42 lympho­
cytes), anergy to seven out of eight skin-test 
antigens and severely reduced in-vitro lympho­
cyte response to phytohemagglutinin, con- 
canavalin A and pokeweed mitogen. Antibod­
ies to human T-lymphotropic virus type III 
(HTLV-III*), determined at the Laboratory 
Centre for Disease Control, Ottawa, were posi­
tive by the Western blot technique.3 The 
ulcers responded to acyclovir, and chronic 
oroesophageal candidiasis was controlled with 
orally administered ketoconazole (200 mg twice 
daily). He continued to have low-grade, inter­
mittent fever (body temperature 38° to 
37.5°C), anorexia, weight loss and intermittent 
diarrhea. Stools were consistently negative for 
parasites. Six months later, the diarrhea 
became more severe, requiring rehydration dur­
ing a visit to Cuba. Periumbilical cramping 
pain also became prominent. The weight loss 
progressed after his return to Canada and he 
was admitted to hospital for investigation. He 
was severely cachectic and had a body temper­
ature of 38°C. The pulse was 110 beats/min, 
blood pressure 100/60 mm Hg and respirations 
20/min.
Oral candidiasis was noted. The abdominal 
examination showed no organomegaly. There 
were local areas of tenderness without rebound 
or guarding. The bowel sounds were normal. 
The hemoglobin was 89 g/L , the leukocyte 
count 6.2 x 109/L  and platelet count 
347 x  109/L . T wo days after admission frank 
signs of peritonitis developed and an abdomi­
nal film showed a small amount of free air 
under the right hemidiaphragm, with multiple 
air-fluid levels.
At laparotomy diffuse peritonitis with fecal 
contamination was found. Numerous ulcers
♦Recently the Human Retrovirus Subcom­
mittee of the International Committee on the 
Taxonomy of Viruses proposed the name 
human immunodeficiency virus (HIV) for all 
the closely related members of this group of 
viruses (Science 1986; 232: 697).
were palpable along the antimesenteric border 
of the small intestine, from the ligament of 
Treitz to the ileocecal valve. Many ulcers were 
deeply penetrating and in two locations had 
perforated the serosal surface. A limited resec­
tion of the portion of intestine with the perfo­
rated ulcers was performed and intestinal 
continuity re-established by an end-to-end 
anastomosis.
He was started on cefazolin, metronidazole 
and netilmycin. His postoperative course was 
complicated by cardiac failure and hypoten­
sion. In addition, pneumocystis pneumonia 
was diagnosed by bronchoalveolar lavage and 
treated with pentamidine isothionate. He refu­
sed treatment with interferon and CMV hyper­
immunoglobulin; 7 days after operation 
refractory hypotension developed and he died. 
Permission for autopsy was refused.
Pathological Findings
The 25-cm segment o f small bowel had 
four ulcers on the mucosal surface (Fig. 
1). The serosal surface was congested and 
covered with a fibrinopurulent exudate. 
The ulcers measured between 2 and 3 cm 
in diameter. Their edges were irregular 
but sharply delineated from the adjacent, 
unaffected mucosa. The ulcers were deep 
and excavated with beds composed of 
necrotic debris and friable tissue. The 
serosal surface underlying the ulcers pro­
truded as rounded sacculations (Fig. 2). 
One o f the ulcers had perforated, while 
the bases of the others were greatly 
attenuated. The intervening uninvolved 
mucosa demonstrated some congestion 
but otherwise appeared normal.
Microscopically, there was loss o f the 
mucosa and underlying tissue in the areas
FIG. 1—Mucosal surface of ileum showing 
multiple well-defined ulcers.
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of ulceration. The ulcer bases consisted 
of granulation tissue with intense acute 
and chronic transmural inflammation 
with some undermining of the mucosal 
surface laterally (Fig. 3). This was 
associated with destruction of the mus- 
cularis propria, resulting in thinning of 
the ulcer bed. In the area of inflamma­
tion there was a vasculitis involving arteri­
oles and venules, but this was mild com­
pared with the degree of inflammation. 
The inflammatory infiltrate was com­
posed predominantly of polymorphs and 
macrophages with few lymphocytes. 
Prominent intranuclear inclusions were 
present in large numbers. These were 
noted in tissue macrophages, vascular 
endothelial and smooth-muscle cells 
(Figs. 4 and 5). In some areas there was 
inflammation and destruction of the mus- 
cularis propria without involvement of 
the overlying mucosa. Stains for fungi, 
acid-fast bacilli and protozoa failed to 
reveal the presence of any organisms. The 
mesenteric lymph nodes showed lym­
phoid depletion, scattered macrophages 
and endothelial cells containing large 
intranuclear inclusions.
Ultrastructural examination demon­
strated numerous viral capsids in the 
nuclei of macrophages containing inclu­
sions (Fig. 6). The capsids measured 100 
nm in diameter and frequently contained 
a concentric inner shell although some 
had an electron-lucent centre or an 
electron-dense core. Immunoperoxidase 
staining revealed the presence of CMV 
(early) antigen in the nuclei of scattered 
macrophages (Fig. 7). Cytomegalovirus 
was also cultured from the urine 
postoperatively.
Discussion
Infection by CMV is most often asymp­
tomatic and diagnosed retrospectively by 
serologic testing. However, in the 
immunocompromised host, it is a fre­
quent cause of symptomatic infections. In 
patients with AIDS, infection of the gas­
trointestinal tract by CMV is being recog­
nized more often.4 7 The patient usually 
presents with diarrhea or gastrointestinal
FIG. 2—Serosal surface of ileum showing 
protruding ulcer base with central area of per­
foration.
FIG. 3—Section of ulcer border showing transmural inflammation and destruction of mus- 
cularis propria (hematoxylin and eosin, initial magnification x 20).
FIG. 4—High-power detail of inclusions in endothelial cells (short arrow) and macrophage 
(long arrow) (hematoxylin and eosin, initial magnification x 750).
FIG. 5— High-power view of muscularis propria showing inflammatory cell infiltrate, des­
truction of muscle and inclusion body in smooth-muscle cell (arrow) (hematoxylin and eosin, 
initial magnification x 600).
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hem orrhage. In renal transplant 
recipients, colonic bleeding from 
cytomegaloviral ulceration of the cecum 
is the commonest cause of massive gas­
trointestinal hemorrhage.8 In patients 
with AIDS, systemic infection with CMV 
is being increasingly recognized and 
believed to be a major cause of death.9
Our patient suffered from an acute 
abdominal emergency condition due to 
perforation of an ileal ulcer caused by 
CMV infection. This unusual manifesta­
tion adds a new dimension to the surgi­
cal complications in patients with AIDS. 
One previous case of ileal perforation due 
to such infection has been reported.10 As 
in our patient, the disease was fatal within 
2 weeks of diagnosis. Perforation of the 
colon has been reported more often10’11
and probably reflects the more frequent 
occurrence of infection of the colon and 
rectum.12' 15 However, it is now recog­
nized that all parts of the gastrointesti­
nal tract, including esophagus, stomach 
and biliary tree can be infected by CMV 
in patients with AIDS.4-7 Enteric infec­
tions in AIDS can also be caused by Cryp­
tosporidium, Isospora belli, Mycobac­
terium avium-intracellulare, Salmonella 
typhi, Shigella sp. and Entamoeba 
histolytica.16 The last three could be the 
cause of intestinal perforation through 
ulceration.
The ulceration caused by CMV infec­
tion is localized and associated with 
intense transmural inflammation that at 
times undermines the overlying mucosa. 
It has been suggested that a vasculitis is
the mechanism by which CMV induces 
lesions in the gastrointestinal trac t.13 
Some vascular inflammation was noted 
in the capillaries and venules of the ulcer­
ated areas in our case and may have con­
tributed to the superficial ulceration of 
the mucosa. However, the extent of the 
inflammation with dissolution of the 
muscularis could not be attributed to a 
vasculitis alone. In addition, infection and 
destruction of the muscularis propria was 
observed without involvement of the 
overlying mucosa. Some w orkers,17 
using in-situ hybridization, have demon­
strated widespread infection of epithelial 
and mesenchymal cells by CMV. It has 
been suggested that local inflammation 
may occur in these infected areas. Our 
observation of inclusion bodies in 
smooth-muscle cells associated with 
severe inflammation supports this notion. 
It appears that destruction of the mus­
cularis propria accounts in large part for 
the perforation and the diverticular pro­
trusions in the serosa.
Drugs that hold some promise for 
effective treatment of cytomegaloviral 
disease include 9(1,3-dihydroxy-2- 
propoxymethyl) guanine (DHPG)18 and 
trisodium phosphonoformate.19 Thus, 
early diagnosis of intestinal disease due 
to CMV is important. Upper and lower 
intestinal disease could be diagnosed early 
by endoscopy, although it must be 
remembered that inclusion bodies may be 
sparse. The use of ultrastructure and 
immunoperoxidase stains can help in con­
firming the diagnosis. Evidence of syste­
mic disease in the form of CMV cultured 
from the urine or detected by DNA hybri­
dization, or a positive buffy-coat culture 
must be sought if the condition is to be 
diagnosed early enough to institute 
treatment.
FIG. 6—Electron micrograph of viral capsids in nucleus of macrophage (initial magnifica­
tion X 85 200).
FIG. 7—Immunoperoxidase stain for early cytomegalovirus antigen. Note positive stain­
ing (arrow) of inclusion in endothelial cell (immunoperoxidase with hematoxylin counterstain, 
initial magnification x 750).
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Anteromedial Displacement of the Tibial Tubercle 
for Patellofemoral Arthralgia
Anterior and medial repositioning of the 
tibial tubercle (anteromedialization) 
reduces patellofemoral pressure and cor­
rects patellar malalignment. Over the last 
6 years this simple procedure was car­
ried out on 53 knees in patients who had 
no athletic inclinations. The average age 
was 40.4 years. Follow-up was at least 
1 year.
A rating system was developed and 
overall the results were 65.9% excellent, 
15.9%  good, 11.4% fair and 6.8%  
poor. In the over-45 age group, the 
results were 57.1% excellent, 28.6%  
good, 14.3% fair and none poor. The 
complication rate was relatively low 
(18.7%).
This procedure appears to be satisfac­
tory for patellofemoral arthralgia when 
malalignment is present, particularly in 
the elderly.
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Le repositionnement median du tubercule 
tibial reduit la pression patello-femorale 
et corrige les defauts d'alignement rotu- 
lien. Au cours des 6 dernieres annees, 
cette operation simple a ete pratiquee 
sur 53 genoux chez des patients n'ayant 
aucun penchant pour les sports. L'age 
moyen etait de 40.4 ans. Des examens 
de surveillance se sont poursuivis sur au 
moins 1 an.
Un systeme devaluation a ete deve- 
loppe qui a mis en evidence 65.9%  
d'excellents, 15.9% de bons, 11.4% de 
moyens et 6.8%  de mauvais resultats. 
Chez les plus de 45 ans, les resultats 
ont ete excellents dans 57.1% des cas, 
bons dans 28.6%  et moyens dans 
14.3%; il n'y a eu aucun mauvais resul- 
tat. Le taux de complication a ete relati- 
vement faible (18.7%).
Cette operation semble etre satisfai- 
sante dans les cas d'arthralgie patello- 
femorale quand il y a defaut d'aligne­
ment, et particulierement chez les 
patients plus ages.
The genesis of patellofemoral pain is 
obscure, and symptoms bear little relation 
to pathological findings.1 The impor­
tance of observable damage to the artic­
ular cartilage is in doubt as are minor 
degrees of malalignment of the patella.
Treatment of patellofemoral arthralgia 
consists initially of exercises, mainly 
quadriceps strengthening and stretching 
and, if that fails, surgery. The surgery 
ranges from patellar shaving and lateral 
release,2 proximal or distal realign­
ment,3'4 tibial tuberosity anteriorization 
(Maquet),5-6 to patellectomy.
Variable results have been reported 
with all of these techniques. Overall, 
patellectomy probably gives the best 
results but, interestingly, after multiple 
patellar procedures, it seldom provides 
total relief of pain.7 The Maquet proce­
dure also gives excellent results, but the 
complication rate is high.7’8
For the last 6 years a simple technique 
of medial repositioning of the tibial tuber­
cle (anteromedialization) combined with 
a lateral release has been used for patel­
lofemoral arthralgia with reasonable 
results, especially in the elderly.
Patients and Methods
Patients who had this procedure per­
formed between 1979 and 1985 were exa­
mined. In all, the follow-up was at least 
1 year. The indications for surgery were 
failure of conservative treatment, after 
more than 6 months of therapy, and some 
degree of patellar malalignment. The 
diagnosis of malalignment was made clin­
ically (i.e., a greater than normal Q 
angle). Radiologic assessment was not 
attempted because we found considera­
ble difficulty in interpreting minor degrees 
of malalignment. Palpable crepitus aris­
ing from the patellofemoral joint was present in all cases.
Surgical Procedure
The actual technique is a combination 
of a Maquet56 and an Elmslie-Trillat 
procedure.9 Under tourniquet control, a
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long midline skin incision is made from 
the midpole of the patella to about 7 cm 
below the tibial tuberosity. The prepatel­
lar fascia is elevated and a wide lateral 
retinacular release performed. The patella 
is then palpated. In cases with severe 
damage to the articular cartilage, the 
patella is shaved. (This may not be neces­
sary as the senior author [H.U.C.] has 
refrained from doing so over the last 3 
years, with no obvious change in results.)
The periosteum over the tibial tuber­
cle is incised longitudinally, leaving a strip 
as wide as the patellar tendon. Residual 
medial and lateral periosteum in the area 
is then elevated. A half-inch osteotome 
is used to cut a rectangular strip of bone 
as wide as the patellar tendon attachment, 
7 cm long and about 1 cm thick. The strip 
is left in place distally and cut proximally
FIG. 1—View of knee 4 weeks after substan­
tial anteromedialization for severe patellar 
malalignment. Graft has not yet united.
just above the attachment of the patellar 
tendon. The free proximal end is then 
twisted up onto the medial cortex of the 
tibia. While it is held in place by thumb 
pressure, the knee is flexed to check that 
the malalignment has been corrected and 
the patella tracks smoothly. The block of 
bone is anchored into place with two or 
three counter sunk AO (Association for 
Osteosynthesis) cancellous screws (Fig. 1). 
The anterior and medial displacement 
usually results in some degree of patellar 
tendon laxity. A small amount of cancel­
lous bone is removed from the original 
donor site and placed under the medial 
side of the graft at its new location and 
the elevated medial periosteum is then 
drawn over it. The tibialis anterior mus­
cle is not sutured back to bone to avoid 
the possibility of an anterior compart­
ment syndrome. A Hemovac drain is left 
in the donor site.
A compression bandage reinforced 
with plaster is used for a day or so, then 
replaced with a plastic back-splint for 6 
weeks for walking. The patient can' be 
fully weight bearing and may start knee 
flexion the day after surgery. Straight leg 
raising is avoided for 6 weeks, although 
gentle isometric contractions of the quad­
riceps are allowed. Most patients reach 
75° of flexion within 5 days at which time 
they are discharged.
Healing of the transposed bone is quite 
rapid. Use of the splint is discontinued at 
6 weeks and vigorous quadriceps exer­
cises, both strengthening and stretching 
are begun. The screws are usually 
removed about 1 year after surgery (Fig. 
2) .
FIG. 2—Just before removal of screws, graft 
is solidly united. This patient required less than 
I cm of anteriorization but considerable medi- 
alization.
Rating System
We developed a rating system to assess 
the results o f operation: excellent implied 
no pain, full flexion and a return to 
preoperative activity levels or better; good 
in which there was mild pain (that did not 
interfere with activity), full flexion and 
a return to preoperative activity levels, 
fair was associated with moderate pain 
(occasioned by increased activity that in­
termittently required analgesics), flexion 
from 0° to 100° and a return to preoper­
ative activity levels; poor implied a result 
less than fair and not improved by 
surgery.
Findings
There were 53 patients (33 women, 20 
men), ranging in age from 19 to 71 years 
(average 40.4 years). Twenty-two patients 
were 45 years of age or older. The 
primary disease in 45 was chondromala­
cia or patellofemoral osteoarthritis; in the 
other 8 it was recurrent patellar subluxa­
tion with accompanying chondromalacia.
Nine patients were excluded from the 
study — five had a high tibial osteotomy 
at the time of the procedure, one a patel­
lofemoral resurfacing and two had under­
gone total knee replacement. One patient 
was not available for review.
Of the 44 patients reviewed, 1 had a 
previous patellectomy and 4 had under­
gone Hauser procedures. Eight had recur­
rent patellar subluxation as the primary 
problem and six a history of direct trauma 
to the anterior aspect of the patella fol­
lowed by the development of retropatel­
lar pain. Of the remaining 30 patients, in 
whom there was no obvious cause of 
patellofemoral chondromalacia, 15 were 
obese.
Of the 44 patients reviewed the rating 
was excellent in 65.9%, good in 15.9%, 
fair in 11.4% and poor in 6.8%. In the 
poor cases, two had a subsequent 
patellectomy and one a patellofemoral 
resurfacing.
Fourteen patients 45 years of age and 
over who had a tibial tuberosity 
anteromedialization only scored 57.1% 
excellent, 28.6% good and 14.3% fair. 
There were no poor results.
Complications
Three of the 53 patients who underwent 
anteromedialization had minor wound 
infections that resolved with antibiotics 
and 3 had wound infections that necessi­
tated drainage and hardware removal.
Two patients had a neuroma from divi­
sion of the infrapatellar branch of the 
saphenous nerve. One patient fell, sus­
taining a graft fracture with 1 cm of sepa­
ration. He still has a 10° quadriceps lag
VOLUME 29, NO. 6, NOVEMBER 1986 /  THE CANADIAN JOURNAL OF SURGERY 457
18 months later and will probably require 
further surgery. One had a stress fracture 
of the tibia through the distal screw hole 
after hardware removal. It healed 
uneventfully with casting.
Discussion
Our technique is similar to that 
described by Fulkerson10 and Miller and 
LaRochelle.11 It is a simple procedure, 
healing is rapid and immobilization 
minimal. Advancement and medialization 
of approximately 1 cm has usually been 
employed, but greater advancement can 
be achieved simply by using a thicker 
graft.
The procedure is a combination of a 
Hauser or Elmslie-Trillat and Maquet. 
The Hauser tibial tubercle transfer, 
because of the slope of the medial surface 
of the tibia, often recesses the patellar ten-
FIG. 3—Congenital dislocation of patella 
shows virtual absence of trochlear groove — 
contraindication for anteriomedialization.
don attachment, thus tightening the patel­
lar tendon — in effect a reverse Maquet, 
conceivably increasing patellofemoral 
pressures. This may well explain the com­
plications of late patellofemoral osteoar­
thritis described by Crosby and Insall.12 
Similarly, the Elmslie-Trillat procedure, 
because a thin slab of bone is used, may 
result in increased patellofem oral 
pressure.
In young people, chondromalacia is 
frequently but not always associated with 
abnormal patellar tracking or a large Q 
angle. We have not seen patients with 
severe patellofemoral chondromalacia 
who had a negative Q angle, and medi­
alization would clearly be contraindicated 
in such cases.
In the elderly and in those with 
advanced patellofemoral osteoarthritis, 
lateral patellar subluxation is almost the 
rule. Skyline x-ray films of advanced 
patellofemoral osteoarthritis show wear­
ing down of the lateral trochlear ridge and 
grooving of the lateral facet. A straight­
forward tibial tubercle anteriorization 
cannot restore normal tracking and sub­
stantial medialization is required. In our 
opinion complete loss of the lateral troch­
lear ridge is a contraindication to this 
procedure as is congenital absence of the 
ridge (Fig. 3). In these rare cases, patel­
lofemoral resurfacing is preferred. Sub­
stantial medialization is difficult with a 
classic Maquet technique, and several 
reports have shown a high complication 
rate with graft breakage, displacement 
and absorption, and skin sloughs.7’8
The incidence of wound problems 
tends to increase with the degree of anteri­
orization as the skin becomes stretched 
(Fig. 4). The subcutaneous tissue in this 
region is of poor quality, especially in 
very obese patients, in whom the majority 
of problems in this series occurred.
There is disagreement about the degree 
of anteriorization required to reduce 
patellofemoral pressure substantially. 
Maquet6 calculated that 2 cm were neces­
sary to reduce patellofemoral pressure by 
50%. Ferguson13 and Ferguson and 
colleagues14 reported that an elevation of 
13 mm reduced stress by 83.5%. 
Nakamura and associates15 suggested
that a 1-cm elevation was optimal and 
that roughly was followed in this series. 
Any degree of rotation on the x-ray film 
appreciably alters measurements of 
advancement. In a series of routine x-ray 
films, therefore, measurements would be 
very inexact.
The present procedure of tibial tuber­
cle anteromedialization combined with a 
lateral release is quick and simple. 
Because no bone graft is harvested from 
elsewhere there is no problem with pain 
at the graft site or graft absorption. With 
the exception of one case of fracture, sub­
sequent tuberosity displacement has not 
proved a problem because the bone is held 
rigidly by the AO screws. Complications 
have been relatively few and results 
reasonably good. It should be emphasized 
that none of our patients were athletes.
Of considerable interest are the excel­
lent results achieved in the elderly with 
frank patellofemoral osteoarthritis. While 
this disease is common in the elderly, it 
is not usually symptomatic. This tech­
nique has worked suprisingly well and in 
the senior author’s hands has completely 
obviated the necessity for patellectomy in 
this age group.
All the patients in this study had sub­
stantial articular cartilage damage. No 
distinction has been made between patel­
lofemoral osteoarthritis and chon­
dromalacia as it is impossible pathologi­
cally to distinguish between the two 
conditions.
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FIG. 4—Well-healed knee after Maquet procedure in which anteriorization was of con­
siderable magnitude. This degree of anteriorization is greater than that normally required to 
relieve patellofemoral symptoms and can present difficulties in wound healing.
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BOOKS REVIEWS 
continued from  page 418 
the orthopedic surgeon to treat these deformi­
ties predictably and with success. The Manage­
ment o f  Spina! Deformities concisely reviews 
these and other topics with the help of an 
impressive list of international contributors.
Timely chapters, using the most recent infor­
mation on the pathogenesis and epidemiology 
of idiopathic scoliosis, have been included with 
an excellent chapter on the biomechanics of spi­
nal deformities. Biomechanics is also threaded 
through each chapter skilfully and presented 
in a readable fashion.
Most of the contributors have addressed var­
ious aspects of idiopathic scoliosis and there 
is a thorough review of infantile scoliosis. 
Adult scoliosis and Scheuermann’s kyphosis 
are also briefly discussed.
Each author provides an extensive bibliog­
raphy citing the most recent information in 
most instances. However, whenever a field is 
progressing rapidly, some issues may be left 
out. The method of interpedicular fixation and 
the important use of spinal cord monitoring 
are not covered in this book. This oversight 
does not detract from this readable and highly 
informative book, but merely points out the 
ever-changing nature of the field.
The book is a welcome addition to the liter­
ature on spinal deformities and should be read 
by the resident staff and the general orthopedic 
surgeon who is interested in keeping abreast 
of this complex field.
Gordon W.D. Armstrong, md, frcsc 
Chief,
Division of Orthopedic Surgery,
Ottawa Civic Hospital,
Ottawa, Ont.
K1Y 4E9
SILVERGIRL'S SURGERY. BILIARY  
TRACT. Edited by James O. Robinson. 
233 pp. Illust. Silvcrgirl, Inc., Austin, Tex., 
1985. $55., clothbound; $19. (US), paper- 
bound. ISBN 9-941432-14-9.
This is the second of a 13-volume series on sur­
gery, medicine and pediatrics to be published 
by Silvergirl, Inc. Each volume will address a 
subspecialty by presenting papers, with 
editorial comment, that were important in the 
development of the respective fields, in this case 
the development of surgery of the biliary tract.
It is an attractive concept, and at least one 
good reason for pursuing the idea was stated 
in 1903 by Mayo-Robson, one of the surgeons 
featured in this history: “ It is sometimes use­
ful in surgical as well as in other matters to 
pause and look backward, if this be done with 
a mind open to find fault with its own past 
acts.”
The volume is divided into nine parts. In my 
view, one should begin by reading part 9, an 
erudite and charming musing on some histor­
ical figures and events. This chapter, read as 
a preface, will arouse one’s interest.
Part 1, written in 1863 by Thudicum, dis­
cusses the historical features of biliary surgery. 
Thudicum reminds us that gallstones have been 
recognized since 1500 BC, the earliest known 
occurrence being an Egyptian priestess whose 
mummy has been dissected. Trallianus and 
Avicenna make reference to gallstones, partic­
ularly as a medicament. Modern biliary sur­
gery began in 1667 when Von der Weil and
Thilesius completed the drainage of an 
empyema necessitatis of the gallbladder.
Part 2 presents the contributions of several 
famous surgeons from Jean-Louis Petit (1743) 
to Lawson Tait (1879). John Bobbs of Indi­
ana did the first cholecystotomy for the 
removal of stones, and Blodgett (1877), 
another American, performed the first planned 
cholecystostomy. His patient died and so did 
the patient on whom Marion Sims operated in 
1878. Although this operation took place in 
Paris, both patient and surgeon were Ameri­
cans. The patient died of bleeding, probably 
because of vitamin K deficiency, a feature of 
obstructive jaundice that was not understood 
until Dam and Schonheyder (1929) and Quick 
(1935) elucidated vitamin K deficiency in the 
jaundiced patient. The redoubtable Swiss sur­
geon Theodor Kocher in 1878 was the first to 
have a patient survive cholecystostomy. He per­
formed the operation in two stages.
Efforts to establish a safe cholecystoen- 
terostomy are addressed in part 3, notably by 
Murphy with his “button” . Part 4 deals with 
the establishment of cholecystectomy as the 
operation of choice. Langenbuch has priority 
here. One can imagine being at this landmark 
operation as one attending a “wet clinic” when 
Langenbuch’s memorialist states that he 
“ ...was not an operator of great excellence, but 
much more a careful, thoughtful individual 
who operated with only strong indications, but 
then was sure and courageous, undaunted by 
hindrances and equal to all bad occasions” .
Parts 5 and 6 deal with the advance of sur­
gery into the bile ducts and with reconstruc­
tive surgery of the injured bile duct. Abbe of 
New York (1889) did the first choledochostomy 
for gallstones. William Mayo was the first to 
describe repair of the injured duct. In 1916 he 
stated, “ It is the general experience that inju­
ries to the common and hepatic ducts are 
usually the result of various operative acci­
dents. In the large majority of cases the acci­
dent is not discovered at the time of operation” 
— and this remains true today.
In part 7, Kelly and Noble describe chronic 
pancreatitis, but curiously make no mention 
of alcoholism as a cause. Best and Hicken dis­
cuss papillary stenosis under the term of biliary 
dyssynergia.
Evarts Graham gives an interesting account 
of the discovery of cholecystography (1924) in 
part 8. It is another story of how excellent 
preparation was consummated by good luck, 
and how either alone would not have sufficed. 
Mirizzi of Argentina (1937) introduced oper­
ative cholangiography, and Bean and 
Mahorner of New Orleans (1972) were the first 
to remove stones from the common bile duct 
by means of Dormia baskets introduced 
through the T-tube tract, using a steerable 
angiography catheter. Credit is given to Oti, 
Takemoto and Nakayama (1970) for introduc­
ing fiberduodenoscopy and retrograde cannu- 
lation of the papilla of Vater, but William 
McCune of Washington (1968) and his col­
leagues should actually be given this credit.
This book is a welcome addition to the liter­
ature of surgery of the biliary tract and to the 
history of surgery.
J.E. Mullens, md, frcsc
Assistant secretary-treasurer,
The Canadian Medical Protective Association, 
PO Box 8225,
Ottawa, Ont.
K1G 3H7
Calgary District 
Hospital Group
Trauma Surgeon —  
Director of 
Trauma Care 
Rockyview General 
Hospital
The Rockyview General 
Hospital, a 450 bed active 
treatment hospital serving 
Calgary and Southern Alberta, is 
seeking an individual to become 
Director of our Level 2 Trauma 
Unit. This hospital is a 
progressive, ultramodern facility 
which already participates in 
existing air and ground 
prehospital transport 
Responsibilites to coordinate 
clinical activites of our Trauma 
Unit and assist in the 
development of a regional trauma 
system.
To organize and be responsible 
for ongoing clinical teaching 
programs in trauma and clinical 
research. To play an active role 
in the Department of Surgery and 
head the Division of Truama 
Surgery.
Requirements — Board certified 
General or Thoracic Surgeon with 
special expertise and training in 
trauma surgery. Non-smokers 
preferred.
Replies should be directed to:
The Director of Surgery, 
c/o Rockyview General 
Hospital, 7007 - 14th 
Street S.W., Calgary,
Alberta T2V 1P9.
Calgary District Hospital Group owns 
and operates Rockyview General 
Hospital, Holy Cross Hospital, Colonel 
Belcher Hospital and Peter Lougheed 
General Hospital
-S86-32
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GENERAL SURGEON: ON — with training and ex­
perience in fracture surgery. The opening is avail­
able immediately w ith staff privileges at St. 
Mary's General Hospital, a 184-bed active treat­
ment facility . This is an excellent opportunity to 
establish a practice in a district referral centre, 
w ith  private office space available in a downtown 
professional building. The call schedule is shared 
in cooperation with three other certified general 
surgeons. Canadian certification is required. For 
further information contact: Mrs. Irene Krys, Ex­
ecutive Director, St. Mary's General Hospital, 41 
Pine St. North, Timmins, ON P4N 6K7. Tel.: (705) 
267-2131, ext. 2120 or Dr. Rob Williams, 
Chief of Staff, St. Mary's General Hospital, 
(705) 268-1447 (office). -S 8 6 -2 8
CLINICAL BURN FELLOWSHIP: -  Six months or 
twelve months, Regional Adult Burn Centre, 
Wellesley Hospital beginning January 1, 1987. 
New ten-bed ultra-modern burn centre, 100 burns 
per year. Position totally funded. Clinical research. 
For more information please contact: Dr. Walter 
Peters, Ste. 224, Turner Wing, Wellesley Hospi­
tal. 160 Wellesley St. E., Toronto, ON M4Y 1J3. 
Tel.: (416) 926-7790. -S 8 6 -2 7
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CARDIOVASCULAR & THORACIC SURGEON: AB
— required for a salaried position for a thoracic and 
vascular practice. The candidate should hold 
FRCSC in cardiovascular and thoracic surgery or 
equivalent. As this is a non-cardiac surgical prac­
tice at present, the candidate should have at least 
tw o  years' experience in thoracic surgery and 
demonstrable experience in full-time research. 
Post-fellowship level is essential. The candidate 
should be eligible for a specialist's licence in Al­
berta. Please refer all correspondence to: Dr. S.S. 
Nakai, 214 Academy Place, 11520-100 Ave., Ed­
monton, AB T5K 0J7. -S 8 6 -2 9
GENERAL SURGEON: ON — required to replace 
a general surgeon in the community of Deep River 
situated on the Ottawa River approximately 200 
km from Ottawa. Fully accredited 35-bed active 
treatment hospital with one OR. Practice draws 
from a community population o f 5000 and a 
catchment area of approximately 8000. Current 
medical staff includes four general practitioners 
and one general surgeon. Excellent recreational fa­
cilities. Apply to: Ellen Sills, Chairman, Deep River 
& District Hospital Board, Box 307, Deep River, 
ON K0J 1P0. — S86-30
VASCULAR SURGEON: -  The Division of Vascu­
lar Surgery at the Wellesley Hospital has an open­
ing for a third vascular surgeon. The appointment 
w ill be full time, will carry a university rank, and 
the successful applicant will be expected to car­
ry out teaching and research in addition to clini­
cal activities. The division is accredited by the 
Royal College of Physicians and Surgeons of 
Canada for post-graduate vascular training. The 
Wellesley Hospital is a fully affiliated teaching 
hospital of the University of Toronto w ith 565 ac­
tive beds and a full range of medical and surgical 
services. Applications should be sent imme­
diately to: Dr. John Provan, Surgeon-in-Chief, 
Chief, Division of Vascular Surgery, 160 Welles­
ley St. East, Ste. 217, E.K. Jones Building, Toron­
to, ON M4Y 1J3. —S86-22
MICROSURGICAL COURSE: — The Department 
of Surgery, McMaster University is now offering 
one week, on-going courses in microsurgery, us­
ing animal facilities and videotapes. These courses 
are for anyone interested in small vessel anasto­
mosis, nerve repairs, vas and fallopian tube recon­
structions. The laboratory is organized to guide 
you through the basic microsurgical techniques to 
more advanced tasks with the help of an assis­
tant on a one-to-one basis. Please call: Dr. A. Tho- 
ma at (416) 523-0019 for further information.
— S86-23
POSITION AVAILABLE 
THE HOSPITAL FOR SICK CHILDREN 
TORONTO, CANADA
Applications are invited for a position of staff neu­
rosurgeon in the Division of Neurosurgery, The Hospi­
tal for Sick Children.
The neurosurgical division at The Hospital for Sick 
Children is an active tertiary care unit with 53 beds, 
which carries out 1000 operative procedures per year.
The successful candidate will have an academic ap­
pointment, commensurate with his/her qualifications 
in the Department of Surgery, University of Toronto.
In accordance with Canadian Immigration rules this 
advertisement is directed at Canadian citizens and 
residents.
Applications with curriculum vitae and a list of three 
referees should be forwarded to:
Dr. Harold J. Hoffman 
Neurosurgeon-in-chief 
The Hospital for Sick Children 
555 University Avenue 
Toronto, Canada 
M5G 1X8
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MAKE
YOUR FIRST CHOICE COUNT
PIPRAOL
ANTIBIOTIC THERAPY FOR P.I.D.
(piperacillin sodium)
PIPRACIL"... appears to be both 
efficacious and (relatively) safe for the 
treatment of polymicrobial infections 
encountered in obstetrics and 
gynecology."1 (Gilstrap)
PIPRACIL was found to be the 
most active beta-lactam against 
B. frag His1 (Tally)
PIPRACIL provides highly effec­
tive broad spectrum activity
PIPRACIL offers a high degree of 
clinical safety
PIPRACIL
WHEN YOUR FI RST CHOI CE M U S T  COUNT
C Y A N A M ID  C A N A D A  IN C  #rv ... . . .... . J
Toronto Pipracil is a registered trade mark of Lederle Piperacillin Inc. I CC1 p I F o r  p r e s c r ib i n g  i n f o r m a t i o n  s e e  p a g e  4 3 4
S FTGLT
Better than catgut — but still catgut
Meet some members 
of our family
Flic third generation of 
n< >nabs< >rbnhle m< >n< >filnment 
sutures has just begun...
SKIN STAPLER
JW  No hang ups!
Staples are now
. t B  /  immediately, automatically 
and completely released 
regardless of direction of 
y  \  stapler movement.
.from the tH-G wound closure system
Davis +  Geek Introduces
S HOT
you’re used to 
without 
the problems 
you’re used to
You told us that you liked using catgut but you didn’t like its 
problems- So we took catgut and made it
• soft and supple 
.  easy to tie
> less likely to curl, "pigtail’' and tangle
• easy to handle and control
DEXON* PLUS
Excellent knot security plus superior handling 
and smoother tissue passage.
quality products from
The New Standard of Excellence
P
DAVIS+GECK A TRADITION OF INNOVATION
Cyanamid Canada Inc. Atria North, 2255 Sheppard Avenue East, Willowdale, (Ontario) M2J 4Y5
•Registered Trademark of Cyanamid Canada Inc.
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